BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= 017678
(368 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|B Chain B, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|C Chain C, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|D Chain D, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIC|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OID|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
Length = 301
Score = 67.8 bits (164), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 42/105 (40%), Positives = 61/105 (58%), Gaps = 11/105 (10%)
Query: 260 SFKYETLEKATNYFNP------SKKLGQGGAGSVYMGSLPNGTTVAVKRLI----FNTRQ 309
SF + L+ TN F+ K+G+GG G VY G + N TTVAVK+L T +
Sbjct: 8 SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEE 66
Query: 310 WVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSL 354
+F E+ +++ +H+NLV+LLG S +G + LVY Y+PN SL
Sbjct: 67 LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL 111
>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4
pdb|2NRU|B Chain B, Crystal Structure Of Irak-4
pdb|2NRU|C Chain C, Crystal Structure Of Irak-4
pdb|2NRU|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 67.8 bits (164), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 42/105 (40%), Positives = 61/105 (58%), Gaps = 11/105 (10%)
Query: 260 SFKYETLEKATNYFNP------SKKLGQGGAGSVYMGSLPNGTTVAVKRLI----FNTRQ 309
SF + L+ TN F+ K+G+GG G VY G + N TTVAVK+L T +
Sbjct: 14 SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEE 72
Query: 310 WVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSL 354
+F E+ +++ +H+NLV+LLG S +G + LVY Y+PN SL
Sbjct: 73 LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL 117
>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4
pdb|2NRY|B Chain B, Crystal Structure Of Irak-4
pdb|2NRY|C Chain C, Crystal Structure Of Irak-4
pdb|2NRY|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 67.8 bits (164), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 42/105 (40%), Positives = 61/105 (58%), Gaps = 11/105 (10%)
Query: 260 SFKYETLEKATNYFNP------SKKLGQGGAGSVYMGSLPNGTTVAVKRLI----FNTRQ 309
SF + L+ TN F+ K+G+GG G VY G + N TTVAVK+L T +
Sbjct: 14 SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEE 72
Query: 310 WVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSL 354
+F E+ +++ +H+NLV+LLG S +G + LVY Y+PN SL
Sbjct: 73 LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL 117
>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|D Chain D, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|G Chain G, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|H Chain H, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
Length = 349
Score = 65.1 bits (157), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 40/95 (42%), Positives = 55/95 (57%), Gaps = 1/95 (1%)
Query: 261 FKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVD-EFFNEVN 319
F L+ A++ F+ LG+GG G VY G L +GT VAVKRL Q + +F EV
Sbjct: 28 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTEVE 87
Query: 320 LISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSL 354
+IS H+NL++L G + E LLVY Y+ N S+
Sbjct: 88 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 122
>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain
pdb|2O8Y|B Chain B, Apo Irak4 Kinase Domain
Length = 298
Score = 64.3 bits (155), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 42/105 (40%), Positives = 58/105 (55%), Gaps = 11/105 (10%)
Query: 260 SFKYETLEKATNYFNP------SKKLGQGGAGSVYMGSLPNGTTVAVKRLI----FNTRQ 309
SF + L+ TN F+ K G+GG G VY G + N TTVAVK+L T +
Sbjct: 5 SFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEE 63
Query: 310 WVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSL 354
+F E+ + + +H+NLV+LLG S +G + LVY Y PN SL
Sbjct: 64 LKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSL 108
>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On
Plant Receptor- Like Kinase Bak1 Activation
pdb|3ULZ|A Chain A, Crystal Structure Of Apo Bak1
Length = 326
Score = 62.0 bits (149), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 39/95 (41%), Positives = 53/95 (55%), Gaps = 1/95 (1%)
Query: 261 FKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVD-EFFNEVN 319
F L+ A++ F LG+GG G VY G L +G VAVKRL Q + +F EV
Sbjct: 20 FSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTEVE 79
Query: 320 LISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSL 354
+IS H+NL++L G + E LLVY Y+ N S+
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 114
>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By
Bacterial Effector Protein Avrpto
Length = 321
Score = 55.1 bits (131), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 37/98 (37%), Positives = 58/98 (59%)
Query: 266 LEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIE 325
LE+ATN F+ +G G G VY G L +G VA+KR + Q ++EF E+ +S
Sbjct: 34 LEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCR 93
Query: 326 HKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFGNCL 363
H +LV L+G E E +L+Y+Y+ N +L + ++G+ L
Sbjct: 94 HPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDL 131
>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|B Chain B, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|C Chain C, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|D Chain D, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
Length = 327
Score = 55.1 bits (131), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 37/98 (37%), Positives = 58/98 (59%)
Query: 266 LEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIE 325
LE+ATN F+ +G G G VY G L +G VA+KR + Q ++EF E+ +S
Sbjct: 34 LEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCR 93
Query: 326 HKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFGNCL 363
H +LV L+G E E +L+Y+Y+ N +L + ++G+ L
Sbjct: 94 HPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDL 131
>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
Gleevec
pdb|3HMI|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
5-Amino-3-{[4-
(Aminosulfonyl)phenyl]amino}-N-(2,
6-Difluorophenyl)-1h-1,2,4- Triazole-1-Carbothioamide
pdb|2XYN|A Chain A, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|B Chain B, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|C Chain C, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
Length = 292
Score = 53.1 bits (126), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 35/83 (42%), Positives = 50/83 (60%), Gaps = 4/83 (4%)
Query: 278 KLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLG-C 335
KLG G G VY+G TVAVK L +T + V+EF E ++ I+H NLV+LLG C
Sbjct: 39 KLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 97
Query: 336 SIEGPESLLVYEYVPNRSLDQFI 358
++E P +V EY+P +L ++
Sbjct: 98 TLE-PPFYIVTEYMPYGNLLDYL 119
>pdb|3A4O|X Chain X, Lyn Kinase Domain
Length = 286
Score = 49.7 bits (117), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 30/82 (36%), Positives = 41/82 (50%), Gaps = 1/82 (1%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
K+LG G G V+MG N T VAVK L T V F E NL+ +++H LV+L
Sbjct: 19 KRLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRLYAVV 77
Query: 337 IEGPESLLVYEYVPNRSLDQFI 358
++ EY+ SL F+
Sbjct: 78 TREEPIYIITEYMAKGSLLDFL 99
>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
pdb|3QRJ|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
Length = 277
Score = 49.3 bits (116), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 36/99 (36%), Positives = 48/99 (48%), Gaps = 4/99 (4%)
Query: 252 TSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQW 310
TSM S S Y+ E KLG G G VY G TVAVK L +T +
Sbjct: 1 TSMDPS--SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME- 57
Query: 311 VDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV 349
V+EF E ++ I+H NLV+LLG P ++ E++
Sbjct: 58 VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFM 96
>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form
pdb|2ZV8|A Chain A, Lyn Tyrosine Kinase Domain-Amp-Pnp Complex
pdb|2ZV9|A Chain A, Lyn Tyrosine Kinase Domain-Pp2 Complex
pdb|2ZVA|A Chain A, Lyn Tyrosine Kinase Domain-dasatinib Complex
Length = 279
Score = 49.3 bits (116), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 30/82 (36%), Positives = 42/82 (51%), Gaps = 1/82 (1%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
KKLG G G V+MG N T VAVK L T V F E NL+ +++H LV+L
Sbjct: 18 KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRLYAVV 76
Query: 337 IEGPESLLVYEYVPNRSLDQFI 358
+ ++ E++ SL F+
Sbjct: 77 TKEEPIYIITEFMAKGSLLDFL 98
>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRI|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRK|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dp- 987
Length = 277
Score = 49.3 bits (116), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 36/99 (36%), Positives = 48/99 (48%), Gaps = 4/99 (4%)
Query: 252 TSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQW 310
TSM S S Y+ E KLG G G VY G TVAVK L +T +
Sbjct: 1 TSMDPS--SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME- 57
Query: 311 VDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYV 349
V+EF E ++ I+H NLV+LLG P ++ E++
Sbjct: 58 VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 96
>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck
In Complex With Non-selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 48.9 bits (115), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 30/82 (36%), Positives = 44/82 (53%), Gaps = 2/82 (2%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
++LG G AG V+MG T VAVK L + D F E NL+ ++H+ LV+L
Sbjct: 19 ERLGAGQAGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 337 IEGPESLLVYEYVPNRSLDQFI 358
+ P ++ EY+ N SL F+
Sbjct: 78 TQEP-IYIITEYMENGSLVDFL 98
>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|C Chain C, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|D Chain D, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|3UE4|A Chain A, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
pdb|3UE4|B Chain B, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
Length = 287
Score = 48.5 bits (114), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 32/92 (34%), Positives = 45/92 (48%), Gaps = 2/92 (2%)
Query: 259 LSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNE 317
+S Y+ E KLG G G VY G TVAVK L +T + V+EF E
Sbjct: 3 MSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKE 61
Query: 318 VNLISSIEHKNLVKLLGCSIEGPESLLVYEYV 349
++ I+H NLV+LLG P ++ E++
Sbjct: 62 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 93
>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2F|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
Length = 287
Score = 48.5 bits (114), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 32/92 (34%), Positives = 45/92 (48%), Gaps = 2/92 (2%)
Query: 259 LSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNE 317
+S Y+ E KLG G G VY G TVAVK L +T + V+EF E
Sbjct: 3 MSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKE 61
Query: 318 VNLISSIEHKNLVKLLGCSIEGPESLLVYEYV 349
++ I+H NLV+LLG P ++ E++
Sbjct: 62 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 93
>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant
Abl Mutant In Complex With The Aurora Kinase Inhibitor
Vx-680
Length = 287
Score = 48.5 bits (114), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 32/92 (34%), Positives = 45/92 (48%), Gaps = 2/92 (2%)
Query: 259 LSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNE 317
+S Y+ E KLG G G VY G TVAVK L +T + V+EF E
Sbjct: 2 MSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKE 60
Query: 318 VNLISSIEHKNLVKLLGCSIEGPESLLVYEYV 349
++ I+H NLV+LLG P ++ E++
Sbjct: 61 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 92
>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082
pdb|2HZ0|B Chain B, Abl Kinase Domain In Complex With Nvp-Aeg082
Length = 270
Score = 48.1 bits (113), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 32/92 (34%), Positives = 45/92 (48%), Gaps = 2/92 (2%)
Query: 259 LSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNE 317
+S Y+ E KLG G G VY G TVAVK L +T + V+EF E
Sbjct: 1 VSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKE 59
Query: 318 VNLISSIEHKNLVKLLGCSIEGPESLLVYEYV 349
++ I+H NLV+LLG P ++ E++
Sbjct: 60 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 91
>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|B Chain B, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|C Chain C, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|D Chain D, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HZ4|A Chain A, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|B Chain B, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|C Chain C, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
Length = 273
Score = 48.1 bits (113), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 32/92 (34%), Positives = 45/92 (48%), Gaps = 2/92 (2%)
Query: 259 LSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNE 317
+S Y+ E KLG G G VY G TVAVK L +T + V+EF E
Sbjct: 1 VSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKE 59
Query: 318 VNLISSIEHKNLVKLLGCSIEGPESLLVYEYV 349
++ I+H NLV+LLG P ++ E++
Sbjct: 60 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 91
>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound
With Ppy-A
pdb|3IK3|A Chain A, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
pdb|3IK3|B Chain B, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
Length = 288
Score = 47.8 bits (112), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 32/91 (35%), Positives = 44/91 (48%), Gaps = 2/91 (2%)
Query: 260 SFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEV 318
S Y+ E KLG G G VY G TVAVK L +T + V+EF E
Sbjct: 2 SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEA 60
Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYV 349
++ I+H NLV+LLG P ++ E++
Sbjct: 61 AVMKEIKHPNLVQLLGVCTREPPFYIIIEFM 91
>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
pdb|3OY3|B Chain B, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
Length = 284
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 32/91 (35%), Positives = 44/91 (48%), Gaps = 2/91 (2%)
Query: 260 SFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEV 318
S Y+ E KLG G G VY G TVAVK L +T + V+EF E
Sbjct: 2 SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEA 60
Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYV 349
++ I+H NLV+LLG P ++ E++
Sbjct: 61 AVMKEIKHPNLVQLLGVCTREPPFYIIIEFM 91
>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970
pdb|2HZI|B Chain B, Abl Kinase Domain In Complex With Pd180970
pdb|3CS9|A Chain A, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|B Chain B, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|C Chain C, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|D Chain D, Human Abl Kinase In Complex With Nilotinib
Length = 277
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 32/91 (35%), Positives = 44/91 (48%), Gaps = 2/91 (2%)
Query: 260 SFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEV 318
S Y+ E KLG G G VY G TVAVK L +T + V+EF E
Sbjct: 6 SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEA 64
Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYV 349
++ I+H NLV+LLG P ++ E++
Sbjct: 65 AVMKEIKHPNLVQLLGVCTREPPFYIITEFM 95
>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
pdb|2GQG|B Chain B, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
Length = 278
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 32/91 (35%), Positives = 44/91 (48%), Gaps = 2/91 (2%)
Query: 260 SFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEV 318
S Y+ E KLG G G VY G TVAVK L +T + V+EF E
Sbjct: 7 SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEA 65
Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYV 349
++ I+H NLV+LLG P ++ E++
Sbjct: 66 AVMKEIKHPNLVQLLGVCTREPPFYIITEFM 96
>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1FPU|B Chain B, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1IEP|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1IEP|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1M52|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1M52|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1OPJ|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPJ|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|2HZN|A Chain A, Abl Kinase Domain In Complex With Nvp-Afg210
pdb|3K5V|A Chain A, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3K5V|B Chain B, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3MS9|A Chain A, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MS9|B Chain B, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MSS|A Chain A, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|B Chain B, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|C Chain C, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|D Chain D, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
Length = 293
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 32/91 (35%), Positives = 44/91 (48%), Gaps = 2/91 (2%)
Query: 260 SFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEV 318
S Y+ E KLG G G VY G TVAVK L +T + V+EF E
Sbjct: 7 SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEA 65
Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYV 349
++ I+H NLV+LLG P ++ E++
Sbjct: 66 AVMKEIKHPNLVQLLGVCTREPPFYIITEFM 96
>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|2QOH|B Chain B, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|3KF4|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KF4|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
Length = 288
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 32/91 (35%), Positives = 44/91 (48%), Gaps = 2/91 (2%)
Query: 260 SFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEV 318
S Y+ E KLG G G VY G TVAVK L +T + V+EF E
Sbjct: 2 SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEA 60
Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYV 349
++ I+H NLV+LLG P ++ E++
Sbjct: 61 AVMKEIKHPNLVQLLGVCTREPPFYIITEFM 91
>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
pdb|2V7A|B Chain B, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
Length = 286
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 32/91 (35%), Positives = 44/91 (48%), Gaps = 2/91 (2%)
Query: 260 SFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEV 318
S Y+ E KLG G G VY G TVAVK L +T + V+EF E
Sbjct: 3 SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEA 61
Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYV 349
++ I+H NLV+LLG P ++ E++
Sbjct: 62 AVMKEIKHPNLVQLLGVCTREPPFYIIIEFM 92
>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A
Dfg-Out Inhibitor Ap24534
Length = 284
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 32/91 (35%), Positives = 44/91 (48%), Gaps = 2/91 (2%)
Query: 260 SFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEV 318
S Y+ E KLG G G VY G TVAVK L +T + V+EF E
Sbjct: 2 SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEA 60
Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYV 349
++ I+H NLV+LLG P ++ E++
Sbjct: 61 AVMKEIKHPNLVQLLGVCTREPPFYIITEFM 91
>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
pdb|2E2B|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
Length = 293
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 32/91 (35%), Positives = 44/91 (48%), Gaps = 2/91 (2%)
Query: 260 SFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEV 318
S Y+ E KLG G G VY G TVAVK L +T + V+EF E
Sbjct: 7 SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEA 65
Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYV 349
++ I+H NLV+LLG P ++ E++
Sbjct: 66 AVMKEIKHPNLVQLLGVCTREPPFYIITEFM 96
>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
pdb|2HIW|B Chain B, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
Length = 287
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 31/88 (35%), Positives = 43/88 (48%), Gaps = 2/88 (2%)
Query: 263 YETLEKATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEVNLI 321
Y+ E KLG G G VY G TVAVK L +T + V+EF E ++
Sbjct: 7 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVM 65
Query: 322 SSIEHKNLVKLLGCSIEGPESLLVYEYV 349
I+H NLV+LLG P ++ E++
Sbjct: 66 KEIKHPNLVQLLGVCTREPPFYIITEFM 93
>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK7|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 277
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 29/73 (39%), Positives = 40/73 (54%), Gaps = 2/73 (2%)
Query: 278 KLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
KLG G G VY G TVAVK L +T + V+EF E ++ I+H NLV+LLG
Sbjct: 18 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 76
Query: 337 IEGPESLLVYEYV 349
P ++ E++
Sbjct: 77 TREPPFYIIIEFM 89
>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
pdb|3PYY|B Chain B, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
Length = 298
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 32/91 (35%), Positives = 44/91 (48%), Gaps = 2/91 (2%)
Query: 260 SFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEV 318
S Y+ E KLG G G VY G TVAVK L +T + V+EF E
Sbjct: 15 SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEA 73
Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYV 349
++ I+H NLV+LLG P ++ E++
Sbjct: 74 AVMKEIKHPNLVQLLGVCTREPPFYIITEFM 104
>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK3|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 29/73 (39%), Positives = 40/73 (54%), Gaps = 2/73 (2%)
Query: 278 KLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
KLG G G VY G TVAVK L +T + V+EF E ++ I+H NLV+LLG
Sbjct: 18 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 76
Query: 337 IEGPESLLVYEYV 349
P ++ E++
Sbjct: 77 TREPPFYIITEFM 89
>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 495
Score = 47.0 bits (110), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 32/92 (34%), Positives = 45/92 (48%), Gaps = 2/92 (2%)
Query: 259 LSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNE 317
+S Y+ E KLG G G VY G TVAVK L +T + V+EF E
Sbjct: 208 VSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKE 266
Query: 318 VNLISSIEHKNLVKLLGCSIEGPESLLVYEYV 349
++ I+H NLV+LLG P ++ E++
Sbjct: 267 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 298
>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of
The Tyrosine Kinase Ack1
pdb|1U46|B Chain B, Crystal Structure Of The Unphosphorylated Kinase Domain Of
The Tyrosine Kinase Ack1
pdb|1U4D|A Chain A, Structure Of The Ack1 Kinase Domain Bound To
Debromohymenialdisine
pdb|1U4D|B Chain B, Structure Of The Ack1 Kinase Domain Bound To
Debromohymenialdisine
pdb|1U54|B Chain B, Crystal Structures Of The Phosphorylated And
Unphosphorylated Kinase Domains Of The Cdc42-Associated
Tyrosine Kinase Ack1 Bound To Amp-Pcp
Length = 291
Score = 47.0 bits (110), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 30/85 (35%), Positives = 46/85 (54%), Gaps = 8/85 (9%)
Query: 277 KKLGQGGAGSVYMGSL--PNGTTVAV-----KRLIFNTRQWVDEFFNEVNLISSIEHKNL 329
+KLG G G V G P+G TV+V K + + + +D+F EVN + S++H+NL
Sbjct: 24 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSL 354
++L G + P +V E P SL
Sbjct: 84 IRLYGVVLTPPMK-MVTELAPLGSL 107
>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And
Unphosphorylated Kinase Domains Of The Cdc42-Associated
Tyrosine Kinase Ack1 Bound To Amp-Pcp
Length = 291
Score = 47.0 bits (110), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 30/85 (35%), Positives = 46/85 (54%), Gaps = 8/85 (9%)
Query: 277 KKLGQGGAGSVYMGSL--PNGTTVAV-----KRLIFNTRQWVDEFFNEVNLISSIEHKNL 329
+KLG G G V G P+G TV+V K + + + +D+F EVN + S++H+NL
Sbjct: 24 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSL 354
++L G + P +V E P SL
Sbjct: 84 IRLYGVVLTPPMK-MVTELAPLGSL 107
>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95
pdb|3EQP|A Chain A, Crystal Structure Of Ack1 With Compound T95
pdb|3EQR|A Chain A, Crystal Structure Of Ack1 With Compound T74
pdb|3EQR|B Chain B, Crystal Structure Of Ack1 With Compound T74
Length = 276
Score = 47.0 bits (110), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 30/85 (35%), Positives = 46/85 (54%), Gaps = 8/85 (9%)
Query: 277 KKLGQGGAGSVYMGSL--PNGTTVAV-----KRLIFNTRQWVDEFFNEVNLISSIEHKNL 329
+KLG G G V G P+G TV+V K + + + +D+F EVN + S++H+NL
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSL 354
++L G + P +V E P SL
Sbjct: 74 IRLYGVVLTPPMK-MVTELAPLGSL 97
>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPL|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 537
Score = 47.0 bits (110), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 32/92 (34%), Positives = 45/92 (48%), Gaps = 2/92 (2%)
Query: 259 LSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNE 317
+S Y+ E KLG G G VY G TVAVK L +T + V+EF E
Sbjct: 247 VSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKE 305
Query: 318 VNLISSIEHKNLVKLLGCSIEGPESLLVYEYV 349
++ I+H NLV+LLG P ++ E++
Sbjct: 306 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 337
>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor
pdb|4EWH|A Chain A, Co-Crystal Structure Of Ack1 With Inhibitor
Length = 275
Score = 47.0 bits (110), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 30/85 (35%), Positives = 46/85 (54%), Gaps = 8/85 (9%)
Query: 277 KKLGQGGAGSVYMGSL--PNGTTVAV-----KRLIFNTRQWVDEFFNEVNLISSIEHKNL 329
+KLG G G V G P+G TV+V K + + + +D+F EVN + S++H+NL
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSL 354
++L G + P +V E P SL
Sbjct: 74 IRLYGVVLTPPMK-MVTELAPLGSL 97
>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain
pdb|4HZR|B Chain B, Crystal Structure Of Ack1 Kinase Domain
Length = 277
Score = 47.0 bits (110), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 30/85 (35%), Positives = 46/85 (54%), Gaps = 8/85 (9%)
Query: 277 KKLGQGGAGSVYMGSL--PNGTTVAV-----KRLIFNTRQWVDEFFNEVNLISSIEHKNL 329
+KLG G G V G P+G TV+V K + + + +D+F EVN + S++H+NL
Sbjct: 18 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSL 354
++L G + P +V E P SL
Sbjct: 78 IRLYGVVLTPPMK-MVTELAPLGSL 101
>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor
Cis-3-[8-amino-1-(4-
Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol
Length = 273
Score = 47.0 bits (110), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 30/85 (35%), Positives = 46/85 (54%), Gaps = 8/85 (9%)
Query: 277 KKLGQGGAGSVYMGSL--PNGTTVAV-----KRLIFNTRQWVDEFFNEVNLISSIEHKNL 329
+KLG G G V G P+G TV+V K + + + +D+F EVN + S++H+NL
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSL 354
++L G + P +V E P SL
Sbjct: 74 IRLYGVVLTPPMK-MVTELAPLGSL 97
>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
pdb|4AQC|B Chain B, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
Length = 301
Score = 47.0 bits (110), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 52/89 (58%), Gaps = 7/89 (7%)
Query: 277 KKLGQGGAGSVYM---GSLPN--GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
++LG+G GSV M L + G VAVK+L +T + + +F E+ ++ S++H N+VK
Sbjct: 22 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 81
Query: 332 LLG-CSIEGPESL-LVYEYVPNRSLDQFI 358
G C G +L L+ EY+P SL ++
Sbjct: 82 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL 110
>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK6|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 47.0 bits (110), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 29/73 (39%), Positives = 40/73 (54%), Gaps = 2/73 (2%)
Query: 278 KLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
KLG G G VY G TVAVK L +T + V+EF E ++ I+H NLV+LLG
Sbjct: 18 KLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 76
Query: 337 IEGPESLLVYEYV 349
P ++ E++
Sbjct: 77 TREPPFYIITEFM 89
>pdb|2FO0|A Chain A, Organization Of The Sh3-Sh2 Unit In Active And Inactive
Forms Of The C-Abl Tyrosine Kinase
Length = 495
Score = 47.0 bits (110), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 32/92 (34%), Positives = 45/92 (48%), Gaps = 2/92 (2%)
Query: 259 LSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNE 317
+S Y+ E KLG G G VY G TVAVK L +T + V+EF E
Sbjct: 205 VSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKE 263
Query: 318 VNLISSIEHKNLVKLLGCSIEGPESLLVYEYV 349
++ I+H NLV+LLG P ++ E++
Sbjct: 264 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 295
>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain
pdb|2XA4|B Chain B, Inhibitors Of Jak2 Kinase Domain
Length = 298
Score = 47.0 bits (110), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 52/89 (58%), Gaps = 7/89 (7%)
Query: 277 KKLGQGGAGSVYM---GSLPN--GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
++LG+G GSV M L + G VAVK+L +T + + +F E+ ++ S++H N+VK
Sbjct: 19 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 332 LLG-CSIEGPESL-LVYEYVPNRSLDQFI 358
G C G +L L+ EY+P SL ++
Sbjct: 79 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL 107
>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1I|B Chain B, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 326
Score = 47.0 bits (110), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 52/89 (58%), Gaps = 7/89 (7%)
Query: 277 KKLGQGGAGSVYM---GSLPN--GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
++LG+G GSV M L + G VAVK+L +T + + +F E+ ++ S++H N+VK
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 332 LLG-CSIEGPESL-LVYEYVPNRSLDQFI 358
G C G +L L+ EY+P SL ++
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL 135
>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|B Chain B, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|C Chain C, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|D Chain D, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
Length = 341
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 30/85 (35%), Positives = 46/85 (54%), Gaps = 8/85 (9%)
Query: 277 KKLGQGGAGSVYMGSL--PNGTTVAV-----KRLIFNTRQWVDEFFNEVNLISSIEHKNL 329
+KLG G G V G P+G TV+V K + + + +D+F EVN + S++H+NL
Sbjct: 18 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSL 354
++L G + P +V E P SL
Sbjct: 78 IRLYGVVLTPPMK-MVTELAPLGSL 101
>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
pdb|4HGE|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
Length = 300
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 52/89 (58%), Gaps = 7/89 (7%)
Query: 277 KKLGQGGAGSVYM---GSLPN--GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
++LG+G GSV M L + G VAVK+L +T + + +F E+ ++ S++H N+VK
Sbjct: 21 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 80
Query: 332 LLG-CSIEGPESL-LVYEYVPNRSLDQFI 358
G C G +L L+ EY+P SL ++
Sbjct: 81 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL 109
>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A
1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor
Length = 303
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 52/89 (58%), Gaps = 7/89 (7%)
Query: 277 KKLGQGGAGSVYM---GSLPN--GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
++LG+G GSV M L + G VAVK+L +T + + +F E+ ++ S++H N+VK
Sbjct: 20 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 79
Query: 332 LLG-CSIEGPESL-LVYEYVPNRSLDQFI 358
G C G +L L+ EY+P SL ++
Sbjct: 80 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL 108
>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|D Chain D, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|E Chain E, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4F08|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F08|B Chain B, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F09|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
Length = 302
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 52/89 (58%), Gaps = 7/89 (7%)
Query: 277 KKLGQGGAGSVYM---GSLPN--GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
++LG+G GSV M L + G VAVK+L +T + + +F E+ ++ S++H N+VK
Sbjct: 23 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 82
Query: 332 LLG-CSIEGPESL-LVYEYVPNRSLDQFI 358
G C G +L L+ EY+P SL ++
Sbjct: 83 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL 111
>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
pdb|3Q32|B Chain B, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
Length = 301
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 52/89 (58%), Gaps = 7/89 (7%)
Query: 277 KKLGQGGAGSVYM---GSLPN--GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
++LG+G GSV M L + G VAVK+L +T + + +F E+ ++ S++H N+VK
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 332 LLG-CSIEGPESL-LVYEYVPNRSLDQFI 358
G C G +L L+ EY+P SL ++
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL 104
>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJC|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJD|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 19
pdb|3TJD|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 19
Length = 298
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 52/89 (58%), Gaps = 7/89 (7%)
Query: 277 KKLGQGGAGSVYM---GSLPN--GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
++LG+G GSV M L + G VAVK+L +T + + +F E+ ++ S++H N+VK
Sbjct: 19 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 332 LLG-CSIEGPESL-LVYEYVPNRSLDQFI 358
G C G +L L+ EY+P SL ++
Sbjct: 79 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL 107
>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|2B7A|B Chain B, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|3FUP|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3FUP|B Chain B, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 293
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 52/89 (58%), Gaps = 7/89 (7%)
Query: 277 KKLGQGGAGSVYM---GSLPN--GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
++LG+G GSV M L + G VAVK+L +T + + +F E+ ++ S++H N+VK
Sbjct: 14 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 73
Query: 332 LLG-CSIEGPESL-LVYEYVPNRSLDQFI 358
G C G +L L+ EY+P SL ++
Sbjct: 74 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL 102
>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E63|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E64|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
Length = 293
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 52/89 (58%), Gaps = 7/89 (7%)
Query: 277 KKLGQGGAGSVYM---GSLPN--GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
++LG+G GSV M L + G VAVK+L +T + + +F E+ ++ S++H N+VK
Sbjct: 15 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 74
Query: 332 LLG-CSIEGPESL-LVYEYVPNRSLDQFI 358
G C G +L L+ EY+P SL ++
Sbjct: 75 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL 103
>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
Length = 298
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 52/89 (58%), Gaps = 7/89 (7%)
Query: 277 KKLGQGGAGSVYM---GSLPN--GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
++LG+G GSV M L + G VAVK+L +T + + +F E+ ++ S++H N+VK
Sbjct: 17 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 76
Query: 332 LLG-CSIEGPESL-LVYEYVPNRSLDQFI 358
G C G +L L+ EY+P SL ++
Sbjct: 77 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL 105
>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii
Inhibtor Nvp-Bbt594
Length = 295
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 52/89 (58%), Gaps = 7/89 (7%)
Query: 277 KKLGQGGAGSVYM---GSLPN--GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
++LG+G GSV M L + G VAVK+L +T + + +F E+ ++ S++H N+VK
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 332 LLG-CSIEGPESL-LVYEYVPNRSLDQFI 358
G C G +L L+ EY+P SL ++
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL 104
>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3LPB|B Chain B, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3KRR|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
Quinoxaline Atp Site Inhibitor
Length = 295
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 52/89 (58%), Gaps = 7/89 (7%)
Query: 277 KKLGQGGAGSVYM---GSLPN--GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
++LG+G GSV M L + G VAVK+L +T + + +F E+ ++ S++H N+VK
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 332 LLG-CSIEGPESL-LVYEYVPNRSLDQFI 358
G C G +L L+ EY+P SL ++
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL 104
>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3KCK|A Chain A, A Novel Chemotype Of Kinase Inhibitors
Length = 313
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 52/89 (58%), Gaps = 7/89 (7%)
Query: 277 KKLGQGGAGSVYM---GSLPN--GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
++LG+G GSV M L + G VAVK+L +T + + +F E+ ++ S++H N+VK
Sbjct: 34 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 93
Query: 332 LLG-CSIEGPESL-LVYEYVPNRSLDQFI 358
G C G +L L+ EY+P SL ++
Sbjct: 94 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL 122
>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain
pdb|4AT3|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Cpd5n
pdb|4AT4|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Ex429
pdb|4AT5|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Gw2580
Length = 299
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 25/89 (28%), Positives = 49/89 (55%), Gaps = 6/89 (6%)
Query: 276 SKKLGQGGAGSVYMGSLPN------GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNL 329
++LG+G G V++ N VAVK L + +F E L+++++H+++
Sbjct: 18 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 77
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFI 358
VK G +EG ++V+EY+ + L++F+
Sbjct: 78 VKFYGVCVEGDPLIMVFEYMKHGDLNKFL 106
>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors
Length = 311
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 52/89 (58%), Gaps = 7/89 (7%)
Query: 277 KKLGQGGAGSVYM---GSLPN--GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
++LG+G GSV M L + G VAVK+L +T + + +F E+ ++ S++H N+VK
Sbjct: 34 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 93
Query: 332 LLG-CSIEGPESL-LVYEYVPNRSLDQFI 358
G C G +L L+ EY+P SL ++
Sbjct: 94 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL 122
>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain Complexed With Imatinib
pdb|3OEZ|B Chain B, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain Complexed With Imatinib
pdb|3OF0|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain
pdb|3OF0|B Chain B, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain
pdb|3QLF|A Chain A, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Pyrazolopyrimidine
5
pdb|3QLF|B Chain B, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Pyrazolopyrimidine
5
pdb|3QLG|A Chain A, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Dasatinib
pdb|3QLG|B Chain B, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Dasatinib
Length = 286
Score = 46.2 bits (108), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 31/84 (36%), Positives = 42/84 (50%), Gaps = 2/84 (2%)
Query: 278 KLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
KLGQG G V+MG+ T VA+K L T + F E ++ I H+ LV+L
Sbjct: 25 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKIRHEKLVQLYAVVS 83
Query: 338 EGPESLLVYEYVPNRSLDQFIFGN 361
E P +V EY+ SL F+ G
Sbjct: 84 EEP-IYIVTEYMSKGSLLDFLKGE 106
>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6D|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6Q|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
pdb|4E6Q|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
Length = 298
Score = 46.2 bits (108), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 31/89 (34%), Positives = 53/89 (59%), Gaps = 7/89 (7%)
Query: 277 KKLGQGGAGSVYM---GSLPN--GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
++LG+G GSV M L + G VAVK+L +T + + +F E+ ++ S++H N+VK
Sbjct: 19 RQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 332 LLG-CSIEGPESL-LVYEYVPNRSLDQFI 358
G C G +L L+ E++P SL +++
Sbjct: 79 YKGVCYSAGRRNLKLIMEFLPYGSLREYL 107
>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck
pdb|2OF4|A Chain A, Crystal Structure Of Furanopyrimidine 1 Bound To Lck
Length = 271
Score = 46.2 bits (108), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 29/82 (35%), Positives = 43/82 (52%), Gaps = 2/82 (2%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
++LG G G V+MG T VAVK L + D F E NL+ ++H+ LV+L
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 337 IEGPESLLVYEYVPNRSLDQFI 358
+ P ++ EY+ N SL F+
Sbjct: 78 TQEP-IYIITEYMENGSLVDFL 98
>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck),
Activated Form (Auto-Phosphorylated On Tyr394)
pdb|3BYO|A Chain A, X-Ray Co-Crystal Structure Of 2-Amino-6-Phenylpyrimido[5',
4':5,6]pyrimido[1,2-A]benzimidazol-5(6h)-One 25 Bound To
Lck
Length = 271
Score = 45.8 bits (107), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 29/82 (35%), Positives = 43/82 (52%), Gaps = 2/82 (2%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
++LG G G V+MG T VAVK L + D F E NL+ ++H+ LV+L
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 337 IEGPESLLVYEYVPNRSLDQFI 358
+ P ++ EY+ N SL F+
Sbjct: 78 TQEP-IYIITEYMENGSLVDFL 98
>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b
pdb|3BYU|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Reverse
Amide 23
Length = 277
Score = 45.8 bits (107), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 29/82 (35%), Positives = 43/82 (52%), Gaps = 2/82 (2%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
++LG G G V+MG T VAVK L + D F E NL+ ++H+ LV+L
Sbjct: 25 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVV 83
Query: 337 IEGPESLLVYEYVPNRSLDQFI 358
+ P ++ EY+ N SL F+
Sbjct: 84 TQEP-IYIITEYMENGSLVDFL 104
>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1
Bound To Lck
Length = 272
Score = 45.8 bits (107), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 29/82 (35%), Positives = 43/82 (52%), Gaps = 2/82 (2%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
++LG G G V+MG T VAVK L + D F E NL+ ++H+ LV+L
Sbjct: 20 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVV 78
Query: 337 IEGPESLLVYEYVPNRSLDQFI 358
+ P ++ EY+ N SL F+
Sbjct: 79 TQEP-IYIITEYMENGSLVDFL 99
>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|2OFV|B Chain B, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|3B2W|A Chain A, Crystal Structure Of Pyrimidine Amide 11 Bound To Lck
Length = 277
Score = 45.8 bits (107), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 29/82 (35%), Positives = 43/82 (52%), Gaps = 2/82 (2%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
++LG G G V+MG T VAVK L + D F E NL+ ++H+ LV+L
Sbjct: 24 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVV 82
Query: 337 IEGPESLLVYEYVPNRSLDQFI 358
+ P ++ EY+ N SL F+
Sbjct: 83 TQEP-IYIITEYMENGSLVDFL 103
>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
pdb|2OG8|B Chain B, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
Length = 265
Score = 45.8 bits (107), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 29/82 (35%), Positives = 43/82 (52%), Gaps = 2/82 (2%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
++LG G G V+MG T VAVK L + D F E NL+ ++H+ LV+L
Sbjct: 14 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVV 72
Query: 337 IEGPESLLVYEYVPNRSLDQFI 358
+ P ++ EY+ N SL F+
Sbjct: 73 TQEP-IYIITEYMENGSLVDFL 93
>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43
Bound To Lck
Length = 273
Score = 45.8 bits (107), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 29/82 (35%), Positives = 43/82 (52%), Gaps = 2/82 (2%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
++LG G G V+MG T VAVK L + D F E NL+ ++H+ LV+L
Sbjct: 21 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVV 79
Query: 337 IEGPESLLVYEYVPNRSLDQFI 358
+ P ++ EY+ N SL F+
Sbjct: 80 TQEP-IYIITEYMENGSLVDFL 100
>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine
Length = 267
Score = 45.8 bits (107), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 29/82 (35%), Positives = 43/82 (52%), Gaps = 2/82 (2%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
++LG G G V+MG T VAVK L + D F E NL+ ++H+ LV+L
Sbjct: 15 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVV 73
Query: 337 IEGPESLLVYEYVPNRSLDQFI 358
+ P ++ EY+ N SL F+
Sbjct: 74 TQEP-IYIITEYMENGSLVDFL 94
>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
pdb|1QPJ|A Chain A, Crystal Structure Of The Lymphocyte-Specific Kinase Lck In
Complex With Staurosporine.
pdb|1QPC|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 45.8 bits (107), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 29/82 (35%), Positives = 43/82 (52%), Gaps = 2/82 (2%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
++LG G G V+MG T VAVK L + D F E NL+ ++H+ LV+L
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 337 IEGPESLLVYEYVPNRSLDQFI 358
+ P ++ EY+ N SL F+
Sbjct: 78 TQEP-IYIITEYMENGSLVDFL 98
>pdb|2PL0|A Chain A, Lck Bound To Imatinib
Length = 289
Score = 45.8 bits (107), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 29/82 (35%), Positives = 43/82 (52%), Gaps = 2/82 (2%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
++LG G G V+MG T VAVK L + D F E NL+ ++H+ LV+L
Sbjct: 29 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVV 87
Query: 337 IEGPESLLVYEYVPNRSLDQFI 358
+ P ++ EY+ N SL F+
Sbjct: 88 TQEP-IYIITEYMENGSLVDFL 108
>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule
Inhibitor
Length = 288
Score = 45.8 bits (107), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 29/82 (35%), Positives = 43/82 (52%), Gaps = 2/82 (2%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
++LG G G V+MG T VAVK L + D F E NL+ ++H+ LV+L
Sbjct: 28 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVV 86
Query: 337 IEGPESLLVYEYVPNRSLDQFI 358
+ P ++ EY+ N SL F+
Sbjct: 87 TQEP-IYIITEYMENGSLVDFL 107
>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule
W259
Length = 287
Score = 45.8 bits (107), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 29/82 (35%), Positives = 43/82 (52%), Gaps = 2/82 (2%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
++LG G G V+MG T VAVK L + D F E NL+ ++H+ LV+L
Sbjct: 27 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVV 85
Query: 337 IEGPESLLVYEYVPNRSLDQFI 358
+ P ++ EY+ N SL F+
Sbjct: 86 TQEP-IYIITEYMENGSLVDFL 106
>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase
Domain Of Human Lck, (Auto-Phosphorylated On Tyr394)
pdb|2ZM4|A Chain A, Crystal Structure Of Imidazo Quinoxaline 1 Bound To The
Kinase Domain Of Human Lck, Activated Form (Auto-
Phosphorylated On Tyr394)
pdb|2ZYB|A Chain A, Crystal Structure Of Phenylimidazo Pyrazin 2 Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC1|A Chain A, Crystal Structure Of Pyrazin Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC2|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC3|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC4|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC5|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC8|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACJ|A Chain A, Crystal Structure Of Imidazo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACK|A Chain A, Crystal Structure Of Pyrrolo Pyrazine Derivative Bound To
The Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD4|A Chain A, Crystal Structure Of Methoxy Benzofuran Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AD5|A Chain A, Crystal Structure Of Triazolone Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD6|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
Length = 285
Score = 45.8 bits (107), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 29/82 (35%), Positives = 43/82 (52%), Gaps = 2/82 (2%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
++LG G G V+MG T VAVK L + D F E NL+ ++H+ LV+L
Sbjct: 25 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVV 83
Query: 337 IEGPESLLVYEYVPNRSLDQFI 358
+ P ++ EY+ N SL F+
Sbjct: 84 TQEP-IYIITEYMENGSLVDFL 104
>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533)
pdb|1YI6|B Chain B, C-Term Tail Segment Of Human Tyrosine Kinase (258-533)
Length = 276
Score = 45.4 bits (106), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 30/84 (35%), Positives = 42/84 (50%), Gaps = 2/84 (2%)
Query: 278 KLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
KLGQG G V+MG+ T VA+K L T + F E ++ + H+ LV+L
Sbjct: 15 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 73
Query: 338 EGPESLLVYEYVPNRSLDQFIFGN 361
E P +V EY+ SL F+ G
Sbjct: 74 EEP-IXIVTEYMSKGSLLDFLKGE 96
>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
pdb|3G6H|B Chain B, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
Length = 286
Score = 45.4 bits (106), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 30/84 (35%), Positives = 42/84 (50%), Gaps = 2/84 (2%)
Query: 278 KLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
KLGQG G V+MG+ T VA+K L T + F E ++ + H+ LV+L
Sbjct: 25 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 338 EGPESLLVYEYVPNRSLDQFIFGN 361
E P +V EY+ SL F+ G
Sbjct: 84 EEP-IYIVIEYMSKGSLLDFLKGE 106
>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|B Chain B, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|C Chain C, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|D Chain D, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
Length = 286
Score = 45.4 bits (106), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 30/84 (35%), Positives = 42/84 (50%), Gaps = 2/84 (2%)
Query: 278 KLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
KLGQG G V+MG+ T VA+K L T + F E ++ + H+ LV+L
Sbjct: 25 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 338 EGPESLLVYEYVPNRSLDQFIFGN 361
E P +V EY+ SL F+ G
Sbjct: 84 EEP-IYIVIEYMSKGSLLDFLKGE 106
>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3D7U|D Chain D, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 277
Score = 45.4 bits (106), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 30/84 (35%), Positives = 42/84 (50%), Gaps = 2/84 (2%)
Query: 278 KLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
KLGQG G V+MG+ T VA+K L T + F E ++ + H+ LV+L
Sbjct: 16 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 74
Query: 338 EGPESLLVYEYVPNRSLDQFIFGN 361
E P +V EY+ SL F+ G
Sbjct: 75 EEP-IYIVTEYMSKGSLLDFLKGE 97
>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase
Activity
pdb|3GEQ|B Chain B, Structural Basis For The Chemical Rescue Of Src Kinase
Activity
Length = 286
Score = 45.4 bits (106), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 30/84 (35%), Positives = 42/84 (50%), Gaps = 2/84 (2%)
Query: 278 KLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
KLGQG G V+MG+ T VA+K L T + F E ++ + H+ LV+L
Sbjct: 25 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 338 EGPESLLVYEYVPNRSLDQFIFGN 361
E P +V EY+ SL F+ G
Sbjct: 84 EEP-IYIVTEYMSKGSLLDFLKGE 106
>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An
Inhibitor
Length = 452
Score = 45.4 bits (106), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 30/84 (35%), Positives = 42/84 (50%), Gaps = 2/84 (2%)
Query: 278 KLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
KLGQG G V+MG+ T VA+K L T + F E ++ + H+ LV+L
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 338 EGPESLLVYEYVPNRSLDQFIFGN 361
E P +V EY+ SL F+ G
Sbjct: 250 EEP-IYIVTEYMSKGSLLDFLKGE 272
>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In
Complex With The Cancer Drug Imatinib.
pdb|2OIQ|B Chain B, Crystal Structure Of Chicken C-Src Kinase Domain In
Complex With The Cancer Drug Imatinib.
pdb|3D7T|B Chain B, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3DQX|A Chain A, Chicken C-Src Kinase Domain In Complex With Atpgs
pdb|3DQX|B Chain B, Chicken C-Src Kinase Domain In Complex With Atpgs
pdb|3EN4|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp121, A Multitargeted
Kinase Inhibitor
pdb|3EN4|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp121, A Multitargeted
Kinase Inhibitor
pdb|3EN5|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp494, A Multitargeted
Kinase Inhibitor
pdb|3EN5|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp494, A Multitargeted
Kinase Inhibitor
pdb|3EN6|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp102, A Multitargeted
Kinase Inhibitor
pdb|3EN6|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp102, A Multitargeted
Kinase Inhibitor
pdb|3EN7|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With S1, A Multitargeted Kinase
Inhibitor
pdb|3EN7|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With S1, A Multitargeted Kinase
Inhibitor
pdb|3EL7|A Chain A, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 3
pdb|3EL8|A Chain A, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 5
pdb|3EL8|B Chain B, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 5
pdb|3F6X|A Chain A, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|B Chain B, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|C Chain C, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|D Chain D, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3G6G|A Chain A, Equally Potent Inhibition Of C-Src And Abl By Compounds
That Recognize Inactive Kinase Conformations
pdb|3G6G|B Chain B, Equally Potent Inhibition Of C-Src And Abl By Compounds
That Recognize Inactive Kinase Conformations
pdb|4AGW|A Chain A, Discovery Of A Small Molecule Type Ii Inhibitor Of Wild-
Type And Gatekeeper Mutants Of Bcr-Abl, Pdgfralpha, Kit,
And Src Kinases
pdb|4AGW|B Chain B, Discovery Of A Small Molecule Type Ii Inhibitor Of Wild-
Type And Gatekeeper Mutants Of Bcr-Abl, Pdgfralpha, Kit,
And Src Kinases
pdb|3UQF|A Chain A, C-Src Kinase Domain In Complex With Bki Rm-1-89
pdb|3UQF|B Chain B, C-Src Kinase Domain In Complex With Bki Rm-1-89
pdb|3UQG|A Chain A, C-Src Kinase Domain In Complex With Bumpless Bki Analog
Uw1243
pdb|3UQG|B Chain B, C-Src Kinase Domain In Complex With Bumpless Bki Analog
Uw1243
pdb|4DGG|A Chain A, C-Src Kinase Domain In Complex With Rm-1-176
pdb|4DGG|B Chain B, C-Src Kinase Domain In Complex With Rm-1-176
Length = 286
Score = 45.4 bits (106), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 30/84 (35%), Positives = 42/84 (50%), Gaps = 2/84 (2%)
Query: 278 KLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
KLGQG G V+MG+ T VA+K L T + F E ++ + H+ LV+L
Sbjct: 25 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 338 EGPESLLVYEYVPNRSLDQFIFGN 361
E P +V EY+ SL F+ G
Sbjct: 84 EEP-IYIVTEYMSKGSLLDFLKGE 106
>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451
pdb|2BDF|B Chain B, Src Kinase In Complex With Inhibitor Ap23451
pdb|2BDJ|A Chain A, Src Kinase In Complex With Inhibitor Ap23464
Length = 279
Score = 45.4 bits (106), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 30/84 (35%), Positives = 42/84 (50%), Gaps = 2/84 (2%)
Query: 278 KLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
KLGQG G V+MG+ T VA+K L T + F E ++ + H+ LV+L
Sbjct: 18 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 76
Query: 338 EGPESLLVYEYVPNRSLDQFIFGN 361
E P +V EY+ SL F+ G
Sbjct: 77 EEP-IYIVTEYMSKGSLLDFLKGE 99
>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc4b
pdb|3U51|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc1
pdb|3U51|B Chain B, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc1
Length = 275
Score = 45.4 bits (106), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 30/84 (35%), Positives = 42/84 (50%), Gaps = 2/84 (2%)
Query: 278 KLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
KLGQG G V+MG+ T VA+K L T + F E ++ + H+ LV+L
Sbjct: 14 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 72
Query: 338 EGPESLLVYEYVPNRSLDQFIFGN 361
E P +V EY+ SL F+ G
Sbjct: 73 EEP-IYIVTEYMSKGSLLDFLKGE 95
>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8)
Length = 325
Score = 45.4 bits (106), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 31/100 (31%), Positives = 50/100 (50%), Gaps = 7/100 (7%)
Query: 265 TLEKATNYFNPSKKLGQGGAGSVYMGSL----PNGTTVAVKRLI--FNTRQWVDEFFNEV 318
T E + + K +G G +G V G L VA+K L + RQ D F +E
Sbjct: 43 TREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRD-FLSEA 101
Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI 358
+++ +H N+++L G G +++V EY+ N SLD F+
Sbjct: 102 SIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL 141
>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8)
Length = 325
Score = 45.1 bits (105), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 31/100 (31%), Positives = 50/100 (50%), Gaps = 7/100 (7%)
Query: 265 TLEKATNYFNPSKKLGQGGAGSVYMGSL----PNGTTVAVKRLI--FNTRQWVDEFFNEV 318
T E + + K +G G +G V G L VA+K L + RQ D F +E
Sbjct: 43 TREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRD-FLSEA 101
Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI 358
+++ +H N+++L G G +++V EY+ N SLD F+
Sbjct: 102 SIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL 141
>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src
pdb|2SRC|A Chain A, Crystal Structure Of Human Tyrosine-protein Kinase C-src,
In Complex With Amp-pnp
Length = 452
Score = 45.1 bits (105), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 30/84 (35%), Positives = 42/84 (50%), Gaps = 2/84 (2%)
Query: 278 KLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
KLGQG G V+MG+ T VA+K L T + F E ++ + H+ LV+L
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 338 EGPESLLVYEYVPNRSLDQFIFGN 361
E P +V EY+ SL F+ G
Sbjct: 250 EEP-IYIVTEYMSKGSLLDFLKGE 272
>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain
Length = 306
Score = 44.7 bits (104), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 26/87 (29%), Positives = 48/87 (55%), Gaps = 6/87 (6%)
Query: 278 KLGQGGAGSVYMGS----LP--NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
+LG+G G V++ LP + VAVK L + +F E L++ ++H+++V+
Sbjct: 25 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 84
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQFI 358
G EG L+V+EY+ + L++F+
Sbjct: 85 FFGVCTEGRPLLMVFEYMRHGDLNRFL 111
>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor
Length = 535
Score = 44.7 bits (104), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 30/85 (35%), Positives = 42/85 (49%), Gaps = 2/85 (2%)
Query: 278 KLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
KLGQG G V+MG+ T VA+K L T + F E ++ + H+ LV+L
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 338 EGPESLLVYEYVPNRSLDQFIFGNC 362
E P +V EY+ SL F+ G
Sbjct: 333 EEP-IYIVTEYMSKGSLLDFLKGET 356
>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain
pdb|1YOJ|B Chain B, Crystal Structure Of Src Kinase Domain
pdb|1YOM|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Purvalanol A
pdb|1YOM|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Purvalanol A
Length = 283
Score = 44.7 bits (104), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 30/84 (35%), Positives = 42/84 (50%), Gaps = 2/84 (2%)
Query: 278 KLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
KLGQG G V+MG+ T VA+K L T + F E ++ + H+ LV+L
Sbjct: 22 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 338 EGPESLLVYEYVPNRSLDQFIFGN 361
E P +V EY+ SL F+ G
Sbjct: 81 EEP-IYIVTEYMNKGSLLDFLKGE 103
>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Cgp77675
pdb|1YOL|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Cgp77675
Length = 283
Score = 44.7 bits (104), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 30/84 (35%), Positives = 42/84 (50%), Gaps = 2/84 (2%)
Query: 278 KLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
KLGQG G V+MG+ T VA+K L T + F E ++ + H+ LV+L
Sbjct: 22 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 338 EGPESLLVYEYVPNRSLDQFIFGN 361
E P +V EY+ SL F+ G
Sbjct: 81 EEP-IYIVTEYMNKGSLLDFLKGE 103
>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka
pdb|4F0I|B Chain B, Crystal Structure Of Apo Trka
Length = 300
Score = 44.7 bits (104), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 26/87 (29%), Positives = 48/87 (55%), Gaps = 6/87 (6%)
Query: 278 KLGQGGAGSVYMGS----LP--NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
+LG+G G V++ LP + VAVK L + +F E L++ ++H+++V+
Sbjct: 19 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 78
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQFI 358
G EG L+V+EY+ + L++F+
Sbjct: 79 FFGVCTEGRPLLMVFEYMRHGDLNRFL 105
>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly
Mutant) In Complex With N6-Benzyl Adp
Length = 452
Score = 44.7 bits (104), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 30/84 (35%), Positives = 42/84 (50%), Gaps = 2/84 (2%)
Query: 278 KLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
KLGQG G V+MG+ T VA+K L T + F E ++ + H+ LV+L
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 338 EGPESLLVYEYVPNRSLDQFIFGN 361
E P +V EY+ SL F+ G
Sbjct: 250 EEP-IYIVGEYMSKGSLLDFLKGE 272
>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To
Vinylsulfonamide- Pyrazolopyrimidine 9
pdb|3SVV|B Chain B, Crystal Structure Of T338c C-Src Covalently Bound To
Vinylsulfonamide- Pyrazolopyrimidine 9
Length = 286
Score = 44.7 bits (104), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 30/84 (35%), Positives = 42/84 (50%), Gaps = 2/84 (2%)
Query: 278 KLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
KLGQG G V+MG+ T VA+K L T + F E ++ + H+ LV+L
Sbjct: 25 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 338 EGPESLLVYEYVPNRSLDQFIFGN 361
E P +V EY+ SL F+ G
Sbjct: 84 EEP-IYIVCEYMSKGSLLDFLKGE 106
>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23
pdb|4AOJ|B Chain B, Human Trka In Complex With The Inhibitor Az-23
pdb|4AOJ|C Chain C, Human Trka In Complex With The Inhibitor Az-23
Length = 329
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 26/87 (29%), Positives = 48/87 (55%), Gaps = 6/87 (6%)
Query: 278 KLGQGGAGSVYMGS----LP--NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVK 331
+LG+G G V++ LP + VAVK L + +F E L++ ++H+++V+
Sbjct: 48 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQFI 358
G EG L+V+EY+ + L++F+
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFL 134
>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound
To Appcp From D. Discoideum
Length = 287
Score = 43.9 bits (102), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 31/90 (34%), Positives = 46/90 (51%), Gaps = 10/90 (11%)
Query: 269 ATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQW-------VDEFFNEVNL 320
A N K++G+GG G V+ G L + + VA+K LI + EF EV +
Sbjct: 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 321 ISSIEHKNLVKLLGCSIEGPESLLVYEYVP 350
+S++ H N+VKL G P +V E+VP
Sbjct: 77 MSNLNHPNIVKLYGLMHNPPR--MVMEFVP 104
>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain
From D. Discoideum Bound To Appcp
Length = 287
Score = 43.9 bits (102), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 31/90 (34%), Positives = 46/90 (51%), Gaps = 10/90 (11%)
Query: 269 ATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQW-------VDEFFNEVNL 320
A N K++G+GG G V+ G L + + VA+K LI + EF EV +
Sbjct: 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 321 ISSIEHKNLVKLLGCSIEGPESLLVYEYVP 350
+S++ H N+VKL G P +V E+VP
Sbjct: 77 MSNLNHPNIVKLYGLMHNPPR--MVMEFVP 104
>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone
Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A
Resolution
pdb|3G2F|B Chain B, Crystal Structure Of The Kinase Domain Of Bone
Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A
Resolution
Length = 336
Score = 43.9 bits (102), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 33/87 (37%), Positives = 48/87 (55%), Gaps = 11/87 (12%)
Query: 279 LGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNL--ISSIEHKNLVKLL--- 333
+G+G G+VY GSL + VAVK F RQ F NE N+ + +EH N+ + +
Sbjct: 21 IGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNIYRVPLMEHDNIARFIVGD 76
Query: 334 -GCSIEGP-ESLLVYEYVPNRSLDQFI 358
+ +G E LLV EY PN SL +++
Sbjct: 77 ERVTADGRMEYLLVMEYYPNGSLXKYL 103
>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To
Appcp From D. Discoideum
pdb|4F0G|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum
pdb|4F1T|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum Bound To The Rock Inhibitor H1152
Length = 287
Score = 43.9 bits (102), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 34/101 (33%), Positives = 51/101 (50%), Gaps = 15/101 (14%)
Query: 269 ATNYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQW-------VDEFFNEVNL 320
A N K++G+GG G V+ G L + + VA+K LI + EF EV +
Sbjct: 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 321 ISSIEHKNLVKLLGCSIEGPESLLVYEYVP-----NRSLDQ 356
+S++ H N+VKL G P +V E+VP +R LD+
Sbjct: 77 MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDK 115
>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
pdb|3P86|B Chain B, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
Length = 309
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 28/85 (32%), Positives = 46/85 (54%), Gaps = 5/85 (5%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLI---FNTRQWVDEFFNEVNLISSIEHKNL 329
N +K+G G G+V+ +G+ VAVK L+ F+ + V+EF EV ++ + H N+
Sbjct: 39 LNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAER-VNEFLREVAIMKRLRHPNI 96
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSL 354
V +G + P +V EY+ SL
Sbjct: 97 VLFMGAVTQPPNLSIVTEYLSRGSL 121
>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
pdb|3PPZ|B Chain B, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
Length = 309
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 28/85 (32%), Positives = 46/85 (54%), Gaps = 5/85 (5%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLI---FNTRQWVDEFFNEVNLISSIEHKNL 329
N +K+G G G+V+ +G+ VAVK L+ F+ + V+EF EV ++ + H N+
Sbjct: 39 LNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAER-VNEFLREVAIMKRLRHPNI 96
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSL 354
V +G + P +V EY+ SL
Sbjct: 97 VLFMGAVTQPPNLSIVTEYLSRGSL 121
>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With
Irreversible Inhibitor
pdb|2QQ7|B Chain B, Crystal Structure Of Drug Resistant Src Kinase Domain With
Irreversible Inhibitor
pdb|2QI8|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain
pdb|2QI8|B Chain B, Crystal Structure Of Drug Resistant Src Kinase Domain
pdb|3F3W|A Chain A, Drug Resistant Csrc Kinase Domain In Complex With
Inhibitor Rl45 (Type Ii)
pdb|3F3W|B Chain B, Drug Resistant Csrc Kinase Domain In Complex With
Inhibitor Rl45 (Type Ii)
pdb|3LOK|A Chain A, Drug Resistant Csrc Kinase Domain In Complex With Covalent
Inhibitor Pd168393
pdb|3LOK|B Chain B, Drug Resistant Csrc Kinase Domain In Complex With Covalent
Inhibitor Pd168393
Length = 286
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 29/84 (34%), Positives = 41/84 (48%), Gaps = 2/84 (2%)
Query: 278 KLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
KLGQG G V+MG+ T VA+K L T + F E ++ + H+ LV+L
Sbjct: 25 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 338 EGPESLLVYEYVPNRSLDQFIFGN 361
E P +V EY+ L F+ G
Sbjct: 84 EEP-IYIVMEYMSKGCLLDFLKGE 106
>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase
Length = 453
Score = 43.1 bits (100), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 29/84 (34%), Positives = 41/84 (48%), Gaps = 2/84 (2%)
Query: 278 KLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
KLGQG G V+MG+ T VA+K L + F E ++ + H+ LV+L
Sbjct: 192 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGNMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 250
Query: 338 EGPESLLVYEYVPNRSLDQFIFGN 361
E P +V EY+ SL F+ G
Sbjct: 251 EEP-IYIVTEYMSKGSLLDFLKGE 273
>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor
pdb|2HWO|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor
pdb|2HWP|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor Pd168393
pdb|2HWP|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor Pd168393
pdb|2QLQ|A Chain A, Crystal Structure Of Src Kinase Domain With Covalent
Inhibitor Rl3
pdb|2QLQ|B Chain B, Crystal Structure Of Src Kinase Domain With Covalent
Inhibitor Rl3
pdb|3F3T|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl38 (Type
Iii)
pdb|3F3T|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl38 (Type
Iii)
pdb|3F3U|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl37 (Type
Iii)
pdb|3F3U|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl37 (Type
Iii)
pdb|3F3V|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type
Ii)
pdb|3F3V|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type
Ii)
pdb|3G5D|A Chain A, Kinase Domain Of Csrc In Complex With Dasatinib
pdb|3G5D|B Chain B, Kinase Domain Of Csrc In Complex With Dasatinib
pdb|3TZ7|A Chain A, Kinase Domain Of Csrc In Complex With Rl103
pdb|3TZ7|B Chain B, Kinase Domain Of Csrc In Complex With Rl103
pdb|3TZ8|A Chain A, Kinase Domain Of Csrc In Complex With Rl104
pdb|3TZ8|B Chain B, Kinase Domain Of Csrc In Complex With Rl104
pdb|3TZ9|A Chain A, Kinase Domain Of Csrc In Complex With Rl130
pdb|3TZ9|B Chain B, Kinase Domain Of Csrc In Complex With Rl130
Length = 286
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 29/84 (34%), Positives = 41/84 (48%), Gaps = 2/84 (2%)
Query: 278 KLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
KLGQG G V+MG+ T VA+K L T + F E ++ + H+ LV+L
Sbjct: 25 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 338 EGPESLLVYEYVPNRSLDQFIFGN 361
E P +V EY+ L F+ G
Sbjct: 84 EEP-IYIVTEYMSKGCLLDFLKGE 106
>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With
Staurosporine
Length = 283
Score = 42.7 bits (99), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 28/82 (34%), Positives = 41/82 (50%), Gaps = 2/82 (2%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
K+LG G G V+MG+ T VA+K L T + F E ++ ++H LV+L
Sbjct: 15 KRLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMS-PESFLEEAQIMKKLKHDKLVQLYAVV 73
Query: 337 IEGPESLLVYEYVPNRSLDQFI 358
E P +V EY+ SL F+
Sbjct: 74 SEEP-IYIVTEYMNKGSLLDFL 94
>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
pdb|3V5Q|B Chain B, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
Length = 297
Score = 42.4 bits (98), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 25/89 (28%), Positives = 49/89 (55%), Gaps = 6/89 (6%)
Query: 276 SKKLGQGGAGSVYMGSLPNGTT------VAVKRLIFNTRQWVDEFFNEVNLISSIEHKNL 329
++LG+G G V++ N + VAVK L T +F E L+++++H+++
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFI 358
VK G +G ++V+EY+ + L++F+
Sbjct: 80 VKFYGVCGDGDPLIMVFEYMKHGDLNKFL 108
>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex
pdb|1AD5|B Chain B, Src Family Kinase Hck-Amp-Pnp Complex
pdb|2HCK|A Chain A, Src Family Kinase Hck-Quercetin Complex
pdb|2HCK|B Chain B, Src Family Kinase Hck-Quercetin Complex
Length = 438
Score = 42.4 bits (98), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 27/83 (32%), Positives = 43/83 (51%), Gaps = 2/83 (2%)
Query: 276 SKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
KKLG G G V+M + T VAVK + + V+ F E N++ +++H LVKL
Sbjct: 187 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAV 245
Query: 336 SIEGPESLLVYEYVPNRSLDQFI 358
+ P ++ E++ SL F+
Sbjct: 246 VTKEP-IYIITEFMAKGSLLDFL 267
>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg-
1009247
Length = 270
Score = 42.4 bits (98), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 27/83 (32%), Positives = 43/83 (51%), Gaps = 2/83 (2%)
Query: 276 SKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
KKLG G G V+M + T VAVK + + V+ F E N++ +++H LVKL
Sbjct: 20 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAV 78
Query: 336 SIEGPESLLVYEYVPNRSLDQFI 358
+ P ++ E++ SL F+
Sbjct: 79 VTKEP-IYIITEFMAKGSLLDFL 100
>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
pdb|1MQB|B Chain B, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
Length = 333
Score = 42.4 bits (98), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 31/103 (30%), Positives = 50/103 (48%), Gaps = 13/103 (12%)
Query: 268 KATNYFNPS-----KKLGQGGAGSVYMGSLPNGT-----TVAVKRLI--FNTRQWVDEFF 315
K T +PS K +G G G VY G L + VA+K L + +Q VD F
Sbjct: 36 KFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD-FL 94
Query: 316 NEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI 358
E ++ H N+++L G + +++ EY+ N +LD+F+
Sbjct: 95 GEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFL 137
>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family-
Selective Tyrosine Kinase Inhibitor
pdb|2C0I|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0I|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0O|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0O|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0T|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-641359
pdb|2C0T|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-641359
Length = 454
Score = 42.4 bits (98), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 27/83 (32%), Positives = 43/83 (51%), Gaps = 2/83 (2%)
Query: 276 SKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
KKLG G G V+M + T VAVK + + V+ F E N++ +++H LVKL
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 336 SIEGPESLLVYEYVPNRSLDQFI 358
+ P ++ E++ SL F+
Sbjct: 252 VTKEP-IYIITEFMAKGSLLDFL 273
>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure
pdb|2GCD|B Chain B, Tao2 Kinase Domain-Staurosporine Structure
Length = 309
Score = 42.0 bits (97), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 23/81 (28%), Positives = 41/81 (50%), Gaps = 6/81 (7%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ----WVDEFFNEVNLISSIEHK 327
F+ +++G G G+VY + N VA+K++ ++ +Q W D EV + + H
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD-IIKEVRFLQKLRHP 75
Query: 328 NLVKLLGCSIEGPESLLVYEY 348
N ++ GC + + LV EY
Sbjct: 76 NTIQYRGCYLREHTAWLVMEY 96
>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1
pdb|1F3M|D Chain D, Crystal Structure Of Human SerineTHREONINE KINASE PAK1
pdb|1YHW|A Chain A, Crystal Structure Of Pak1 Kinase Domain With One Point
Mutations (K299r)
Length = 297
Score = 42.0 bits (97), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 23/88 (26%), Positives = 45/88 (51%), Gaps = 1/88 (1%)
Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
+K+GQG +G+VY + G VA++++ + + NE+ ++ ++ N+V L
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 336 SIEGPESLLVYEYVPNRSLDQFIFGNCL 363
+ G E +V EY+ SL + C+
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETCM 113
>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point
Mutations (K299r, T423e)
pdb|2HY8|1 Chain 1, Pak1 Complex With St2001
Length = 297
Score = 41.6 bits (96), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 23/88 (26%), Positives = 45/88 (51%), Gaps = 1/88 (1%)
Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
+K+GQG +G+VY + G VA++++ + + NE+ ++ ++ N+V L
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 336 SIEGPESLLVYEYVPNRSLDQFIFGNCL 363
+ G E +V EY+ SL + C+
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETCM 113
>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With Pf-03758309
pdb|4APP|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With (S)-N-(5-(3-Benzyl-1-Methylpiperazine-4-
Carbonyl)-6,6-Dimethyl-1,4,5,6-Tetrahydropyrrolo(3,4-C)
Pyrazol-3-Yl)-3-Phenoxybenzamide
Length = 296
Score = 41.6 bits (96), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 24/89 (26%), Positives = 49/89 (55%), Gaps = 1/89 (1%)
Query: 271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNL 329
+Y + K+G+G G V + ++ +G VAVK++ +Q + FNEV ++ +H+N+
Sbjct: 24 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 83
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFI 358
V++ + G E +V E++ +L +
Sbjct: 84 VEMYNSYLVGDELWVVMEFLEGGALTDIV 112
>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium
Complex Lambda-Fl172
pdb|3FY0|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium
Complex Dw1
pdb|4DAW|A Chain A, Crystal Structure Of Pak1 Kinase Domain With The Ruthenium
Phthalimide Complex
Length = 297
Score = 41.6 bits (96), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 23/88 (26%), Positives = 45/88 (51%), Gaps = 1/88 (1%)
Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
+K+GQG +G+VY + G VA++++ + + NE+ ++ ++ N+V L
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 336 SIEGPESLLVYEYVPNRSLDQFIFGNCL 363
+ G E +V EY+ SL + C+
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETCM 113
>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain
pdb|3Q53|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain In Complex
With Atp
Length = 306
Score = 41.6 bits (96), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 23/88 (26%), Positives = 45/88 (51%), Gaps = 1/88 (1%)
Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
+K+GQG +G+VY + G VA++++ + + NE+ ++ ++ N+V L
Sbjct: 27 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 86
Query: 336 SIEGPESLLVYEYVPNRSLDQFIFGNCL 363
+ G E +V EY+ SL + C+
Sbjct: 87 YLVGDELWVVMEYLAGGSLTDVVTETCM 114
>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4
pdb|2BVA|B Chain B, Crystal Structure Of The Human P21-Activated Kinase 4
Length = 292
Score = 41.6 bits (96), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 24/89 (26%), Positives = 49/89 (55%), Gaps = 1/89 (1%)
Query: 271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNL 329
+Y + K+G+G G V + ++ +G VAVK++ +Q + FNEV ++ +H+N+
Sbjct: 20 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFI 358
V++ + G E +V E++ +L +
Sbjct: 80 VEMYNSYLVGDELWVVMEFLEGGALTDIV 108
>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXR|B Chain B, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXS|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complexed With Pp2
Length = 268
Score = 41.6 bits (96), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 30/76 (39%), Positives = 37/76 (48%), Gaps = 3/76 (3%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLG-C 335
K+LG G G V +G VAVK +I DEFF E + + H LVK G C
Sbjct: 14 KELGSGQFGVVKLGKWKGQYDVAVK-MIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 336 SIEGPESLLVYEYVPN 351
S E P +V EY+ N
Sbjct: 73 SKEYP-IYIVTEYISN 87
>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5Q|B Chain B, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5R|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5R|B Chain B, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
Length = 348
Score = 41.6 bits (96), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 23/81 (28%), Positives = 41/81 (50%), Gaps = 6/81 (7%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQ----WVDEFFNEVNLISSIEHK 327
F+ +++G G G+VY + N VA+K++ ++ +Q W D EV + + H
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD-IIKEVRFLQKLRHP 114
Query: 328 NLVKLLGCSIEGPESLLVYEY 348
N ++ GC + + LV EY
Sbjct: 115 NTIQYRGCYLREHTAWLVMEY 135
>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain
pdb|3Q4Z|B Chain B, Structure Of Unphosphorylated Pak1 Kinase Domain
Length = 306
Score = 41.6 bits (96), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 23/88 (26%), Positives = 45/88 (51%), Gaps = 1/88 (1%)
Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
+K+GQG +G+VY + G VA++++ + + NE+ ++ ++ N+V L
Sbjct: 27 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 86
Query: 336 SIEGPESLLVYEYVPNRSLDQFIFGNCL 363
+ G E +V EY+ SL + C+
Sbjct: 87 YLVGDELWVVMEYLAGGSLTDVVTETCM 114
>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In
Complex With A Consensus Peptide
Length = 301
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 23/80 (28%), Positives = 46/80 (57%), Gaps = 1/80 (1%)
Query: 271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNL 329
+Y + K+G+G G V + ++ +G VAVK++ +Q + FNEV ++ +H+N+
Sbjct: 29 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 88
Query: 330 VKLLGCSIEGPESLLVYEYV 349
V++ + G E +V E++
Sbjct: 89 VEMYNSYLVGDELWVVMEFL 108
>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With Cgp74514a
pdb|2J0I|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4
Length = 303
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 24/89 (26%), Positives = 49/89 (55%), Gaps = 1/89 (1%)
Query: 271 NYFNPSKKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNL 329
+Y + K+G+G G V + ++ +G VAVK++ +Q + FNEV ++ +H+N+
Sbjct: 31 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 90
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFI 358
V++ + G E +V E++ +L +
Sbjct: 91 VEMYNSYLVGDELWVVMEFLEGGALTDIV 119
>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBT|D Chain D, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBW|B Chain B, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BBW|A Chain A, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BCE|A Chain A, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|B Chain B, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|C Chain C, Crystal Structure Of The Erbb4 Kinase
Length = 328
Score = 40.8 bits (94), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 31/88 (35%), Positives = 50/88 (56%), Gaps = 7/88 (7%)
Query: 277 KKLGQGGAGSVYMG-SLPNGTTV----AVKRLIFNTRQWVD-EFFNEVNLISSIEHKNLV 330
K LG G G+VY G +P G TV A+K L T + EF +E +++S++H +LV
Sbjct: 21 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 80
Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFI 358
+LLG + P LV + +P+ L +++
Sbjct: 81 RLLGVCL-SPTIQLVTQLMPHGCLLEYV 107
>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
pdb|2R4B|B Chain B, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
Length = 321
Score = 40.8 bits (94), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 31/88 (35%), Positives = 50/88 (56%), Gaps = 7/88 (7%)
Query: 277 KKLGQGGAGSVYMG-SLPNGTTV----AVKRLIFNTRQWVD-EFFNEVNLISSIEHKNLV 330
K LG G G+VY G +P G TV A+K L T + EF +E +++S++H +LV
Sbjct: 44 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 103
Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFI 358
+LLG + P LV + +P+ L +++
Sbjct: 104 RLLGVCL-SPTIQLVTQLMPHGCLLEYV 130
>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIF|B Chain B, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIG|A Chain A, Catalytic Domain Of Human Pak4
pdb|4FIG|B Chain B, Catalytic Domain Of Human Pak4
pdb|4FIH|A Chain A, Catalytic Domain Of Human Pak4 With Qkftglprqw Peptide
pdb|4FII|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIJ|A Chain A, Catalytic Domain Of Human Pak4
Length = 346
Score = 40.8 bits (94), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 22/73 (30%), Positives = 43/73 (58%), Gaps = 1/73 (1%)
Query: 278 KLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
K+G+G G V + ++ +G VAVK++ +Q + FNEV ++ +H+N+V++
Sbjct: 81 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 140
Query: 337 IEGPESLLVYEYV 349
+ G E +V E++
Sbjct: 141 LVGDELWVVMEFL 153
>pdb|4FIE|A Chain A, Full-Length Human Pak4
pdb|4FIE|B Chain B, Full-Length Human Pak4
Length = 423
Score = 40.8 bits (94), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 22/73 (30%), Positives = 43/73 (58%), Gaps = 1/73 (1%)
Query: 278 KLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
K+G+G G V + ++ +G VAVK++ +Q + FNEV ++ +H+N+V++
Sbjct: 158 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 217
Query: 337 IEGPESLLVYEYV 349
+ G E +V E++
Sbjct: 218 LVGDELWVVMEFL 230
>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound
Structure
Length = 344
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 30/95 (31%), Positives = 50/95 (52%), Gaps = 6/95 (6%)
Query: 269 ATNYFNPSKKLGQGGAGSVYMG--SLPNGT--TVAVKRL-IFNTRQWVDEFFNEVNLISS 323
ATN + K +G G G V G LP+ +VA+K L + T + +F E +++
Sbjct: 15 ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 73
Query: 324 IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI 358
+H N+++L G + ++V EY+ N SLD F+
Sbjct: 74 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 108
>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor
Awl-Ii- 38.3
pdb|4G2F|A Chain A, Human Epha3 Kinase Domain In Complex With Compound 7
pdb|4GK2|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 66
pdb|4GK3|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 87
pdb|4GK4|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 90
Length = 361
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 30/95 (31%), Positives = 50/95 (52%), Gaps = 6/95 (6%)
Query: 269 ATNYFNPSKKLGQGGAGSVYMG--SLPNG--TTVAVKRL-IFNTRQWVDEFFNEVNLISS 323
ATN + K +G G G V G LP+ +VA+K L + T + +F E +++
Sbjct: 32 ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 90
Query: 324 IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI 358
+H N+++L G + ++V EY+ N SLD F+
Sbjct: 91 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 125
>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:s768a Triple Mutant
Length = 373
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 30/95 (31%), Positives = 50/95 (52%), Gaps = 6/95 (6%)
Query: 269 ATNYFNPSKKLGQGGAGSVYMG--SLPNGT--TVAVKRL-IFNTRQWVDEFFNEVNLISS 323
ATN + K +G G G V G LP+ +VA+K L + T + +F E +++
Sbjct: 44 ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 324 IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI 358
+H N+++L G + ++V EY+ N SLD F+
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 137
>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant
Length = 373
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 30/95 (31%), Positives = 50/95 (52%), Gaps = 6/95 (6%)
Query: 269 ATNYFNPSKKLGQGGAGSVYMG--SLPNGT--TVAVKRL-IFNTRQWVDEFFNEVNLISS 323
ATN + K +G G G V G LP+ +VA+K L + T + +F E +++
Sbjct: 44 ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 324 IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI 358
+H N+++L G + ++V EY+ N SLD F+
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 137
>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant
Length = 373
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 30/95 (31%), Positives = 50/95 (52%), Gaps = 6/95 (6%)
Query: 269 ATNYFNPSKKLGQGGAGSVYMG--SLPNGT--TVAVKRL-IFNTRQWVDEFFNEVNLISS 323
ATN + K +G G G V G LP+ +VA+K L + T + +F E +++
Sbjct: 44 ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 324 IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI 358
+H N+++L G + ++V EY+ N SLD F+
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 137
>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f
Double Mutant
Length = 373
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 30/95 (31%), Positives = 50/95 (52%), Gaps = 6/95 (6%)
Query: 269 ATNYFNPSKKLGQGGAGSVYMG--SLPNGT--TVAVKRL-IFNTRQWVDEFFNEVNLISS 323
ATN + K +G G G V G LP+ +VA+K L + T + +F E +++
Sbjct: 44 ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 324 IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI 358
+H N+++L G + ++V EY+ N SLD F+
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 137
>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:y742f Triple Mutant
Length = 373
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 30/95 (31%), Positives = 50/95 (52%), Gaps = 6/95 (6%)
Query: 269 ATNYFNPSKKLGQGGAGSVYMG--SLPNGT--TVAVKRL-IFNTRQWVDEFFNEVNLISS 323
ATN + K +G G G V G LP+ +VA+K L + T + +F E +++
Sbjct: 44 ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 324 IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI 358
+H N+++L G + ++V EY+ N SLD F+
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 137
>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596:y602:s768g Triple Mutant
Length = 373
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 30/95 (31%), Positives = 50/95 (52%), Gaps = 6/95 (6%)
Query: 269 ATNYFNPSKKLGQGGAGSVYMG--SLPNGT--TVAVKRL-IFNTRQWVDEFFNEVNLISS 323
ATN + K +G G G V G LP+ +VA+K L + T + +F E +++
Sbjct: 44 ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 324 IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI 358
+H N+++L G + ++V EY+ N SLD F+
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 137
>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane
Region
pdb|2QO2|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Dephosphorylated, Apo Structure
pdb|2QO9|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Phosphorylated, Amp-pnp Bound
Length = 373
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 30/95 (31%), Positives = 50/95 (52%), Gaps = 6/95 (6%)
Query: 269 ATNYFNPSKKLGQGGAGSVYMG--SLPNGT--TVAVKRL-IFNTRQWVDEFFNEVNLISS 323
ATN + K +G G G V G LP+ +VA+K L + T + +F E +++
Sbjct: 44 ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 324 IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI 358
+H N+++L G + ++V EY+ N SLD F+
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 137
>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To
Substrate Kqwdnye[ptyr]iw
pdb|3FY2|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To
Substrate Kqwdnyefiw
Length = 371
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 30/95 (31%), Positives = 50/95 (52%), Gaps = 6/95 (6%)
Query: 269 ATNYFNPSKKLGQGGAGSVYMG--SLPNGT--TVAVKRL-IFNTRQWVDEFFNEVNLISS 323
ATN + K +G G G V G LP+ +VA+K L + T + +F E +++
Sbjct: 42 ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 100
Query: 324 IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI 358
+H N+++L G + ++V EY+ N SLD F+
Sbjct: 101 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 135
>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein
Kina
pdb|2P0C|B Chain B, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein
Kina
pdb|3BRB|A Chain A, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Tyrosine- Protein Kinase Mer In Complex
With Adp
pdb|3BRB|B Chain B, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Tyrosine- Protein Kinase Mer In Complex
With Adp
pdb|3BPR|A Chain A, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|B Chain B, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|C Chain C, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|D Chain D, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3TCP|A Chain A, Crystal Structure Of The Catalytic Domain Of The
Proto-Oncogene Tyrosine-Protein Kinase Mer In Complex
With Inhibitor Unc569
pdb|3TCP|B Chain B, Crystal Structure Of The Catalytic Domain Of The
Proto-Oncogene Tyrosine-Protein Kinase Mer In Complex
With Inhibitor Unc569
Length = 313
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 30/86 (34%), Positives = 47/86 (54%), Gaps = 6/86 (6%)
Query: 259 LSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSL--PNGTT--VAVK--RLIFNTRQWVD 312
L K E + N K LG+G GSV G+L +GT+ VAVK +L ++++ ++
Sbjct: 22 LQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIE 81
Query: 313 EFFNEVNLISSIEHKNLVKLLGCSIE 338
EF +E + H N+++LLG IE
Sbjct: 82 EFLSEAACMKDFSHPNVIRLLGVCIE 107
>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGW|B Chain B, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGY|A Chain A, Crystal Structure Of Itk Inhibitor Complex
pdb|3QGY|B Chain B, Crystal Structure Of Itk Inhibitor Complex
Length = 286
Score = 39.3 bits (90), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 22/82 (26%), Positives = 42/82 (51%), Gaps = 1/82 (1%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
+++G G G V++G N VA+K + + D+F E ++ + H LV+L G
Sbjct: 33 QEIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMS-EDDFIEEAEVMMKLSHPKLVQLYGVC 91
Query: 337 IEGPESLLVYEYVPNRSLDQFI 358
+E LV+E++ + L ++
Sbjct: 92 LEQAPICLVFEFMEHGCLSDYL 113
>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5
pdb|2F57|B Chain B, Crystal Structure Of The Human P21-activated Kinase 5
Length = 317
Score = 38.9 bits (89), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 23/82 (28%), Positives = 42/82 (51%), Gaps = 1/82 (1%)
Query: 278 KLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
K+G+G G V + + + G VAVK++ +Q + FNEV ++ H N+V +
Sbjct: 52 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSY 111
Query: 337 IEGPESLLVYEYVPNRSLDQFI 358
+ G E +V E++ +L +
Sbjct: 112 LVGDELWVVMEFLEGGALTDIV 133
>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo
Form)
pdb|4FVQ|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain
(Mg-Atp-Bound Form)
Length = 289
Score = 38.9 bits (89), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 31/97 (31%), Positives = 48/97 (49%), Gaps = 10/97 (10%)
Query: 273 FNPSKKLGQGGAGSVYMG--------SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI 324
FN S LGQG ++ G + T V +K L R + + FF +++S +
Sbjct: 12 FNES--LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKL 69
Query: 325 EHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFGN 361
HK+LV G + G E++LV E+V SLD ++ N
Sbjct: 70 SHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKN 106
>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase
Kinase 5
pdb|2CLQ|B Chain B, Structure Of Mitogen-Activated Protein Kinase Kinase
Kinase 5
Length = 295
Score = 38.9 bits (89), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 25/77 (32%), Positives = 37/77 (48%), Gaps = 1/77 (1%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
LG+G G VY G L N +A+K + ++ E+ L ++HKN+V+ LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 338 EGPESLLVYEYVPNRSL 354
E + E VP SL
Sbjct: 90 ENGFIKIFMEQVPGGSL 106
>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
pdb|3VW6|B Chain B, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
Length = 269
Score = 38.5 bits (88), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 25/77 (32%), Positives = 37/77 (48%), Gaps = 1/77 (1%)
Query: 279 LGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
LG+G G VY G L N +A+K + ++ E+ L ++HKN+V+ LG
Sbjct: 16 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 75
Query: 338 EGPESLLVYEYVPNRSL 354
E + E VP SL
Sbjct: 76 ENGFIKIFMEQVPGGSL 92
>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5)
Length = 295
Score = 38.1 bits (87), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 34/126 (26%), Positives = 57/126 (45%), Gaps = 20/126 (15%)
Query: 242 EDRNN-LGLYATSMKKSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLP----NGT 296
ED N + +A ++ SC+ T+E+ +G G G V G L
Sbjct: 6 EDPNQAVHEFAKEIEASCI-----TIERV---------IGAGEFGEVCSGRLKLPGKREL 51
Query: 297 TVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLD 355
VA+K L + T + +F E +++ +H N++ L G + ++V EY+ N SLD
Sbjct: 52 PVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLD 111
Query: 356 QFIFGN 361
F+ N
Sbjct: 112 TFLKKN 117
>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
pdb|2IVS|B Chain B, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
Length = 314
Score = 38.1 bits (87), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 31/90 (34%), Positives = 47/90 (52%), Gaps = 9/90 (10%)
Query: 277 KKLGQGGAGSV------YMGSLPNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNL 329
K LG+G G V ++ TTVAVK L N + + + +E N++ + H ++
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 330 VKLLG-CSIEGPESLLVYEYVPNRSLDQFI 358
+KL G CS +GP LL+ EY SL F+
Sbjct: 89 IKLYGACSQDGP-LLLIVEYAKYGSLRGFL 117
>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Pp1
Length = 314
Score = 38.1 bits (87), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 31/90 (34%), Positives = 47/90 (52%), Gaps = 9/90 (10%)
Query: 277 KKLGQGGAGSV------YMGSLPNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNL 329
K LG+G G V ++ TTVAVK L N + + + +E N++ + H ++
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 330 VKLLG-CSIEGPESLLVYEYVPNRSLDQFI 358
+KL G CS +GP LL+ EY SL F+
Sbjct: 89 IKLYGACSQDGP-LLLIVEYAKYGSLRGFL 117
>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain
pdb|2IVU|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Zd6474
pdb|2X2K|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2L|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|B Chain B, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
Length = 314
Score = 38.1 bits (87), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 31/90 (34%), Positives = 47/90 (52%), Gaps = 9/90 (10%)
Query: 277 KKLGQGGAGSV------YMGSLPNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNL 329
K LG+G G V ++ TTVAVK L N + + + +E N++ + H ++
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 330 VKLLG-CSIEGPESLLVYEYVPNRSLDQFI 358
+KL G CS +GP LL+ EY SL F+
Sbjct: 89 IKLYGACSQDGP-LLLIVEYAKYGSLRGFL 117
>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant
V617f (Mg- Atp-Bound Form)
Length = 289
Score = 37.4 bits (85), Expect = 0.013, Method: Compositional matrix adjust.
Identities = 31/97 (31%), Positives = 47/97 (48%), Gaps = 10/97 (10%)
Query: 273 FNPSKKLGQGGAGSVYMG--------SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI 324
FN S LGQG ++ G + T V +K L R + + FF +++S +
Sbjct: 12 FNES--LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKL 69
Query: 325 EHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFIFGN 361
HK+LV G G E++LV E+V SLD ++ N
Sbjct: 70 SHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKN 106
>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5J|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5L|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|C Chain C, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|D Chain D, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V8T|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8T|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8W|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
pdb|3V8W|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
Length = 266
Score = 37.4 bits (85), Expect = 0.015, Method: Compositional matrix adjust.
Identities = 22/82 (26%), Positives = 41/82 (50%), Gaps = 1/82 (1%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
+++G G G V++G N VA+K I ++F E ++ + H LV+L G
Sbjct: 13 QEIGSGQFGLVHLGYWLNKDKVAIKT-IREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 337 IEGPESLLVYEYVPNRSLDQFI 358
+E LV+E++ + L ++
Sbjct: 72 LEQAPICLVFEFMEHGCLSDYL 93
>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure
Length = 344
Score = 37.4 bits (85), Expect = 0.015, Method: Compositional matrix adjust.
Identities = 29/95 (30%), Positives = 49/95 (51%), Gaps = 6/95 (6%)
Query: 269 ATNYFNPSKKLGQGGAGSVYMG--SLPNG--TTVAVKRL-IFNTRQWVDEFFNEVNLISS 323
ATN + K +G G G V G LP+ +VA+K L + T + +F E +++
Sbjct: 15 ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 73
Query: 324 IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI 358
+H N+++L G + ++V E + N SLD F+
Sbjct: 74 FDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL 108
>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SM2|B Chain B, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|A Chain A, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|B Chain B, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNX|A Chain A, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
pdb|1SNX|B Chain B, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
Length = 264
Score = 37.4 bits (85), Expect = 0.015, Method: Compositional matrix adjust.
Identities = 22/82 (26%), Positives = 41/82 (50%), Gaps = 1/82 (1%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
+++G G G V++G N VA+K I ++F E ++ + H LV+L G
Sbjct: 11 QEIGSGQFGLVHLGYWLNKDKVAIKT-IREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 337 IEGPESLLVYEYVPNRSLDQFI 358
+E LV+E++ + L ++
Sbjct: 70 LEQAPICLVFEFMEHGCLSDYL 91
>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52
pdb|4HCU|A Chain A, Crystal Structure Of Itk In Complext With Compound 40
pdb|4HCV|A Chain A, Crystal Structure Of Itk In Complex With Compound 53
Length = 269
Score = 37.0 bits (84), Expect = 0.016, Method: Compositional matrix adjust.
Identities = 21/82 (25%), Positives = 41/82 (50%), Gaps = 1/82 (1%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
+++G G G V++G N VA+K + ++F E ++ + H LV+L G
Sbjct: 16 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVC 74
Query: 337 IEGPESLLVYEYVPNRSLDQFI 358
+E LV+E++ + L ++
Sbjct: 75 LEQAPICLVFEFMEHGCLSDYL 96
>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MIY|B Chain B, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MJ1|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Ro5191614
pdb|3MJ2|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Bms-509744
Length = 266
Score = 37.0 bits (84), Expect = 0.016, Method: Compositional matrix adjust.
Identities = 22/82 (26%), Positives = 41/82 (50%), Gaps = 1/82 (1%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
+++G G G V++G N VA+K I ++F E ++ + H LV+L G
Sbjct: 13 QEIGSGQFGLVHLGYWLNKDKVAIKT-IREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 337 IEGPESLLVYEYVPNRSLDQFI 358
+E LV+E++ + L ++
Sbjct: 72 LEQAPICLVFEFMEHGCLSDYL 93
>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole
Inhibitor
Length = 290
Score = 37.0 bits (84), Expect = 0.016, Method: Compositional matrix adjust.
Identities = 34/104 (32%), Positives = 53/104 (50%), Gaps = 8/104 (7%)
Query: 271 NYFNPSKKLGQG--GAGSVYMGSLPN---GTTVAVKRLIFNT-RQWVDEFFNEVNLISSI 324
Y + LG+G G S+Y N G VAVK L Q + E+ ++ ++
Sbjct: 8 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTL 67
Query: 325 EHKNLVKLLGC-SIEGPESL-LVYEYVPNRSLDQFIFGNCLFLA 366
H+++VK GC +G +S+ LV EYVP SL ++ +C+ LA
Sbjct: 68 YHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLA 111
>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole
Inhibitor
Length = 291
Score = 37.0 bits (84), Expect = 0.016, Method: Compositional matrix adjust.
Identities = 34/104 (32%), Positives = 53/104 (50%), Gaps = 8/104 (7%)
Query: 271 NYFNPSKKLGQG--GAGSVYMGSLPN---GTTVAVKRLIFNT-RQWVDEFFNEVNLISSI 324
Y + LG+G G S+Y N G VAVK L Q + E+ ++ ++
Sbjct: 9 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTL 68
Query: 325 EHKNLVKLLGC-SIEGPESL-LVYEYVPNRSLDQFIFGNCLFLA 366
H+++VK GC +G +S+ LV EYVP SL ++ +C+ LA
Sbjct: 69 YHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLA 112
>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:y742a Triple Mutant
Length = 373
Score = 37.0 bits (84), Expect = 0.016, Method: Compositional matrix adjust.
Identities = 29/95 (30%), Positives = 49/95 (51%), Gaps = 6/95 (6%)
Query: 269 ATNYFNPSKKLGQGGAGSVYMG--SLPNGT--TVAVKRL-IFNTRQWVDEFFNEVNLISS 323
ATN + K +G G G V G LP+ +VA+K L + T + +F E +++
Sbjct: 44 ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 324 IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI 358
+H N+++L G + ++V E + N SLD F+
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL 137
>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded
Form)
Length = 325
Score = 37.0 bits (84), Expect = 0.017, Method: Compositional matrix adjust.
Identities = 25/95 (26%), Positives = 44/95 (46%), Gaps = 16/95 (16%)
Query: 248 GLYATSMKKSCLSFKYETLEKATNYFNPSK------KLGQGGAGSVYMGSLPNGTTVAVK 301
LY SMK+ E T NP +LG G G VY + +A
Sbjct: 17 NLYFQSMKQ---------YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAA 67
Query: 302 RLI-FNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
++I + + ++++ E+++++S +H N+VKLL
Sbjct: 68 KVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 102
>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5-
Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6-
Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide
Length = 325
Score = 37.0 bits (84), Expect = 0.018, Method: Compositional matrix adjust.
Identities = 25/95 (26%), Positives = 44/95 (46%), Gaps = 16/95 (16%)
Query: 248 GLYATSMKKSCLSFKYETLEKATNYFNPSK------KLGQGGAGSVYMGSLPNGTTVAVK 301
LY SMK+ E T NP +LG G G VY + +A
Sbjct: 17 NLYFQSMKQ---------YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAA 67
Query: 302 RLI-FNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
++I + + ++++ E+++++S +H N+VKLL
Sbjct: 68 KVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 102
>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Dephosphorylated, Amp-Pnp Bound
pdb|2QOQ|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Base, Amp-Pnp
Bound Structure
Length = 373
Score = 37.0 bits (84), Expect = 0.018, Method: Compositional matrix adjust.
Identities = 29/95 (30%), Positives = 49/95 (51%), Gaps = 6/95 (6%)
Query: 269 ATNYFNPSKKLGQGGAGSVYMG--SLPNGT--TVAVKRL-IFNTRQWVDEFFNEVNLISS 323
ATN + K +G G G V G LP+ +VA+K L + T + +F E +++
Sbjct: 44 ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 324 IEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI 358
+H N+++L G + ++V E + N SLD F+
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL 137
>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (
Diphosphorylated Form) Bound To 5- Amino-3-((4-(
Aminosulfonyl)phenyl)amino)-N-(2,6-
Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide
Length = 325
Score = 37.0 bits (84), Expect = 0.018, Method: Compositional matrix adjust.
Identities = 25/95 (26%), Positives = 44/95 (46%), Gaps = 16/95 (16%)
Query: 248 GLYATSMKKSCLSFKYETLEKATNYFNPSK------KLGQGGAGSVYMGSLPNGTTVAVK 301
LY SMK+ E T NP +LG G G VY + +A
Sbjct: 17 NLYFQSMKQ---------YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAA 67
Query: 302 RLI-FNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
++I + + ++++ E+++++S +H N+VKLL
Sbjct: 68 KVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 102
>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole
Inhibitor
Length = 291
Score = 37.0 bits (84), Expect = 0.019, Method: Compositional matrix adjust.
Identities = 27/98 (27%), Positives = 47/98 (47%), Gaps = 7/98 (7%)
Query: 267 EKATNYFNPSKKLGQGGAGSVYMGSLP----NGTTVAVKRLI--FNTRQWVDEFFNEVNL 320
E +Y + +G G G V G L + VA+K L + RQ EF +E ++
Sbjct: 10 EIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQ-RREFLSEASI 68
Query: 321 ISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI 358
+ EH N+++L G +++ E++ N +LD F+
Sbjct: 69 MGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFL 106
>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r
In Complex With Dasatinib
Length = 265
Score = 37.0 bits (84), Expect = 0.019, Method: Compositional matrix adjust.
Identities = 23/75 (30%), Positives = 36/75 (48%), Gaps = 1/75 (1%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
K+LG G G V G VA+K +I DEF E ++ ++ H+ LV+L G
Sbjct: 15 KELGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 337 IEGPESLLVYEYVPN 351
+ ++ EY+ N
Sbjct: 74 TKQRPIFIITEYMAN 88
>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain
pdb|1K2P|B Chain B, Crystal Structure Of Bruton's Tyrosine Kinase Domain
Length = 263
Score = 36.6 bits (83), Expect = 0.020, Method: Compositional matrix adjust.
Identities = 23/75 (30%), Positives = 36/75 (48%), Gaps = 1/75 (1%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
K+LG G G V G VA+K +I DEF E ++ ++ H+ LV+L G
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 337 IEGPESLLVYEYVPN 351
+ ++ EY+ N
Sbjct: 69 TKQRPIFIITEYMAN 83
>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights
Into Receptor Autoregulation
Length = 343
Score = 36.6 bits (83), Expect = 0.021, Method: Compositional matrix adjust.
Identities = 26/89 (29%), Positives = 43/89 (48%), Gaps = 7/89 (7%)
Query: 277 KKLGQGGAGSVYMGSLPN------GTTVAVKRLIFNTRQWVD-EFFNEVNLISSIEHKNL 329
+ +G+G G V+ P T VAVK L + +F E L++ ++ N+
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFI 358
VKLLG G L++EY+ L++F+
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFL 141
>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW8|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
Length = 302
Score = 36.6 bits (83), Expect = 0.021, Method: Compositional matrix adjust.
Identities = 27/94 (28%), Positives = 48/94 (51%), Gaps = 4/94 (4%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW--VDEFFNEVNLISSIEHKNL 329
F +K+G+G G VY + G VA+K++ +T E++L+ + H N+
Sbjct: 8 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFGNCL 363
VKLL + LV+E+V ++ L +F+ + L
Sbjct: 68 VKLLDVIHTENKLYLVFEHV-DQDLKKFMDASAL 100
>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7)
pdb|3DKO|A Chain A, Complex Between The Kinase Domain Of Human Ephrin Type-A
Receptor 7 (Epha7) And Inhibitor Alw-Ii-49-7
Length = 318
Score = 36.6 bits (83), Expect = 0.022, Method: Compositional matrix adjust.
Identities = 25/85 (29%), Positives = 41/85 (48%), Gaps = 5/85 (5%)
Query: 279 LGQGGAGSVYMGSLP----NGTTVAVKRL-IFNTRQWVDEFFNEVNLISSIEHKNLVKLL 333
+G G G V G L VA+K L + T + +F E +++ +H N+V L
Sbjct: 51 IGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLE 110
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFI 358
G G ++V E++ N +LD F+
Sbjct: 111 GVVTRGKPVMIVIEFMENGALDAFL 135
>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain
pdb|3P08|B Chain B, Crystal Structure Of The Human Btk Kinase Domain
Length = 267
Score = 36.6 bits (83), Expect = 0.023, Method: Compositional matrix adjust.
Identities = 23/75 (30%), Positives = 36/75 (48%), Gaps = 1/75 (1%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
K+LG G G V G VA+K +I DEF E ++ ++ H+ LV+L G
Sbjct: 14 KELGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 72
Query: 337 IEGPESLLVYEYVPN 351
+ ++ EY+ N
Sbjct: 73 TKQRPIFIITEYMAN 87
>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-Isopropyl-7-
(4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3-
Ylamino)-2h- Phthalazin-1-One
pdb|3PIY|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With R406
pdb|3PIZ|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
(5-Amino-1-O-
Tolyl-1h-Pyrazol-4-Yl)-[3-(1-Methanesulfonyl-Piperidin-
4-Yl)-Phenyl]- Methanone
pdb|3PJ1|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
3-(2,6-Dichloro-
Phenyl)-7-[4-(2-Diethylamino-Ethoxy)-Phenylamino]-1-
Methyl-3,4- Dihydro-1h-Pyrimido[4,5-D]pyrimidin-2-One
pdb|3PJ2|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-[4-(2-
Diethylamino-Ethoxy)-Phenylamino]-6-(4-Fluoro-Phenoxy)-
8-Methyl-8h- Pyrido[2,3-D]pyrimidin-7-One
pdb|3PJ3|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-Methyl-5-[(E)-
(3-Phenyl-Acryloyl)amino]-N-(2-Phenyl-3h-Imidazo[4,
5-B]pyridin-6-Yl)- Benzamide
Length = 274
Score = 36.6 bits (83), Expect = 0.023, Method: Compositional matrix adjust.
Identities = 23/75 (30%), Positives = 36/75 (48%), Gaps = 1/75 (1%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
K+LG G G V G VA+K +I DEF E ++ ++ H+ LV+L G
Sbjct: 21 KELGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 79
Query: 337 IEGPESLLVYEYVPN 351
+ ++ EY+ N
Sbjct: 80 TKQRPIFIITEYMAN 94
>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex
With Inhibitor Cgi1746
Length = 271
Score = 36.6 bits (83), Expect = 0.024, Method: Compositional matrix adjust.
Identities = 23/75 (30%), Positives = 36/75 (48%), Gaps = 1/75 (1%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
K+LG G G V G VA+K +I DEF E ++ ++ H+ LV+L G
Sbjct: 15 KELGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 337 IEGPESLLVYEYVPN 351
+ ++ EY+ N
Sbjct: 74 TKQRPIFIITEYMAN 88
>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K526e Mutation Responsible For
Crouzon Syndrome
pdb|2PZP|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K526e Mutation Responsible For
Crouzon Syndrome
Length = 324
Score = 36.6 bits (83), Expect = 0.024, Method: Compositional matrix adjust.
Identities = 29/93 (31%), Positives = 49/93 (52%), Gaps = 12/93 (12%)
Query: 277 KKLGQGGAGSVYMGSL--------PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
K LG+G G V M TVAVK L + T + + + +E+ ++ I +H
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKH 100
Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFI 358
KN++ LLG C+ +GP ++V EY +L +++
Sbjct: 101 KNIINLLGACTQDGPLYVIV-EYASKGNLREYL 132
>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWV|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWW|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWX|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWY|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWZ|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX0|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX1|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2X9F|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2XVD|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|4BB4|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
Length = 302
Score = 36.6 bits (83), Expect = 0.025, Method: Compositional matrix adjust.
Identities = 27/98 (27%), Positives = 47/98 (47%), Gaps = 7/98 (7%)
Query: 267 EKATNYFNPSKKLGQGGAGSVYMGSLP----NGTTVAVKRLI--FNTRQWVDEFFNEVNL 320
E +Y + +G G G V G L + VA+K L + RQ EF +E ++
Sbjct: 12 EIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQ-RREFLSEASI 70
Query: 321 ISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI 358
+ EH N+++L G +++ E++ N +LD F+
Sbjct: 71 MGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFL 108
>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine
Kinase Bound To A Pyrrolopyrimidine-Containing Compound
Length = 283
Score = 36.2 bits (82), Expect = 0.027, Method: Compositional matrix adjust.
Identities = 23/75 (30%), Positives = 36/75 (48%), Gaps = 1/75 (1%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
K+LG G G V G VA+K +I DEF E ++ ++ H+ LV+L G
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 337 IEGPESLLVYEYVPN 351
+ ++ EY+ N
Sbjct: 89 TKQRPIFIITEYMAN 103
>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
pdb|3GQL|B Chain B, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
pdb|3GQL|C Chain C, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
Length = 326
Score = 36.2 bits (82), Expect = 0.028, Method: Compositional matrix adjust.
Identities = 30/93 (32%), Positives = 51/93 (54%), Gaps = 12/93 (12%)
Query: 277 KKLGQGGAGSVYMGSL-------PNGTT-VAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
K LG+G G V + PN T VAVK L + T + + + +E+ ++ I +H
Sbjct: 34 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFI 358
KN++ LLG C+ +GP ++V EY +L +++
Sbjct: 94 KNIINLLGACTQDGPLYVIV-EYASKGNLREYL 125
>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549h Mutation Responsible For
Crouzon Syndrome.
pdb|2PWL|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549h Mutation Responsible For
Crouzon Syndrome
Length = 324
Score = 36.2 bits (82), Expect = 0.029, Method: Compositional matrix adjust.
Identities = 29/93 (31%), Positives = 49/93 (52%), Gaps = 12/93 (12%)
Query: 277 KKLGQGGAGSVYMGSL--------PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
K LG+G G V M TVAVK L + T + + + +E+ ++ I +H
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFI 358
KN++ LLG C+ +GP ++V EY +L +++
Sbjct: 101 KNIIHLLGACTQDGPLYVIV-EYASKGNLREYL 132
>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And
Inactive Conformations Suggests A Mechanism Of
Activation For Tec Family Kinases
Length = 283
Score = 36.2 bits (82), Expect = 0.029, Method: Compositional matrix adjust.
Identities = 23/75 (30%), Positives = 36/75 (48%), Gaps = 1/75 (1%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
K+LG G G V G VA+K +I DEF E ++ ++ H+ LV+L G
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 337 IEGPESLLVYEYVPN 351
+ ++ EY+ N
Sbjct: 89 TKQRPIFIITEYMAN 103
>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K641r Mutation Responsible For
Pfeiffer Syndrome
pdb|2PZR|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K641r Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 36.2 bits (82), Expect = 0.030, Method: Compositional matrix adjust.
Identities = 29/93 (31%), Positives = 49/93 (52%), Gaps = 12/93 (12%)
Query: 277 KKLGQGGAGSVYMGSL--------PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
K LG+G G V M TVAVK L + T + + + +E+ ++ I +H
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFI 358
KN++ LLG C+ +GP ++V EY +L +++
Sbjct: 101 KNIINLLGACTQDGPLYVIV-EYASKGNLREYL 132
>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1
pdb|1FGK|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1
pdb|1FGI|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su5402 Inhibitor
pdb|1FGI|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su5402 Inhibitor
pdb|1AGW|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su4984 Inhibitor
pdb|1AGW|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su4984 Inhibitor
pdb|2FGI|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fgf
Receptor 1 In Complex With Inhibitor Pd173074
pdb|2FGI|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of Fgf
Receptor 1 In Complex With Inhibitor Pd173074
Length = 310
Score = 36.2 bits (82), Expect = 0.030, Method: Compositional matrix adjust.
Identities = 30/93 (32%), Positives = 51/93 (54%), Gaps = 12/93 (12%)
Query: 277 KKLGQGGAGSVYMGSL-------PNGTT-VAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
K LG+G G V + PN T VAVK L + T + + + +E+ ++ I +H
Sbjct: 27 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 86
Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFI 358
KN++ LLG C+ +GP ++V EY +L +++
Sbjct: 87 KNIINLLGACTQDGPLYVIV-EYASKGNLREYL 118
>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|C Chain C, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|D Chain D, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome
Length = 324
Score = 36.2 bits (82), Expect = 0.031, Method: Compositional matrix adjust.
Identities = 29/93 (31%), Positives = 49/93 (52%), Gaps = 12/93 (12%)
Query: 277 KKLGQGGAGSVYMGSL--------PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
K LG+G G V M TVAVK L + T + + + +E+ ++ I +H
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFI 358
KN++ LLG C+ +GP ++V EY +L +++
Sbjct: 101 KNIINLLGACTQDGPLYVIV-EYASKGNLREYL 132
>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast
Growth Factor Receptor 1 In Complex With 5-(2-Thienyl)
Nicotinic Acid
pdb|3JS2|B Chain B, Crystal Structure Of Minimal Kinase Domain Of Fibroblast
Growth Factor Receptor 1 In Complex With 5-(2-Thienyl)
Nicotinic Acid
pdb|3KY2|A Chain A, Crystal Structure Of Fibroblast Growth Factor Receptor 1
Kinase Domain
pdb|3KY2|B Chain B, Crystal Structure Of Fibroblast Growth Factor Receptor 1
Kinase Domain
Length = 317
Score = 36.2 bits (82), Expect = 0.032, Method: Compositional matrix adjust.
Identities = 30/93 (32%), Positives = 51/93 (54%), Gaps = 12/93 (12%)
Query: 277 KKLGQGGAGSVYMGSL-------PNGTT-VAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
K LG+G G V + PN T VAVK L + T + + + +E+ ++ I +H
Sbjct: 34 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFI 358
KN++ LLG C+ +GP ++V EY +L +++
Sbjct: 94 KNIINLLGACTQDGPLYVIV-EYASKGNLREYL 125
>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|B Chain B, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|C Chain C, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|D Chain D, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
Length = 317
Score = 36.2 bits (82), Expect = 0.032, Method: Compositional matrix adjust.
Identities = 30/93 (32%), Positives = 51/93 (54%), Gaps = 12/93 (12%)
Query: 277 KKLGQGGAGSVYMGSL-------PNGTT-VAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
K LG+G G V + PN T VAVK L + T + + + +E+ ++ I +H
Sbjct: 34 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFI 358
KN++ LLG C+ +GP ++V EY +L +++
Sbjct: 94 KNIINLLGACTQDGPLYVIV-EYASKGNLREYL 125
>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 269
Score = 36.2 bits (82), Expect = 0.032, Method: Compositional matrix adjust.
Identities = 26/83 (31%), Positives = 41/83 (49%), Gaps = 4/83 (4%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
+ +G+G G V +G G VAVK F E ++++ + H NLV+LLG
Sbjct: 18 QTIGKGEFGDVMLGDY-RGNKVAVK--CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 74
Query: 337 IEGPESL-LVYEYVPNRSLDQFI 358
+E L +V EY+ SL ++
Sbjct: 75 VEEKGGLYIVTEYMAKGSLVDYL 97
>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf
Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp
Analog And Substrate Peptide
Length = 334
Score = 36.2 bits (82), Expect = 0.032, Method: Compositional matrix adjust.
Identities = 29/93 (31%), Positives = 49/93 (52%), Gaps = 12/93 (12%)
Query: 277 KKLGQGGAGSVYMGSL--------PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
K LG+G G V M TVAVK L + T + + + +E+ ++ I +H
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFI 358
KN++ LLG C+ +GP ++V EY +L +++
Sbjct: 101 KNIINLLGACTQDGPLYVIV-EYASKGNLREYL 132
>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
Length = 326
Score = 36.2 bits (82), Expect = 0.033, Method: Compositional matrix adjust.
Identities = 30/93 (32%), Positives = 51/93 (54%), Gaps = 12/93 (12%)
Query: 277 KKLGQGGAGSVYMGSL-------PNGTT-VAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
K LG+G G V + PN T VAVK L + T + + + +E+ ++ I +H
Sbjct: 34 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFI 358
KN++ LLG C+ +GP ++V EY +L +++
Sbjct: 94 KNIINLLGACTQDGPLYVIV-EYASKGNLREYL 125
>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains
Trapped In Trans-Phosphorylation Reaction
Length = 334
Score = 36.2 bits (82), Expect = 0.033, Method: Compositional matrix adjust.
Identities = 29/93 (31%), Positives = 49/93 (52%), Gaps = 12/93 (12%)
Query: 277 KKLGQGGAGSVYMGSL--------PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
K LG+G G V M TVAVK L + T + + + +E+ ++ I +H
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFI 358
KN++ LLG C+ +GP ++V EY +L +++
Sbjct: 101 KNIINLLGACTQDGPLYVIV-EYASKGNLREYL 132
>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3-
Methoxybenzyl)-7-Azaindole
pdb|3C4F|B Chain B, Fgfr Tyrosine Kinase Domain In Complex With 3-(3-
Methoxybenzyl)-7-Azaindole
Length = 302
Score = 36.2 bits (82), Expect = 0.033, Method: Compositional matrix adjust.
Identities = 30/93 (32%), Positives = 51/93 (54%), Gaps = 12/93 (12%)
Query: 277 KKLGQGGAGSVYMGSL-------PNGTT-VAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
K LG+G G V + PN T VAVK L + T + + + +E+ ++ I +H
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFI 358
KN++ LLG C+ +GP ++V EY +L +++
Sbjct: 79 KNIINLLGACTQDGPLYVIV-EYASKGNLREYL 110
>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 1
pdb|4F63|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 1
pdb|4F64|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 6
pdb|4F64|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 6
pdb|4F65|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 8
pdb|4F65|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 8
Length = 309
Score = 36.2 bits (82), Expect = 0.033, Method: Compositional matrix adjust.
Identities = 30/93 (32%), Positives = 51/93 (54%), Gaps = 12/93 (12%)
Query: 277 KKLGQGGAGSVYMGSL-------PNGTT-VAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
K LG+G G V + PN T VAVK L + T + + + +E+ ++ I +H
Sbjct: 26 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 85
Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFI 358
KN++ LLG C+ +GP ++V EY +L +++
Sbjct: 86 KNIINLLGACTQDGPLYVIV-EYASKGNLREYL 117
>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase
In Complex With Arq 069
pdb|3RHX|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase
In Complex With Arq 069
Length = 306
Score = 36.2 bits (82), Expect = 0.033, Method: Compositional matrix adjust.
Identities = 30/93 (32%), Positives = 51/93 (54%), Gaps = 12/93 (12%)
Query: 277 KKLGQGGAGSVYMGSL-------PNGTT-VAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
K LG+G G V + PN T VAVK L + T + + + +E+ ++ I +H
Sbjct: 23 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 82
Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFI 358
KN++ LLG C+ +GP ++V EY +L +++
Sbjct: 83 KNIINLLGACTQDGPLYVIV-EYASKGNLREYL 114
>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549t Mutation Responsible For
Pfeiffer Syndrome
pdb|2PZ5|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549t Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 36.2 bits (82), Expect = 0.033, Method: Compositional matrix adjust.
Identities = 29/93 (31%), Positives = 49/93 (52%), Gaps = 12/93 (12%)
Query: 277 KKLGQGGAGSVYMGSL--------PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
K LG+G G V M TVAVK L + T + + + +E+ ++ I +H
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFI 358
KN++ LLG C+ +GP ++V EY +L +++
Sbjct: 101 KNIITLLGACTQDGPLYVIV-EYASKGNLREYL 132
>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|B Chain B, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|C Chain C, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|D Chain D, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|E Chain E, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|F Chain F, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
Length = 450
Score = 36.2 bits (82), Expect = 0.034, Method: Compositional matrix adjust.
Identities = 26/83 (31%), Positives = 43/83 (51%), Gaps = 4/83 (4%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
+ +G+G G V +G G VAVK + + F E ++++ + H NLV+LLG
Sbjct: 199 QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 337 IEGPESL-LVYEYVPNRSLDQFI 358
+E L +V EY+ SL ++
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYL 278
>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In
Complex With Inhibitor Staurosporine
Length = 278
Score = 35.8 bits (81), Expect = 0.035, Method: Compositional matrix adjust.
Identities = 26/83 (31%), Positives = 41/83 (49%), Gaps = 4/83 (4%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
+ +G+G G V +G G VAVK F E ++++ + H NLV+LLG
Sbjct: 27 QTIGKGEFGDVMLGDY-RGNKVAVK--CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 337 IEGPESL-LVYEYVPNRSLDQFI 358
+E L +V EY+ SL ++
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYL 106
>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3D7U|C Chain C, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 263
Score = 35.8 bits (81), Expect = 0.036, Method: Compositional matrix adjust.
Identities = 26/83 (31%), Positives = 41/83 (49%), Gaps = 4/83 (4%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
+ +G+G G V +G G VAVK F E ++++ + H NLV+LLG
Sbjct: 12 QTIGKGEFGDVMLGDY-RGNKVAVK--CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 337 IEGPESL-LVYEYVPNRSLDQFI 358
+E L +V EY+ SL ++
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYL 91
>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1GIJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|2DS1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
Length = 298
Score = 35.8 bits (81), Expect = 0.038, Method: Compositional matrix adjust.
Identities = 27/94 (28%), Positives = 47/94 (50%), Gaps = 4/94 (4%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW--VDEFFNEVNLISSIEHKNL 329
F +K+G+G G VY + G VA+K++ +T E++L+ + H N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFGNCL 363
VKLL + LV+E+V ++ L F+ + L
Sbjct: 64 VKLLDVIHTENKLYLVFEHV-HQDLKTFMDASAL 96
>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase
Domain With
3-(2,6-Dichloro-3,
5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1-
Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398)
pdb|3TT0|B Chain B, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase
Domain With
3-(2,6-Dichloro-3,
5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1-
Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398)
Length = 382
Score = 35.8 bits (81), Expect = 0.038, Method: Compositional matrix adjust.
Identities = 30/93 (32%), Positives = 51/93 (54%), Gaps = 12/93 (12%)
Query: 277 KKLGQGGAGSVYMGSL-------PNGTT-VAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
K LG+G G V + PN T VAVK L + T + + + +E+ ++ I +H
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFI 358
KN++ LLG C+ +GP ++V EY +L +++
Sbjct: 135 KNIINLLGACTQDGPLYVIV-EYASKGNLREYL 166
>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3D4Q|B Chain B, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3PSB|A Chain A, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PSB|B Chain B, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PPJ|A Chain A, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPJ|B Chain B, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPK|A Chain A, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PPK|B Chain B, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PRF|A Chain A, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRF|B Chain B, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRI|A Chain A, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3PRI|B Chain B, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3Q4C|A Chain A, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3Q4C|B Chain B, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3PSD|A Chain A, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3PSD|B Chain B, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3SKC|A Chain A, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3SKC|B Chain B, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3TV4|A Chain A, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV4|B Chain B, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV6|A Chain A, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|3TV6|B Chain B, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|4E26|A Chain A, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E26|B Chain B, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E4X|A Chain A, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4E4X|B Chain B, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4G9C|A Chain A, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
pdb|4G9C|B Chain B, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
Length = 307
Score = 35.8 bits (81), Expect = 0.040, Method: Compositional matrix adjust.
Identities = 21/78 (26%), Positives = 38/78 (48%), Gaps = 1/78 (1%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
+++G G G+VY G V + + T Q + F NEV ++ H N++ +G S
Sbjct: 42 QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 337 IEGPESLLVYEYVPNRSL 354
+ P+ +V ++ SL
Sbjct: 102 TK-PQLAIVTQWCEGSSL 118
>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
pdb|3IDP|B Chain B, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
Length = 300
Score = 35.8 bits (81), Expect = 0.041, Method: Compositional matrix adjust.
Identities = 21/78 (26%), Positives = 38/78 (48%), Gaps = 1/78 (1%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
+++G G G+VY G V + + T Q + F NEV ++ H N++ +G S
Sbjct: 34 QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 93
Query: 337 IEGPESLLVYEYVPNRSL 354
+ P+ +V ++ SL
Sbjct: 94 TK-PQLAIVTQWCEGSSL 110
>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
pdb|4G9R|B Chain B, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
Length = 307
Score = 35.8 bits (81), Expect = 0.041, Method: Compositional matrix adjust.
Identities = 21/78 (26%), Positives = 38/78 (48%), Gaps = 1/78 (1%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
+++G G G+VY G V + + T Q + F NEV ++ H N++ +G S
Sbjct: 42 QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 337 IEGPESLLVYEYVPNRSL 354
+ P+ +V ++ SL
Sbjct: 102 TK-PQLAIVTQWCEGSSL 118
>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
pdb|2FB8|B Chain B, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
Length = 281
Score = 35.8 bits (81), Expect = 0.042, Method: Compositional matrix adjust.
Identities = 21/78 (26%), Positives = 38/78 (48%), Gaps = 1/78 (1%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
+++G G G+VY G V + + T Q + F NEV ++ H N++ +G S
Sbjct: 19 QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 337 IEGPESLLVYEYVPNRSL 354
+ P+ +V ++ SL
Sbjct: 79 TK-PQLAIVTQWCEGSSL 95
>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
pdb|4DBN|B Chain B, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
Length = 284
Score = 35.8 bits (81), Expect = 0.044, Method: Compositional matrix adjust.
Identities = 21/78 (26%), Positives = 38/78 (48%), Gaps = 1/78 (1%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
+++G G G+VY G V + + T Q + F NEV ++ H N++ +G S
Sbjct: 19 QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 337 IEGPESLLVYEYVPNRSL 354
+ P+ +V ++ SL
Sbjct: 79 TK-PQLAIVTQWCEGSSL 95
>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With
Vuf 12058
Length = 285
Score = 35.8 bits (81), Expect = 0.044, Method: Compositional matrix adjust.
Identities = 27/92 (29%), Positives = 44/92 (47%), Gaps = 7/92 (7%)
Query: 276 SKKLGQGGAGSVYMGSLP----NGTTVAVKRLI--FNTRQWVDEFFNEVNLISSIEHKNL 329
K +G G G V G L VA+K L + +Q D F +E +++ +H N+
Sbjct: 13 EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRD-FLSEASIMGQFDHPNI 71
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFGN 361
+ L G + +++ EY+ N SLD F+ N
Sbjct: 72 IHLEGVVTKCKPVMIITEYMENGSLDAFLRKN 103
>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
pdb|3II5|B Chain B, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
Length = 306
Score = 35.8 bits (81), Expect = 0.044, Method: Compositional matrix adjust.
Identities = 21/78 (26%), Positives = 38/78 (48%), Gaps = 1/78 (1%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
+++G G G+VY G V + + T Q + F NEV ++ H N++ +G S
Sbjct: 41 QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 100
Query: 337 IEGPESLLVYEYVPNRSL 354
+ P+ +V ++ SL
Sbjct: 101 TK-PQLAIVTQWCEGSSL 117
>pdb|4H58|A Chain A, Braf In Complex With Compound 3
pdb|4H58|B Chain B, Braf In Complex With Compound 3
pdb|4H58|C Chain C, Braf In Complex With Compound 3
Length = 275
Score = 35.8 bits (81), Expect = 0.044, Method: Compositional matrix adjust.
Identities = 21/78 (26%), Positives = 38/78 (48%), Gaps = 1/78 (1%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
+++G G G+VY G V + + T Q + F NEV ++ H N++ +G S
Sbjct: 14 QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 337 IEGPESLLVYEYVPNRSL 354
+ P+ +V ++ SL
Sbjct: 74 TK-PQLAIVTQWCEGSSL 90
>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
pdb|3Q96|B Chain B, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
Length = 282
Score = 35.4 bits (80), Expect = 0.045, Method: Compositional matrix adjust.
Identities = 21/78 (26%), Positives = 38/78 (48%), Gaps = 1/78 (1%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
+++G G G+VY G V + + T Q + F NEV ++ H N++ +G S
Sbjct: 16 QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 75
Query: 337 IEGPESLLVYEYVPNRSL 354
+ P+ +V ++ SL
Sbjct: 76 TK-PQLAIVTQWCEGSSL 92
>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720
pdb|3C4C|B Chain B, B-Raf Kinase In Complex With Plx4720
Length = 280
Score = 35.4 bits (80), Expect = 0.045, Method: Compositional matrix adjust.
Identities = 21/78 (26%), Positives = 38/78 (48%), Gaps = 1/78 (1%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
+++G G G+VY G V + + T Q + F NEV ++ H N++ +G S
Sbjct: 18 QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 77
Query: 337 IEGPESLLVYEYVPNRSL 354
+ P+ +V ++ SL
Sbjct: 78 TK-PQLAIVTQWCEGSSL 94
>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|1VYW|C Chain C, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|2C4G|A Chain A, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2C4G|C Chain C, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2BPM|A Chain A, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BPM|C Chain C, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BKZ|A Chain A, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2BKZ|C Chain C, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2WIH|A Chain A, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIH|C Chain C, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIP|A Chain A, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WIP|C Chain C, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WPA|A Chain A, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WPA|C Chain C, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WXV|A Chain A, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
pdb|2WXV|C Chain C, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
Length = 309
Score = 35.4 bits (80), Expect = 0.045, Method: Compositional matrix adjust.
Identities = 26/94 (27%), Positives = 48/94 (51%), Gaps = 4/94 (4%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW--VDEFFNEVNLISSIEHKNL 329
F +K+G+G G VY + G VA+K++ +T E++L+ + H N+
Sbjct: 9 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFGNCL 363
VKLL + LV+E++ ++ L +F+ + L
Sbjct: 69 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASAL 101
>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6
Length = 321
Score = 35.4 bits (80), Expect = 0.045, Method: Compositional matrix adjust.
Identities = 22/82 (26%), Positives = 42/82 (51%), Gaps = 1/82 (1%)
Query: 278 KLGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
K+G+G G V + + G VAVK + +Q + FNEV ++ +H N+V++
Sbjct: 52 KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 337 IEGPESLLVYEYVPNRSLDQFI 358
+ G E ++ E++ +L +
Sbjct: 112 LVGEELWVLMEFLQGGALTDIV 133
>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain
pdb|2Y6O|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With
Dasatinib
Length = 291
Score = 35.4 bits (80), Expect = 0.046, Method: Compositional matrix adjust.
Identities = 27/92 (29%), Positives = 44/92 (47%), Gaps = 7/92 (7%)
Query: 276 SKKLGQGGAGSVYMGSLP----NGTTVAVKRLI--FNTRQWVDEFFNEVNLISSIEHKNL 329
K +G G G V G L VA+K L + +Q D F +E +++ +H N+
Sbjct: 19 EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRD-FLSEASIMGQFDHPNI 77
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFGN 361
+ L G + +++ EY+ N SLD F+ N
Sbjct: 78 IHLEGVVTKCKPVMIITEYMENGSLDAFLRKN 109
>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B
Length = 289
Score = 35.4 bits (80), Expect = 0.046, Method: Compositional matrix adjust.
Identities = 26/94 (27%), Positives = 48/94 (51%), Gaps = 4/94 (4%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW--VDEFFNEVNLISSIEHKNL 329
F +K+G+G G VY + G VA+K++ +T E++L+ + H N+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFGNCL 363
VKLL + LV+E++ ++ L +F+ + L
Sbjct: 65 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASAL 97
>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006
pdb|1UWJ|B Chain B, The Complex Of Mutant V599e B-raf And Bay439006
Length = 276
Score = 35.4 bits (80), Expect = 0.047, Method: Compositional matrix adjust.
Identities = 21/78 (26%), Positives = 38/78 (48%), Gaps = 1/78 (1%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
+++G G G+VY G V + + T Q + F NEV ++ H N++ +G S
Sbjct: 14 QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 337 IEGPESLLVYEYVPNRSL 354
+ P+ +V ++ SL
Sbjct: 74 TK-PQLAIVTQWCEGSSL 90
>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
pdb|4FK3|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
Length = 292
Score = 35.4 bits (80), Expect = 0.047, Method: Compositional matrix adjust.
Identities = 21/78 (26%), Positives = 38/78 (48%), Gaps = 1/78 (1%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
+++G G G+VY G V + + T Q + F NEV ++ H N++ +G S
Sbjct: 30 QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 337 IEGPESLLVYEYVPNRSL 354
+ P+ +V ++ SL
Sbjct: 90 TK-PQLAIVTQWCEGSSL 106
>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOO|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
Length = 299
Score = 35.4 bits (80), Expect = 0.047, Method: Compositional matrix adjust.
Identities = 26/94 (27%), Positives = 48/94 (51%), Gaps = 4/94 (4%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW--VDEFFNEVNLISSIEHKNL 329
F +K+G+G G VY + G VA+K++ +T E++L+ + H N+
Sbjct: 6 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFGNCL 363
VKLL + LV+E++ ++ L +F+ + L
Sbjct: 66 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASAL 98
>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E
pdb|4EOR|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOR|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
Length = 298
Score = 35.4 bits (80), Expect = 0.047, Method: Compositional matrix adjust.
Identities = 26/94 (27%), Positives = 48/94 (51%), Gaps = 4/94 (4%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW--VDEFFNEVNLISSIEHKNL 329
F +K+G+G G VY + G VA+K++ +T E++L+ + H N+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFGNCL 363
VKLL + LV+E++ ++ L +F+ + L
Sbjct: 65 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASAL 97
>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JST|C Chain C, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JSU|A Chain A, P27(Kip1)CYCLIN ACDK2 COMPLEX
pdb|1FQ1|B Chain B, Crystal Structure Of Kinase Associated Phosphatase (Kap)
In Complex With Phospho-Cdk2
pdb|2C6T|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6T|C Chain C, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2CJM|A Chain A, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CJM|C Chain C, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2UZB|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZB|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|4II5|A Chain A, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
pdb|4II5|C Chain C, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
Length = 298
Score = 35.4 bits (80), Expect = 0.047, Method: Compositional matrix adjust.
Identities = 26/94 (27%), Positives = 48/94 (51%), Gaps = 4/94 (4%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW--VDEFFNEVNLISSIEHKNL 329
F +K+G+G G VY + G VA+K++ +T E++L+ + H N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFGNCL 363
VKLL + LV+E++ ++ L +F+ + L
Sbjct: 64 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASAL 96
>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide,
Compound (S)-8b
pdb|3IG7|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efp With Cdk-2
pdb|3IGG|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efq With Cdk-2
pdb|1B38|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1B39|A Chain A, Human Cyclin-Dependent Kinase 2 Phosphorylated On Thr 160
pdb|1E1V|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu2058
pdb|1E1X|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu6027
pdb|1H00|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H07|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H08|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|2R3R|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|4ACM|A Chain A, Cdk2 In Complex With
3-Amino-6-(4-{[2-(Dimethylamino)ethyl]
Sulfamoyl}-Phenyl)-N-Pyridin-3-Ylpyrazine-2-Carboxamide
pdb|3SW4|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|3SW7|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|1OIQ|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
pdb|1V1K|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1URW|A Chain A, Cdk2 In Complex With An Imidazo[1,2-B]pyridazine
pdb|2VV9|A Chain A, Cdk2 In Complex With An Imidazole Piperazine
pdb|2W06|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5c
pdb|2R3G|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3H|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3F|A Chain A, Crystal Structure Of Cyclin-dependent Kinase 2 With
Inhibitor
Length = 299
Score = 35.4 bits (80), Expect = 0.048, Method: Compositional matrix adjust.
Identities = 26/94 (27%), Positives = 48/94 (51%), Gaps = 4/94 (4%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW--VDEFFNEVNLISSIEHKNL 329
F +K+G+G G VY + G VA+K++ +T E++L+ + H N+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFGNCL 363
VKLL + LV+E++ ++ L +F+ + L
Sbjct: 65 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASAL 97
>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a)
Length = 306
Score = 35.4 bits (80), Expect = 0.048, Method: Compositional matrix adjust.
Identities = 27/92 (29%), Positives = 44/92 (47%), Gaps = 7/92 (7%)
Query: 276 SKKLGQGGAGSVYMGSLP----NGTTVAVKRLI--FNTRQWVDEFFNEVNLISSIEHKNL 329
K +G G G V G L VA+K L + +Q D F +E +++ +H N+
Sbjct: 34 EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRD-FLSEASIMGQFDHPNI 92
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFGN 361
+ L G + +++ EY+ N SLD F+ N
Sbjct: 93 IHLEGVVTKCKPVMIITEYMENGSLDAFLRKN 124
>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1FIN|C Chain C, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1CKP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Purvalanol B
pdb|1BUH|A Chain A, Crystal Structure Of The Human Cdk2 Kinase Complex With
Cell Cycle-Regulatory Protein Ckshs1
pdb|1DM2|A Chain A, Human Cyclin-Dependent Kinase 2 Complexed With The
Inhibitor Hymenialdisine
pdb|1DI8|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With
4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline
pdb|1F5Q|A Chain A, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1F5Q|C Chain C, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1FVT|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With An Oxindole Inhibitor
pdb|1FVV|A Chain A, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1FVV|C Chain C, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1JSV|A Chain A, The Structure Of Cyclin-dependent Kinase 2 (cdk2) In
Complex With 4-[(6-amino-4-pyrimidinyl)
Amino]benzenesulfonamide
pdb|1G5S|A Chain A, Crystal Structure Of Human Cyclin Dependent Kinase 2
(Cdk2) In Complex With The Inhibitor H717
pdb|1JVP|P Chain P, Crystal Structure Of Human Cdk2 (Unphosphorylated) In
Complex With Pkf049-365
pdb|1GIH|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1KE5|A Chain A, Cdk2 Complexed With N-methyl-4-{[(2-oxo-1,2-dihydro-3h-
Indol-3-ylidene)methyl]amino}benzenesulfonamide
pdb|1KE6|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
N-Methyl-{4-
[2-(7-Oxo-6,7-Dihydro-8h-[1,3]thiazolo[5,4-E]indol-8-
Ylidene)hydrazino]phenyl}methanesulfonamide
pdb|1KE7|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[(2,2-
Dioxido-1,
3-Dihydro-2-Benzothien-5-Yl)amino]methylene}-5-
(1,3-Oxazol-5-Yl)-1,3-Dihydro-2h-Indol-2-One
pdb|1KE8|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
4-{[(2-Oxo-
1,2-Dihydro-3h-Indol-3-Ylidene)methyl]amino}-N-(1,3-
Thiazol-2-Yl)benzenesulfonamide
pdb|1KE9|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[4-
({[amino(Imino)methyl]aminosulfonyl)anilino]methylene}-
2- Oxo-2,3-Dihydro-1h-Indole
pdb|1H0V|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor
2-Amino-6-[(R)-Pyrrolidino-5'-Yl]methoxypurine
pdb|1H0W|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 2-Amino-6-[cyclohex-3-Enyl]methoxypurine
pdb|1P2A|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Trisubstituted Naphthostyril Inhibitor
pdb|1OKV|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKV|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKW|A Chain A, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OKW|C Chain C, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OL1|A Chain A, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL1|C Chain C, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL2|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1OL2|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1PW2|A Chain A, Apo Structure Of Human Cyclin-Dependent Kinase 2
pdb|1PXI|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-(2,5-dichloro-thiophen-3-yl)-pyrimidin-2-
Ylamine
pdb|1PXJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine
pdb|1PXK|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-dimethyl-thiazol-5-yl)pyrimidin-2-yl]-
N'-hydroxyiminoformamide
pdb|1PXL|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-yl]-
(4-trifluoromethyl-phenyl)-amine
pdb|1R78|A Chain A, Cdk2 Complex With A 4-alkynyl Oxindole Inhibitor
pdb|1PXM|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-
Ylamino]-Phenol
pdb|1PXN|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-
Pyrimidin-2-Ylamino]-Phenol
pdb|1PXO|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-
Yl]-(3-Nitro-Phenyl)-Amine
pdb|1PXP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-
N',N'-Dimethyl-Benzene-1,4-Diamine
pdb|1VYZ|A Chain A, Structure Of Cdk2 Complexed With Pnu-181227
pdb|1PYE|A Chain A, Crystal Structure Of Cdk2 With Inhibitor
pdb|1URC|A Chain A, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1URC|C Chain C, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1W0X|C Chain C, Crystals Structure Of Human Cdk2 In Complex With The
Inhibitor Olomoucine.
pdb|1WCC|A Chain A, Screening For Fragment Binding By X-Ray Crystallography
pdb|1Y8Y|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|1Y91|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|2BHE|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 5-Bromo-Indirubine
pdb|2BHH|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 4-Hydroxypiperindinesulfonyl-Indirubine
pdb|2B52|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Dph-
042562
pdb|2B53|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Din-
234325
pdb|2B54|A Chain A, Human Cyclin Dependent Kinase 2 (Ckd2)complexed With Din-
232305
pdb|2B55|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With
Indenopyraxole Din-101312
pdb|2BTR|A Chain A, Structure Of Cdk2 Complexed With Pnu-198873
pdb|2BTS|A Chain A, Structure Of Cdk2 Complexed With Pnu-230032
pdb|2C68|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C69|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6I|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6K|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6L|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6M|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6O|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2EXM|A Chain A, Human Cdk2 In Complex With Isopentenyladenine
pdb|1YKR|A Chain A, Crystal Structure Of Cdk2 With An Aminoimidazo Pyridine
Inhibitor
pdb|2A0C|X Chain X, Human Cdk2 In Complex With Olomoucine Ii, A Novel 2,6,9-
Trisubstituted Purine Cyclin-Dependent Kinase Inhibitor
pdb|2C5N|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5N|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5Y|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2A4L|A Chain A, Human Cyclin-Dependent Kinase 2 In Complex With
Roscovitine
pdb|2FVD|A Chain A, Cyclin Dependent Kinase 2 (Cdk2) With Diaminopyrimidine
Inhibitor
pdb|2I40|A Chain A, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2I40|C Chain C, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2CLX|A Chain A, 4-Arylazo-3,5-Diamino-1h-Pyrazole Cdk Inhibitors: Sar
Study, Crystal Structure In Complex With Cdk2,
Selectivity, And Cellular Effects
pdb|2DUV|A Chain A, Structure Of Cdk2 With A 3-Hydroxychromones
pdb|2UUE|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UUE|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UZN|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZO|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2V0D|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|1AQ1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Staurosporine
pdb|1HCK|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1HCL|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|2J9M|A Chain A, Crystal Structure Of Cdk2 In Complex With Macrocyclic
Aminopyrimidine
pdb|2V22|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2V22|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2VTA|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTH|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design
pdb|2VTI|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTJ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTL|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTM|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTN|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTO|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTP|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTQ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTR|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTS|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTT|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VU3|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2R64|A Chain A, Crystal Structure Of A 3-Aminoindazole Compound With Cdk2
pdb|2W05|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5b
pdb|3EID|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EID|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EOC|A Chain A, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|3EOC|C Chain C, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|2W1H|A Chain A, Fragment-Based Discovery Of The Pyrazol-4-Yl Urea
(At9283), A Multi-Targeted Kinase Inhibitor With Potent
Aurora Kinase Activity
pdb|3F5X|A Chain A, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3F5X|C Chain C, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3FZ1|A Chain A, Crystal Structure Of A Benzthiophene Inhibitor Bound To
Human Cyclin-Dependent Kinase-2 (Cdk-2)
pdb|2WEV|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WEV|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|3LFN|A Chain A, Crystal Structure Of Cdk2 With Sar57, An Aminoindazole
Type Inhibitor
pdb|3LFQ|A Chain A, Crystal Structure Of Cdk2 With Sar60, An Aminoindazole
Type Inhibitor
pdb|3LFS|A Chain A, Crystal Structure Of Cdk2 With Sar37, An Aminoindazole
Type Inhibitor
pdb|2XMY|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|2XNB|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|3LE6|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Pyrazolobenzodiazepine Inhibitor
pdb|3NS9|A Chain A, Crystal Structure Of Cdk2 In Complex With Inhibitor Bs-194
pdb|3S2P|A Chain A, Crystal Structure Of Cdk2 With A 2-Aminopyrimidine
Compound
pdb|3UNJ|A Chain A, Cdk2 In Complex With Inhibitor Yl1-038-31
pdb|3UNK|A Chain A, Cdk2 In Complex With Inhibitor Yl5-083
pdb|3TI1|A Chain A, Cdk2 In Complex With Sunitinib
pdb|3TIY|A Chain A, Cdk2 In Complex With Nsc 35676
pdb|3TIZ|A Chain A, Cdk2 In Complex With Nsc 111848
Length = 298
Score = 35.4 bits (80), Expect = 0.048, Method: Compositional matrix adjust.
Identities = 26/94 (27%), Positives = 48/94 (51%), Gaps = 4/94 (4%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW--VDEFFNEVNLISSIEHKNL 329
F +K+G+G G VY + G VA+K++ +T E++L+ + H N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFGNCL 363
VKLL + LV+E++ ++ L +F+ + L
Sbjct: 64 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASAL 96
>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-dependent Kinase Inhibitors Identified Through
Structure-based Hybridisation
Length = 299
Score = 35.4 bits (80), Expect = 0.048, Method: Compositional matrix adjust.
Identities = 26/94 (27%), Positives = 48/94 (51%), Gaps = 4/94 (4%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW--VDEFFNEVNLISSIEHKNL 329
F +K+G+G G VY + G VA+K++ +T E++L+ + H N+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFGNCL 363
VKLL + LV+E++ ++ L +F+ + L
Sbjct: 65 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASAL 97
>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A
Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine
Length = 299
Score = 35.4 bits (80), Expect = 0.048, Method: Compositional matrix adjust.
Identities = 26/94 (27%), Positives = 48/94 (51%), Gaps = 4/94 (4%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW--VDEFFNEVNLISSIEHKNL 329
F +K+G+G G VY + G VA+K++ +T E++L+ + H N+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFGNCL 363
VKLL + LV+E++ ++ L +F+ + L
Sbjct: 65 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASAL 97
>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHT|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHU|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHU|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHV|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3BHV|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3MY5|A Chain A, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3MY5|C Chain C, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3TNW|A Chain A, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|3TNW|C Chain C, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|4BCO|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCO|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 300
Score = 35.4 bits (80), Expect = 0.049, Method: Compositional matrix adjust.
Identities = 26/94 (27%), Positives = 48/94 (51%), Gaps = 4/94 (4%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW--VDEFFNEVNLISSIEHKNL 329
F +K+G+G G VY + G VA+K++ +T E++L+ + H N+
Sbjct: 6 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFGNCL 363
VKLL + LV+E++ ++ L +F+ + L
Sbjct: 66 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASAL 98
>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine
pdb|2R3Q|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3M|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3I|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3N|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3O|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3P|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3K|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3J|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3L|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|1W8C|A Chain A, Co-crystal Structure Of
6-cyclohexylmethoxy-8-isopropyl-9h- Purin-2-ylamine And
Monomeric Cdk2
Length = 299
Score = 35.4 bits (80), Expect = 0.049, Method: Compositional matrix adjust.
Identities = 26/94 (27%), Positives = 48/94 (51%), Gaps = 4/94 (4%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW--VDEFFNEVNLISSIEHKNL 329
F +K+G+G G VY + G VA+K++ +T E++L+ + H N+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFGNCL 363
VKLL + LV+E++ ++ L +F+ + L
Sbjct: 65 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASAL 97
>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2
Complexed With A Nucleoside Inhibitor
Length = 298
Score = 35.4 bits (80), Expect = 0.049, Method: Compositional matrix adjust.
Identities = 26/94 (27%), Positives = 48/94 (51%), Gaps = 4/94 (4%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW--VDEFFNEVNLISSIEHKNL 329
F +K+G+G G VY + G VA+K++ +T E++L+ + H N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFGNCL 363
VKLL + LV+E++ ++ L +F+ + L
Sbjct: 64 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASAL 96
>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1QMZ|C Chain C, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1GY3|A Chain A, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1GY3|C Chain C, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1P5E|A Chain A, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1P5E|C Chain C, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|2CCH|A Chain A, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCH|C Chain C, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCI|A Chain A, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2CCI|C Chain C, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2G9X|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|2G9X|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|3DDP|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDP|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDQ|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DDQ|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DOG|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
pdb|3DOG|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
Length = 299
Score = 35.4 bits (80), Expect = 0.049, Method: Compositional matrix adjust.
Identities = 26/94 (27%), Positives = 48/94 (51%), Gaps = 4/94 (4%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW--VDEFFNEVNLISSIEHKNL 329
F +K+G+G G VY + G VA+K++ +T E++L+ + H N+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFGNCL 363
VKLL + LV+E++ ++ L +F+ + L
Sbjct: 65 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASAL 97
>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1E9H|C Chain C, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1PKD|A Chain A, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|1PKD|C Chain C, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
Length = 297
Score = 35.4 bits (80), Expect = 0.050, Method: Compositional matrix adjust.
Identities = 26/94 (27%), Positives = 48/94 (51%), Gaps = 4/94 (4%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW--VDEFFNEVNLISSIEHKNL 329
F +K+G+G G VY + G VA+K++ +T E++L+ + H N+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFGNCL 363
VKLL + LV+E++ ++ L +F+ + L
Sbjct: 65 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASAL 97
>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHR|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
Length = 298
Score = 35.4 bits (80), Expect = 0.050, Method: Compositional matrix adjust.
Identities = 26/94 (27%), Positives = 48/94 (51%), Gaps = 4/94 (4%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW--VDEFFNEVNLISSIEHKNL 329
F +K+G+G G VY + G VA+K++ +T E++L+ + H N+
Sbjct: 6 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFGNCL 363
VKLL + LV+E++ ++ L +F+ + L
Sbjct: 66 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASAL 98
>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site
pdb|3EZV|A Chain A, Cdk-2 With Indazole Inhibitor 9 Bound At Its Active Site
Length = 300
Score = 35.4 bits (80), Expect = 0.050, Method: Compositional matrix adjust.
Identities = 26/94 (27%), Positives = 48/94 (51%), Gaps = 4/94 (4%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW--VDEFFNEVNLISSIEHKNL 329
F +K+G+G G VY + G VA+K++ +T E++L+ + H N+
Sbjct: 6 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFGNCL 363
VKLL + LV+E++ ++ L +F+ + L
Sbjct: 66 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASAL 98
>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006
pdb|1UWH|B Chain B, The Complex Of Wild Type B-Raf And Bay439006
Length = 276
Score = 35.4 bits (80), Expect = 0.051, Method: Compositional matrix adjust.
Identities = 21/78 (26%), Positives = 37/78 (47%), Gaps = 1/78 (1%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
+++G G G+VY G V + + T Q + F NEV ++ H N++ +G S
Sbjct: 14 QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 337 IEGPESLLVYEYVPNRSL 354
P+ +V ++ SL
Sbjct: 74 T-APQLAIVTQWCEGSSL 90
>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
pdb|3OG7|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
Length = 289
Score = 35.4 bits (80), Expect = 0.051, Method: Compositional matrix adjust.
Identities = 21/78 (26%), Positives = 37/78 (47%), Gaps = 1/78 (1%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
+++G G G+VY G V + + T Q + F NEV ++ H N++ +G S
Sbjct: 30 QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 337 IEGPESLLVYEYVPNRSL 354
P+ +V ++ SL
Sbjct: 90 T-APQLAIVTQWCEGSSL 106
>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
pdb|4EOS|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
Length = 300
Score = 35.4 bits (80), Expect = 0.052, Method: Compositional matrix adjust.
Identities = 26/94 (27%), Positives = 48/94 (51%), Gaps = 4/94 (4%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW--VDEFFNEVNLISSIEHKNL 329
F +K+G+G G VY + G VA+K++ +T E++L+ + H N+
Sbjct: 7 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFGNCL 363
VKLL + LV+E++ ++ L +F+ + L
Sbjct: 67 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASAL 99
>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOP|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 300
Score = 35.4 bits (80), Expect = 0.052, Method: Compositional matrix adjust.
Identities = 26/94 (27%), Positives = 48/94 (51%), Gaps = 4/94 (4%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW--VDEFFNEVNLISSIEHKNL 329
F +K+G+G G VY + G VA+K++ +T E++L+ + H N+
Sbjct: 7 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFGNCL 363
VKLL + LV+E++ ++ L +F+ + L
Sbjct: 67 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASAL 99
>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOQ|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
Length = 301
Score = 35.4 bits (80), Expect = 0.053, Method: Compositional matrix adjust.
Identities = 26/94 (27%), Positives = 48/94 (51%), Gaps = 4/94 (4%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW--VDEFFNEVNLISSIEHKNL 329
F +K+G+G G VY + G VA+K++ +T E++L+ + H N+
Sbjct: 8 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFGNCL 363
VKLL + LV+E++ ++ L +F+ + L
Sbjct: 68 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASAL 100
>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCQ|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 301
Score = 35.4 bits (80), Expect = 0.053, Method: Compositional matrix adjust.
Identities = 26/94 (27%), Positives = 48/94 (51%), Gaps = 4/94 (4%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW--VDEFFNEVNLISSIEHKNL 329
F +K+G+G G VY + G VA+K++ +T E++L+ + H N+
Sbjct: 7 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFGNCL 363
VKLL + LV+E++ ++ L +F+ + L
Sbjct: 67 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASAL 99
>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
pdb|4I3Z|C Chain C, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
Length = 296
Score = 35.4 bits (80), Expect = 0.053, Method: Compositional matrix adjust.
Identities = 26/94 (27%), Positives = 48/94 (51%), Gaps = 4/94 (4%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW--VDEFFNEVNLISSIEHKNL 329
F +K+G+G G VY + G VA+K++ +T E++L+ + H N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFGNCL 363
VKLL + LV+E++ ++ L +F+ + L
Sbjct: 64 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASAL 96
>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1P|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1Q|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1Q|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1R|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1R|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1S|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H1S|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H24|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H24|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H25|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H25|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H26|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H26|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H27|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H27|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H28|A Chain A, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|1H28|C Chain C, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|2WMA|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMA|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
Length = 303
Score = 35.4 bits (80), Expect = 0.054, Method: Compositional matrix adjust.
Identities = 26/94 (27%), Positives = 48/94 (51%), Gaps = 4/94 (4%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW--VDEFFNEVNLISSIEHKNL 329
F +K+G+G G VY + G VA+K++ +T E++L+ + H N+
Sbjct: 9 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFGNCL 363
VKLL + LV+E++ ++ L +F+ + L
Sbjct: 69 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASAL 101
>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|B Chain B, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|C Chain C, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|D Chain D, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|E Chain E, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|F Chain F, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
Length = 294
Score = 35.4 bits (80), Expect = 0.054, Method: Compositional matrix adjust.
Identities = 26/86 (30%), Positives = 44/86 (51%), Gaps = 6/86 (6%)
Query: 278 KLGQGGAGSVYMG--SLPNGTTVAVKRLIFNTRQ---WVDEFFNEVNLISSIEHKNLVKL 332
KLG GG +VY+ ++ N VA+K + R+ + F EV+ S + H+N+V +
Sbjct: 18 KLGGGGMSTVYLAEDTILN-IKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 333 LGCSIEGPESLLVYEYVPNRSLDQFI 358
+ E LV EY+ +L ++I
Sbjct: 77 IDVDEEDDCYYLVMEYIEGPTLSEYI 102
>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed
With Imidazo[1,5-A]quinoxaline
Length = 267
Score = 35.4 bits (80), Expect = 0.054, Method: Compositional matrix adjust.
Identities = 22/82 (26%), Positives = 40/82 (48%), Gaps = 1/82 (1%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
+++G G G V++G N VA+K I ++F E ++ + H LV+L G
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIK-TIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 337 IEGPESLLVYEYVPNRSLDQFI 358
+E LV E++ + L ++
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYL 94
>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OGU|C Chain C, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OI9|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OI9|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
Length = 302
Score = 35.4 bits (80), Expect = 0.056, Method: Compositional matrix adjust.
Identities = 26/94 (27%), Positives = 48/94 (51%), Gaps = 4/94 (4%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW--VDEFFNEVNLISSIEHKNL 329
F +K+G+G G VY + G VA+K++ +T E++L+ + H N+
Sbjct: 8 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFGNCL 363
VKLL + LV+E++ ++ L +F+ + L
Sbjct: 68 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASAL 100
>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXQ|A Chain A, Cdk2 In Complex With 3 Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXR|A Chain A, Apo Cdk2 Crystallized From Jeffamine
pdb|3PXY|A Chain A, Cdk2 In Complex With Inhibitor Jws648
pdb|3PXZ|A Chain A, Cdk2 Ternary Complex With Jws648 And Ans
pdb|3PY0|A Chain A, Cdk2 In Complex With Inhibitor Su9516
pdb|3PY1|A Chain A, Cdk2 Ternary Complex With Su9516 And Ans
pdb|3QL8|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-260
pdb|3QQF|A Chain A, Cdk2 In Complex With Inhibitor L1
pdb|3QQG|A Chain A, Cdk2 In Complex With Inhibitor L2-5
pdb|3QQH|A Chain A, Cdk2 In Complex With Inhibitor L2-2
pdb|3QQJ|A Chain A, Cdk2 In Complex With Inhibitor L2
pdb|3QQL|A Chain A, Cdk2 In Complex With Inhibitor L3
pdb|3QRT|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc2-55
pdb|3QRU|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-12
pdb|3QWJ|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-142
pdb|3QWK|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-150
pdb|3QX2|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-190
pdb|3QX4|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-78
pdb|3QXO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-84
pdb|3QZF|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-52
pdb|3QZG|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-76
pdb|3QZH|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-124
pdb|3QZI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-126
pdb|3R1Q|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-102
pdb|3R1S|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-127
pdb|3R1Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-134
pdb|3R28|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-140
pdb|3R6X|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-158
pdb|3R71|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-162
pdb|3R73|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-164
pdb|3R7E|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-67
pdb|3R7I|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-74
pdb|3R7U|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-75
pdb|3R7V|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-9
pdb|3R7Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-88
pdb|3R83|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-92
pdb|3R8L|A Chain A, Cdk2 In Complex With Inhibitor L3-4
pdb|3R8M|A Chain A, Cdk2 In Complex With Inhibitor L3-3
pdb|3R8P|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-6
pdb|3RAI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-160
pdb|3RM6|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-80
pdb|3RM7|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-91
pdb|3ROY|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-154
pdb|3RPO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-156
pdb|4EZ3|A Chain A, Cdk2 In Complex With Nsc 134199
pdb|4EZ7|A Chain A, Cdk2 In Complex With Staurosporine And 2 Molecules Of
8-Anilino-1- Naphthalene Sulfonic Acid
pdb|3QQK|A Chain A, Cdk2 In Complex With Inhibitor L4
pdb|3QTQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-137
pdb|3QTR|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-148
pdb|3QTS|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-12
pdb|3QTU|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-132
pdb|3QTW|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-13
pdb|3QTX|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-35
pdb|3QTZ|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-36
pdb|3QU0|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-38
pdb|3QXP|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
pdb|3R8U|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-132
pdb|3R8V|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-135
pdb|3R8Z|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-136
pdb|3R9D|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-135
pdb|3R9H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-142
pdb|3R9N|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-21
pdb|3R9O|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-143
pdb|3RAH|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-22
pdb|3RAK|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-32
pdb|3RAL|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-34
pdb|3RJC|A Chain A, Cdk2 In Complex With Inhibitor L4-12
pdb|3RK5|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-72
pdb|3RK7|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-71
pdb|3RK9|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-74
pdb|3RKB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-73
pdb|3RMF|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-33
pdb|3RNI|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-86
pdb|3RPR|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-49
pdb|3RPV|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-88
pdb|3RPY|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-40
pdb|3RZB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-23
pdb|3S00|A Chain A, Cdk2 In Complex With Inhibitor L4-14
pdb|3S0O|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-138
pdb|3S1H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-39
pdb|3SQQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-96
pdb|4GCJ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
Length = 306
Score = 35.0 bits (79), Expect = 0.058, Method: Compositional matrix adjust.
Identities = 26/94 (27%), Positives = 48/94 (51%), Gaps = 4/94 (4%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW--VDEFFNEVNLISSIEHKNL 329
F +K+G+G G VY + G VA+K++ +T E++L+ + H N+
Sbjct: 12 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFGNCL 363
VKLL + LV+E++ ++ L +F+ + L
Sbjct: 72 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASAL 104
>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine
Length = 306
Score = 35.0 bits (79), Expect = 0.060, Method: Compositional matrix adjust.
Identities = 26/94 (27%), Positives = 48/94 (51%), Gaps = 4/94 (4%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW--VDEFFNEVNLISSIEHKNL 329
F +K+G+G G VY + G VA+K++ +T E++L+ + H N+
Sbjct: 12 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFGNCL 363
VKLL + LV+E++ ++ L +F+ + L
Sbjct: 72 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASAL 104
>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex
With An Hydantoin Inhibitor
Length = 305
Score = 35.0 bits (79), Expect = 0.063, Method: Compositional matrix adjust.
Identities = 29/106 (27%), Positives = 50/106 (47%), Gaps = 9/106 (8%)
Query: 261 FKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPN------GTTVAVKRL--IFNTRQWVD 312
F + E A S++LGQG G VY G T VA+K + + R+ +
Sbjct: 6 FVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI- 64
Query: 313 EFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI 358
EF NE +++ ++V+LLG +G +L++ E + L ++
Sbjct: 65 EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 110
>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420
Length = 504
Score = 35.0 bits (79), Expect = 0.067, Method: Compositional matrix adjust.
Identities = 22/86 (25%), Positives = 40/86 (46%), Gaps = 14/86 (16%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIF--------------NTRQWVDEFFNEVNLIS 322
+KLG G G V + NG + ++I N ++ +E +NE++L+
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 323 SIEHKNLVKLLGCSIEGPESLLVYEY 348
S++H N++KL + LV E+
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEF 127
>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
Bound To Su11274
pdb|4AOT|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
(Lok) Bound To Gw830263a
pdb|4AOT|B Chain B, Crystal Structure Of Human Serine Threonine Kinase-10
(Lok) Bound To Gw830263a
pdb|4EQU|A Chain A, Human Stk-10 (Lok) Kinase Domain In Dfg-Out Conformation
With Inhibitor Dsa-7
pdb|4EQU|B Chain B, Human Stk-10 (Lok) Kinase Domain In Dfg-Out Conformation
With Inhibitor Dsa-7
Length = 302
Score = 35.0 bits (79), Expect = 0.067, Method: Compositional matrix adjust.
Identities = 19/83 (22%), Positives = 42/83 (50%), Gaps = 1/83 (1%)
Query: 278 KLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
+LG G G VY + G A K + + + ++++ E+ ++++ +H +VKLLG
Sbjct: 26 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 337 IEGPESLLVYEYVPNRSLDQFIF 359
+ ++ E+ P ++D +
Sbjct: 86 YHDGKLWIMIEFCPGGAVDAIML 108
>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
Bound To Novel Bosutinib Isoform 1, Previously Thought
To Be Bosutinib
Length = 293
Score = 35.0 bits (79), Expect = 0.068, Method: Compositional matrix adjust.
Identities = 19/83 (22%), Positives = 42/83 (50%), Gaps = 1/83 (1%)
Query: 278 KLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCS 336
+LG G G VY + G A K + + + ++++ E+ ++++ +H +VKLLG
Sbjct: 18 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 77
Query: 337 IEGPESLLVYEYVPNRSLDQFIF 359
+ ++ E+ P ++D +
Sbjct: 78 YHDGKLWIMIEFCPGGAVDAIML 100
>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOI|C Chain C, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 299
Score = 35.0 bits (79), Expect = 0.072, Method: Compositional matrix adjust.
Identities = 26/94 (27%), Positives = 47/94 (50%), Gaps = 4/94 (4%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW--VDEFFNEVNLISSIEHKNL 329
F +K+G+G G VY + G VA+K++ +T E++L+ + H N+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFGNCL 363
VKLL + LV+E++ ++ L F+ + L
Sbjct: 65 VKLLDVIHTENKLYLVFEFL-HQDLKDFMDASAL 97
>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein
Kinase 6 (Mapk6)
pdb|2I6L|B Chain B, Crystal Structure Of Human Mitogen Activated Protein
Kinase 6 (Mapk6)
Length = 320
Score = 35.0 bits (79), Expect = 0.074, Method: Compositional matrix adjust.
Identities = 22/66 (33%), Positives = 35/66 (53%), Gaps = 5/66 (7%)
Query: 277 KKLGQGGAGSVYMGSLPNG--TTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLG 334
K LG GG G V+ ++ N VA+K+++ Q V E+ +I ++H N+VK+
Sbjct: 17 KPLGCGGNGLVF-SAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVF- 74
Query: 335 CSIEGP 340
I GP
Sbjct: 75 -EILGP 79
>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain
pdb|1OEC|A Chain A, Fgfr2 Kinase Domain
Length = 316
Score = 35.0 bits (79), Expect = 0.076, Method: Compositional matrix adjust.
Identities = 29/93 (31%), Positives = 49/93 (52%), Gaps = 12/93 (12%)
Query: 277 KKLGQGGAGSVYMGSL--------PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
K LG+G G V M TVAVK L + T + + + +E+ ++ I +H
Sbjct: 33 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 92
Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFI 358
KN++ LLG C+ +GP ++V EY +L +++
Sbjct: 93 KNIINLLGACTQDGPLYVIV-EYASKGNLREYL 124
>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565a Mutation Responsible For
Pfeiffer Syndrome
pdb|2Q0B|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565a Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 34.7 bits (78), Expect = 0.078, Method: Compositional matrix adjust.
Identities = 26/80 (32%), Positives = 42/80 (52%), Gaps = 11/80 (13%)
Query: 277 KKLGQGGAGSVYMGSL--------PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
K LG+G G V M TVAVK L + T + + + +E+ ++ I +H
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 327 KNLVKLLG-CSIEGPESLLV 345
KN++ LLG C+ +GP ++V
Sbjct: 101 KNIINLLGACTQDGPLYVIV 120
>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex
With A Staurosporine Analogue
Length = 290
Score = 34.7 bits (78), Expect = 0.079, Method: Compositional matrix adjust.
Identities = 27/88 (30%), Positives = 42/88 (47%), Gaps = 7/88 (7%)
Query: 278 KLGQGGAGSVYMGSLP-----NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKL 332
+LG+G GSV + G VAVK+L + +F E+ ++ ++ +VK
Sbjct: 14 QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 73
Query: 333 LGCSIEG--PESLLVYEYVPNRSLDQFI 358
G S PE LV EY+P+ L F+
Sbjct: 74 RGVSYGPGRPELRLVMEYLPSGCLRDFL 101
>pdb|3B2T|A Chain A, Structure Of Phosphotransferase
pdb|3B2T|B Chain B, Structure Of Phosphotransferase
Length = 311
Score = 34.7 bits (78), Expect = 0.080, Method: Compositional matrix adjust.
Identities = 29/93 (31%), Positives = 49/93 (52%), Gaps = 12/93 (12%)
Query: 277 KKLGQGGAGSVYMGSL--------PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
K LG+G G V M TVAVK L + T + + + +E+ ++ I +H
Sbjct: 28 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 87
Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFI 358
KN++ LLG C+ +GP ++V EY +L +++
Sbjct: 88 KNIINLLGACTQDGPLYVIV-EYASKGNLREYL 119
>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase
In Complex With Arq 069
pdb|3RI1|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase
In Complex With Arq 069
Length = 313
Score = 34.7 bits (78), Expect = 0.083, Method: Compositional matrix adjust.
Identities = 29/93 (31%), Positives = 49/93 (52%), Gaps = 12/93 (12%)
Query: 277 KKLGQGGAGSVYMGSL--------PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
K LG+G G V M TVAVK L + T + + + +E+ ++ I +H
Sbjct: 30 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 89
Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFI 358
KN++ LLG C+ +GP ++V EY +L +++
Sbjct: 90 KNIINLLGACTQDGPLYVIV-EYASKGNLREYL 121
>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone
Morp Protein Receptor Type-1b (Bmpr1b) In Complex With
Fkbp12 An 193189
pdb|3MDY|C Chain C, Crystal Structure Of The Cytoplasmic Domain Of The Bone
Morp Protein Receptor Type-1b (Bmpr1b) In Complex With
Fkbp12 An 193189
Length = 337
Score = 34.7 bits (78), Expect = 0.083, Method: Compositional matrix adjust.
Identities = 27/93 (29%), Positives = 46/93 (49%), Gaps = 10/93 (10%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSI--EHKNLVKLLG 334
K++G+G G V+MG G VAVK + F T + +F E + ++ H+N++ +
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVK-VFFTTEE--ASWFRETEIYQTVLMRHENILGFIA 98
Query: 335 CSIEGPESL----LVYEYVPNRSLDQFIFGNCL 363
I+G S L+ +Y N SL ++ L
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYLKSTTL 131
>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|B Chain B, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|C Chain C, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|D Chain D, Igf-1rk In Complex With Ligand Msc1609119a-1
Length = 304
Score = 34.7 bits (78), Expect = 0.084, Method: Compositional matrix adjust.
Identities = 28/103 (27%), Positives = 49/103 (47%), Gaps = 9/103 (8%)
Query: 264 ETLEKATNYFNPSKKLGQGGAGSVYMGSLPN------GTTVAVKRL--IFNTRQWVDEFF 315
+ E A S++LGQG G VY G T VA+K + + R+ + EF
Sbjct: 8 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFL 66
Query: 316 NEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI 358
NE +++ ++V+LLG +G +L++ E + L ++
Sbjct: 67 NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 109
>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565g Mutation Responsible For
Pfeiffer Syndrome
pdb|2PY3|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565g Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 34.7 bits (78), Expect = 0.085, Method: Compositional matrix adjust.
Identities = 26/80 (32%), Positives = 42/80 (52%), Gaps = 11/80 (13%)
Query: 277 KKLGQGGAGSVYMGSL--------PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
K LG+G G V M TVAVK L + T + + + +E+ ++ I +H
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 327 KNLVKLLG-CSIEGPESLLV 345
KN++ LLG C+ +GP ++V
Sbjct: 101 KNIINLLGACTQDGPLYVIV 120
>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild
Type Fgf Receptor 2 (Fgfr2) Kinase Domain
pdb|2PSQ|B Chain B, Crystal Structure Of Unphosphorylated Unactivated Wild
Type Fgf Receptor 2 (Fgfr2) Kinase Domain
Length = 370
Score = 34.7 bits (78), Expect = 0.088, Method: Compositional matrix adjust.
Identities = 29/93 (31%), Positives = 49/93 (52%), Gaps = 12/93 (12%)
Query: 277 KKLGQGGAGSVYMGSL--------PNGTTVAVKRLIFN-TRQWVDEFFNEVNLISSI-EH 326
K LG+G G V M TVAVK L + T + + + +E+ ++ I +H
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 327 KNLVKLLG-CSIEGPESLLVYEYVPNRSLDQFI 358
KN++ LLG C+ +GP ++V EY +L +++
Sbjct: 147 KNIINLLGACTQDGPLYVIV-EYASKGNLREYL 178
>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain
pdb|1JQH|B Chain B, Igf-1 Receptor Kinase Domain
pdb|1JQH|C Chain C, Igf-1 Receptor Kinase Domain
Length = 308
Score = 34.7 bits (78), Expect = 0.089, Method: Compositional matrix adjust.
Identities = 28/103 (27%), Positives = 49/103 (47%), Gaps = 9/103 (8%)
Query: 264 ETLEKATNYFNPSKKLGQGGAGSVYMGSLPN------GTTVAVKRL--IFNTRQWVDEFF 315
+ E A S++LGQG G VY G T VA+K + + R+ + EF
Sbjct: 12 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFL 70
Query: 316 NEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI 358
NE +++ ++V+LLG +G +L++ E + L ++
Sbjct: 71 NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 113
>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|B Chain B, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|C Chain C, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|D Chain D, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|3F5P|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|B Chain B, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|C Chain C, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|D Chain D, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|E Chain E, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|F Chain F, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|G Chain G, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|H Chain H, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|I Chain I, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|J Chain J, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|K Chain K, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|M Chain M, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|L Chain L, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|R Chain R, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|S Chain S, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|T Chain T, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
Length = 308
Score = 34.7 bits (78), Expect = 0.093, Method: Compositional matrix adjust.
Identities = 28/100 (28%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 267 EKATNYFNPSKKLGQGGAGSVYMGSLPN------GTTVAVKRL--IFNTRQWVDEFFNEV 318
E A S++LGQG G VY G T VA+K + + R+ + EF NE
Sbjct: 15 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEA 73
Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI 358
+++ ++V+LLG +G +L++ E + L ++
Sbjct: 74 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 113
>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A
Benzimidazole Inhibitor
pdb|3NW5|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (11b)
pdb|3NW6|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (11a)
pdb|3NW7|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (34)
Length = 307
Score = 34.7 bits (78), Expect = 0.094, Method: Compositional matrix adjust.
Identities = 28/100 (28%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 267 EKATNYFNPSKKLGQGGAGSVYMGSLPN------GTTVAVKRL--IFNTRQWVDEFFNEV 318
E A S++LGQG G VY G T VA+K + + R+ + EF NE
Sbjct: 14 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEA 72
Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI 358
+++ ++V+LLG +G +L++ E + L ++
Sbjct: 73 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 112
>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor
Discovered Through Site-Directed Dynamic Tethering
Length = 272
Score = 34.3 bits (77), Expect = 0.100, Method: Compositional matrix adjust.
Identities = 20/82 (24%), Positives = 38/82 (46%), Gaps = 4/82 (4%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWV----DEFFNEVNLISSIEHKN 328
F+ + LG+G G+VY+ + +++F T+ + EV + S + H N
Sbjct: 14 FDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 329 LVKLLGCSIEGPESLLVYEYVP 350
+++L G + L+ EY P
Sbjct: 74 ILRLYGYFHDATRVYLILEYAP 95
>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|B Chain B, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|C Chain C, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|D Chain D, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
Length = 301
Score = 34.3 bits (77), Expect = 0.10, Method: Compositional matrix adjust.
Identities = 28/100 (28%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 267 EKATNYFNPSKKLGQGGAGSVYMGSLPN------GTTVAVKRL--IFNTRQWVDEFFNEV 318
E A S++LGQG G VY G T VA+K + + R+ + EF NE
Sbjct: 8 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEA 66
Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI 358
+++ ++V+LLG +G +L++ E + L ++
Sbjct: 67 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 106
>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|B Chain B, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|C Chain C, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|D Chain D, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
Length = 286
Score = 34.3 bits (77), Expect = 0.10, Method: Compositional matrix adjust.
Identities = 25/88 (28%), Positives = 43/88 (48%), Gaps = 5/88 (5%)
Query: 279 LGQGGAGSVYMG--SLPNGTT--VAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLL 333
+G G G V G LP VA+K L T + +F +E +++ +H N++ L
Sbjct: 15 IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 74
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFGN 361
G + +++ E++ N SLD F+ N
Sbjct: 75 GVVTKSTPVMIITEFMENGSLDSFLRQN 102
>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|B Chain B, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|C Chain C, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|D Chain D, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
Length = 336
Score = 34.3 bits (77), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 28/103 (27%), Positives = 49/103 (47%), Gaps = 9/103 (8%)
Query: 264 ETLEKATNYFNPSKKLGQGGAGSVYMGSLPN------GTTVAVKRL--IFNTRQWVDEFF 315
+ E A S++LGQG G VY G T VA+K + + R+ + EF
Sbjct: 40 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFL 98
Query: 316 NEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI 358
NE +++ ++V+LLG +G +L++ E + L ++
Sbjct: 99 NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 141
>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly,
Lys240->arg, Met302- >leu) In Complex With
1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]-
Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea
pdb|3DJ5|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 290.
pdb|3DJ6|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 823.
pdb|3DJ7|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 130.
pdb|3D15|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With
1-(3-Chloro-Phenyl)-3-
{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)-
Ethyl]-Thiazol-2- Yl}-Urea [sns-314]
pdb|3D2I|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With 1-{5-[2-(1-Methyl-1h-
Pyrazolo[4,
3-D]pyrimidin-7-Ylamino)-Ethyl]-Thiazol-2-Yl}-3-
(3-Trifluoromethyl-Phenyl)-Urea
pdb|3D2K|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With
[7-(2-{2-[3-(3-Chloro-
Phenyl)-Ureido]-Thiazol-5-Yl}-Ethylamino)-Pyrazolo[4,3-
D]pyrimidin-1-Yl]-Acetic Acid
Length = 272
Score = 34.3 bits (77), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 20/82 (24%), Positives = 38/82 (46%), Gaps = 4/82 (4%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWV----DEFFNEVNLISSIEHKN 328
F+ + LG+G G+VY+ + +++F T+ + EV + S + H N
Sbjct: 14 FDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 329 LVKLLGCSIEGPESLLVYEYVP 350
+++L G + L+ EY P
Sbjct: 74 ILRLYGYFHDATRVYLILEYAP 95
>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW6|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
Length = 302
Score = 34.3 bits (77), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 26/94 (27%), Positives = 47/94 (50%), Gaps = 4/94 (4%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW--VDEFFNEVNLISSIEHKNL 329
F +K+G+G G VY + G VA+K++ +T E++L+ + H N+
Sbjct: 8 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFGNCL 363
VKLL + LV+E++ ++ L F+ + L
Sbjct: 68 VKLLDVIHTENKLYLVFEFL-HQDLKTFMDASAL 100
>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
pdb|1JPA|B Chain B, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
Length = 312
Score = 34.3 bits (77), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 25/88 (28%), Positives = 43/88 (48%), Gaps = 5/88 (5%)
Query: 279 LGQGGAGSVYMG--SLPNGTT--VAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLVKLL 333
+G G G V G LP VA+K L T + +F +E +++ +H N++ L
Sbjct: 41 IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 100
Query: 334 GCSIEGPESLLVYEYVPNRSLDQFIFGN 361
G + +++ E++ N SLD F+ N
Sbjct: 101 GVVTKSTPVMIITEFMENGSLDSFLRQN 128
>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With Bms-754807
[1-(4-((5-Cyclopropyl-
1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2,
4]triazin-2-Yl)-N-
(6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide]
Length = 315
Score = 34.3 bits (77), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 28/100 (28%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 267 EKATNYFNPSKKLGQGGAGSVYMGSLPN------GTTVAVKRL--IFNTRQWVDEFFNEV 318
E A S++LGQG G VY G T VA+K + + R+ + EF NE
Sbjct: 14 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEA 72
Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI 358
+++ ++V+LLG +G +L++ E + L ++
Sbjct: 73 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 112
>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1
Receptor Kinase In Complex With Pqip
Length = 301
Score = 34.3 bits (77), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 28/100 (28%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 267 EKATNYFNPSKKLGQGGAGSVYMGSLPN------GTTVAVKRL--IFNTRQWVDEFFNEV 318
E A S++LGQG G VY G T VA+K + + R+ + EF NE
Sbjct: 8 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEA 66
Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI 358
+++ ++V+LLG +G +L++ E + L ++
Sbjct: 67 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 106
>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia
pdb|3GC0|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia In
Complex With Amp
Length = 329
Score = 34.3 bits (77), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 22/77 (28%), Positives = 36/77 (46%), Gaps = 3/77 (3%)
Query: 278 KLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW--VDEFFNEVNLISSIEHKNLVKLLG 334
KLG+G G VY TVA+KR+ + EV+L+ ++H+N+++L
Sbjct: 41 KLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKS 100
Query: 335 CSIEGPESLLVYEYVPN 351
L++EY N
Sbjct: 101 VIHHNHRLHLIFEYAEN 117
>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor
Kinase
Length = 299
Score = 34.3 bits (77), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 28/100 (28%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 267 EKATNYFNPSKKLGQGGAGSVYMGSLPN------GTTVAVKRL--IFNTRQWVDEFFNEV 318
E A S++LGQG G VY G T VA+K + + R+ + EF NE
Sbjct: 6 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEA 64
Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI 358
+++ ++V+LLG +G +L++ E + L ++
Sbjct: 65 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 104
>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a
Resolution.
pdb|1P4O|B Chain B, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a
Resolution
Length = 322
Score = 34.3 bits (77), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 28/100 (28%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 267 EKATNYFNPSKKLGQGGAGSVYMGSLPN------GTTVAVKRL--IFNTRQWVDEFFNEV 318
E A S++LGQG G VY G T VA+K + + R+ + EF NE
Sbjct: 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEA 79
Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI 358
+++ ++V+LLG +G +L++ E + L ++
Sbjct: 80 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 119
>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EON|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 34.3 bits (77), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 26/94 (27%), Positives = 47/94 (50%), Gaps = 4/94 (4%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW--VDEFFNEVNLISSIEHKNL 329
F +K+G+G G VY + G VA+K++ +T E++L+ + H N+
Sbjct: 6 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFGNCL 363
VKLL + LV+E++ + L +F+ + L
Sbjct: 66 VKLLDVIHTENKLYLVFEFL-SMDLKKFMDASAL 98
>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
pdb|3LXL|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
Length = 327
Score = 34.3 bits (77), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 28/88 (31%), Positives = 44/88 (50%), Gaps = 7/88 (7%)
Query: 278 KLGQGGAGSVYMGSLP-----NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKL 332
+LG+G GSV + G VAVK+L + +F E+ ++ ++ +VK
Sbjct: 30 QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 89
Query: 333 LGCSI-EGPESL-LVYEYVPNRSLDQFI 358
G S G +SL LV EY+P+ L F+
Sbjct: 90 RGVSYGPGRQSLRLVMEYLPSGCLRDFL 117
>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
pdb|4EOM|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
Length = 301
Score = 33.9 bits (76), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 26/94 (27%), Positives = 47/94 (50%), Gaps = 4/94 (4%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW--VDEFFNEVNLISSIEHKNL 329
F +K+G+G G VY + G VA+K++ +T E++L+ + H N+
Sbjct: 8 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFGNCL 363
VKLL + LV+E++ + L +F+ + L
Sbjct: 68 VKLLDVIHTENKLYLVFEFL-SMDLKKFMDASAL 100
>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo
Pyridine Inhibitor
pdb|3ETA|B Chain B, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo
Pyridine Inhibitor
Length = 317
Score = 33.9 bits (76), Expect = 0.14, Method: Compositional matrix adjust.
Identities = 27/90 (30%), Positives = 48/90 (53%), Gaps = 9/90 (10%)
Query: 277 KKLGQGGAGSVYMGSLPN------GTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKN 328
++LGQG G VY G+ + T VAVK + + R+ + EF NE +++ +
Sbjct: 22 RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEASVMKGFTCHH 80
Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFI 358
+V+LLG +G +L+V E + + L ++
Sbjct: 81 VVRLLGVVSKGQPTLVVMELMAHGDLKSYL 110
>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth
Factor-1 Receptor Kinase Domain
pdb|1M7N|B Chain B, Crystal Structure Of Unactivated Apo Insulin-Like Growth
Factor-1 Receptor Kinase Domain
Length = 322
Score = 33.9 bits (76), Expect = 0.14, Method: Compositional matrix adjust.
Identities = 28/100 (28%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 267 EKATNYFNPSKKLGQGGAGSVYMGSLPN------GTTVAVKRL--IFNTRQWVDEFFNEV 318
E A S++LGQG G VY G T VA+K + + R+ + EF NE
Sbjct: 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEA 79
Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFI 358
+++ ++V+LLG +G +L++ E + L ++
Sbjct: 80 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 119
>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A
Pentacyclic Inhibitor
pdb|3COH|B Chain B, Crystal Structure Of Aurora-A In Complex With A
Pentacyclic Inhibitor
Length = 268
Score = 33.9 bits (76), Expect = 0.14, Method: Compositional matrix adjust.
Identities = 20/82 (24%), Positives = 37/82 (45%), Gaps = 4/82 (4%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWV----DEFFNEVNLISSIEHKN 328
F + LG+G G+VY+ N + +++F + + EV + S + H N
Sbjct: 10 FEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 329 LVKLLGCSIEGPESLLVYEYVP 350
+++L G + L+ EY P
Sbjct: 70 ILRLYGYFHDSTRVYLILEYAP 91
>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site
Inhibitor Showing High Selectivity Within The Janus
Kinase Family
Length = 315
Score = 33.9 bits (76), Expect = 0.15, Method: Compositional matrix adjust.
Identities = 28/88 (31%), Positives = 44/88 (50%), Gaps = 7/88 (7%)
Query: 278 KLGQGGAGSVYMGSLP-----NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKL 332
+LG+G GSV + G VAVK+L + +F E+ ++ ++ +VK
Sbjct: 18 QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 77
Query: 333 LGCSI-EGPESL-LVYEYVPNRSLDQFI 358
G S G +SL LV EY+P+ L F+
Sbjct: 78 RGVSYGPGRQSLRLVMEYLPSGCLRDFL 105
>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((s)-1,2,2-trimethyl-propyl)-amide
pdb|4HVG|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((s)-2-hydroxy-1,2-dimethyl-propyl)- Amide
pdb|4HVH|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((r)-2-hydroxy-1,2-dimethyl-propyl
pdb|4HVI|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((r)-1-methyl-2-oxo-2-piperidin-1-yl- Ethyl)-amide
Length = 314
Score = 33.9 bits (76), Expect = 0.15, Method: Compositional matrix adjust.
Identities = 28/88 (31%), Positives = 44/88 (50%), Gaps = 7/88 (7%)
Query: 278 KLGQGGAGSVYMGSLP-----NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKL 332
+LG+G GSV + G VAVK+L + +F E+ ++ ++ +VK
Sbjct: 17 QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 76
Query: 333 LGCSI-EGPESL-LVYEYVPNRSLDQFI 358
G S G +SL LV EY+P+ L F+
Sbjct: 77 RGVSYGPGRQSLRLVMEYLPSGCLRDFL 104
>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of
The Insulin Receptor Tyrosine Kinase
Length = 306
Score = 33.9 bits (76), Expect = 0.15, Method: Compositional matrix adjust.
Identities = 27/90 (30%), Positives = 48/90 (53%), Gaps = 9/90 (10%)
Query: 277 KKLGQGGAGSVYMGSLPN------GTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKN 328
++LGQG G VY G+ + T VAVK + + R+ + EF NE +++ +
Sbjct: 23 RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEASVMKGFTCHH 81
Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFI 358
+V+LLG +G +L+V E + + L ++
Sbjct: 82 VVRLLGVVSKGQPTLVVMELMAHGDLKSYL 111
>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Human Insulin Receptor
Length = 306
Score = 33.9 bits (76), Expect = 0.15, Method: Compositional matrix adjust.
Identities = 27/90 (30%), Positives = 48/90 (53%), Gaps = 9/90 (10%)
Query: 277 KKLGQGGAGSVYMGSLPN------GTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKN 328
++LGQG G VY G+ + T VAVK + + R+ + EF NE +++ +
Sbjct: 23 RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEASVMKGFTCHH 81
Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFI 358
+V+LLG +G +L+V E + + L ++
Sbjct: 82 VVRLLGVVSKGQPTLVVMELMAHGDLKSYL 111
>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex
With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2-
Yl]amino}phenyl)acetic Acid
Length = 303
Score = 33.9 bits (76), Expect = 0.16, Method: Compositional matrix adjust.
Identities = 27/90 (30%), Positives = 48/90 (53%), Gaps = 9/90 (10%)
Query: 277 KKLGQGGAGSVYMGSLPN------GTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKN 328
++LGQG G VY G+ + T VAVK + + R+ + EF NE +++ +
Sbjct: 20 RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEASVMKGFTCHH 78
Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFI 358
+V+LLG +G +L+V E + + L ++
Sbjct: 79 VVRLLGVVSKGQPTLVVMELMAHGDLKSYL 108
>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor
pdb|3EKN|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor
Length = 307
Score = 33.9 bits (76), Expect = 0.16, Method: Compositional matrix adjust.
Identities = 27/90 (30%), Positives = 48/90 (53%), Gaps = 9/90 (10%)
Query: 277 KKLGQGGAGSVYMGSLPN------GTTVAVKRLIFNT--RQWVDEFFNEVNLISSIEHKN 328
++LGQG G VY G+ + T VAVK + + R+ + EF NE +++ +
Sbjct: 24 RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEASVMKGFTCHH 82
Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFI 358
+V+LLG +G +L+V E + + L ++
Sbjct: 83 VVRLLGVVSKGQPTLVVMELMAHGDLKSYL 112
>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex
With Peptide Substrate And Atp Analog
pdb|1GAG|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With A Bisubstrate Inhibitor
Length = 306
Score = 33.9 bits (76), Expect = 0.17, Method: Compositional matrix adjust.
Identities = 27/90 (30%), Positives = 48/90 (53%), Gaps = 9/90 (10%)
Query: 277 KKLGQGGAGSVYMGSLPN------GTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKN 328
++LGQG G VY G+ + T VAVK + + R+ + EF NE +++ +
Sbjct: 23 RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEASVMKGFTCHH 81
Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFI 358
+V+LLG +G +L+V E + + L ++
Sbjct: 82 VVRLLGVVSKGQPTLVVMELMAHGDLKSYL 111
>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|1RQQ|B Chain B, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|2AUH|A Chain A, Crystal Structure Of The Grb14 Bps Region In Complex With
The Insulin Receptor Tyrosine Kinase
pdb|2B4S|B Chain B, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|2B4S|D Chain D, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|3BU3|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide
pdb|3BU5|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide And Atp
pdb|3BU6|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Phosphopeptide
Length = 306
Score = 33.5 bits (75), Expect = 0.17, Method: Compositional matrix adjust.
Identities = 27/90 (30%), Positives = 48/90 (53%), Gaps = 9/90 (10%)
Query: 277 KKLGQGGAGSVYMGSLPN------GTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKN 328
++LGQG G VY G+ + T VAVK + + R+ + EF NE +++ +
Sbjct: 23 RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEASVMKGFTCHH 81
Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFI 358
+V+LLG +G +L+V E + + L ++
Sbjct: 82 VVRLLGVVSKGQPTLVVMELMAHGDLKSYL 111
>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The
Insulin Receptor Tyrosine Kinase
Length = 306
Score = 33.5 bits (75), Expect = 0.17, Method: Compositional matrix adjust.
Identities = 27/90 (30%), Positives = 48/90 (53%), Gaps = 9/90 (10%)
Query: 277 KKLGQGGAGSVYMGSLPN------GTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKN 328
++LGQG G VY G+ + T VAVK + + R+ + EF NE +++ +
Sbjct: 23 RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEASVMKGFTCHH 81
Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFI 358
+V+LLG +G +L+V E + + L ++
Sbjct: 82 VVRLLGVVSKGQPTLVVMELMAHGDLKSYL 111
>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PK9|C Chain C, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PMI|A Chain A, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
pdb|2PMI|C Chain C, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
Length = 317
Score = 33.5 bits (75), Expect = 0.17, Method: Compositional matrix adjust.
Identities = 25/99 (25%), Positives = 50/99 (50%), Gaps = 5/99 (5%)
Query: 269 ATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEF-FNEVNLISSIEH 326
+++ F +KLG G +VY G + G VA+K + ++ + E++L+ ++H
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 327 KNLVKLLGCSIEGPESLLVYEYVPN---RSLDQFIFGNC 362
+N+V+L + LV+E++ N + +D GN
Sbjct: 63 ENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNT 101
>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOK|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOL|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOL|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 33.5 bits (75), Expect = 0.18, Method: Compositional matrix adjust.
Identities = 23/80 (28%), Positives = 40/80 (50%), Gaps = 3/80 (3%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW--VDEFFNEVNLISSIEHKNL 329
F +K+G+G G VY + G VA+K++ +T E++L+ + H N+
Sbjct: 7 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 330 VKLLGCSIEGPESLLVYEYV 349
VKLL + LV+E++
Sbjct: 67 VKLLDVIHTENKLYLVFEFL 86
>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
pdb|4EOJ|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
Length = 302
Score = 33.5 bits (75), Expect = 0.20, Method: Compositional matrix adjust.
Identities = 23/80 (28%), Positives = 40/80 (50%), Gaps = 3/80 (3%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW--VDEFFNEVNLISSIEHKNL 329
F +K+G+G G VY + G VA+K++ +T E++L+ + H N+
Sbjct: 8 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 330 VKLLGCSIEGPESLLVYEYV 349
VKLL + LV+E++
Sbjct: 68 VKLLDVIHTENKLYLVFEFL 87
>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
Length = 299
Score = 33.5 bits (75), Expect = 0.21, Method: Compositional matrix adjust.
Identities = 25/94 (26%), Positives = 47/94 (50%), Gaps = 4/94 (4%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW--VDEFFNEVNLISSIEHKNL 329
F +K+G+G G VY + G VA+ ++ +T E++L+ + H N+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFGNCL 363
VKLL + LV+E++ ++ L +F+ + L
Sbjct: 65 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASAL 97
>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
Length = 298
Score = 33.5 bits (75), Expect = 0.21, Method: Compositional matrix adjust.
Identities = 25/94 (26%), Positives = 47/94 (50%), Gaps = 4/94 (4%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW--VDEFFNEVNLISSIEHKNL 329
F +K+G+G G VY + G VA+ ++ +T E++L+ + H N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFIFGNCL 363
VKLL + LV+E++ ++ L +F+ + L
Sbjct: 64 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASAL 96
>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1)
pdb|3OMV|B Chain B, Crystal Structure Of C-Raf (Raf-1)
Length = 307
Score = 33.1 bits (74), Expect = 0.22, Method: Compositional matrix adjust.
Identities = 16/59 (27%), Positives = 29/59 (49%)
Query: 276 SKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLG 334
S ++G G G+VY G V + +++ T + F NEV ++ H N++ +G
Sbjct: 41 STRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMG 99
>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In
A Putative Auto-Inhibition State
Length = 340
Score = 32.7 bits (73), Expect = 0.29, Method: Compositional matrix adjust.
Identities = 17/49 (34%), Positives = 27/49 (55%), Gaps = 1/49 (2%)
Query: 256 KSCLSFKYETLEKATNYFNPSKKLGQGGAGSV-YMGSLPNGTTVAVKRL 303
K+C+S + E + P +LG+G G V M +P+G +AVKR+
Sbjct: 36 KACISIGNQNFEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRI 84
>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase
pdb|3COM|B Chain B, Crystal Structure Of Mst1 Kinase
Length = 314
Score = 32.7 bits (73), Expect = 0.29, Method: Compositional matrix adjust.
Identities = 21/83 (25%), Positives = 41/83 (49%), Gaps = 3/83 (3%)
Query: 267 EKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIE 325
++ F+ +KLG+G GSVY G VA+K++ + + E E++++ +
Sbjct: 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCD 82
Query: 326 HKNLVKLLGCSIEGPESLLVYEY 348
++VK G + + +V EY
Sbjct: 83 SPHVVKYYGSYFKNTDLWIVMEY 105
>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And
Kinase Domains
Length = 361
Score = 32.7 bits (73), Expect = 0.30, Method: Compositional matrix adjust.
Identities = 20/68 (29%), Positives = 34/68 (50%), Gaps = 6/68 (8%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWV-----DEFFNEVNLISSIEH 326
F K LG G G+VY G +P G V + I R+ E +E +++S+++
Sbjct: 51 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDN 110
Query: 327 KNLVKLLG 334
++ +LLG
Sbjct: 111 PHVCRLLG 118
>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine
Kinase
pdb|3FZP|A Chain A, Crystal Structure Of Pyk2 Complexed With Atpgs
pdb|3FZR|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-431396
pdb|3FZS|A Chain A, Crystal Structure Of Pyk2 Complexed With Birb796
pdb|3FZT|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-4618433
pdb|3H3C|A Chain A, Crystal Structure Of Pyk2 In Complex With Sulfoximine-
Substituted Trifluoromethylpyrimidine Analog
pdb|3ET7|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-2318841
Length = 277
Score = 32.7 bits (73), Expect = 0.30, Method: Compositional matrix adjust.
Identities = 26/91 (28%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 276 SKKLGQGGAGSVYMGSLPN----GTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLV 330
++ LG+G G VY G N VAVK + T ++F +E ++ +++H ++V
Sbjct: 13 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 72
Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFGN 361
KL+G E P + ++ E P L ++ N
Sbjct: 73 KLIGIIEEEP-TWIIMELYPYGELGHYLERN 102
>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine
Kinase 2 Beta (ptk2b)
Length = 281
Score = 32.7 bits (73), Expect = 0.31, Method: Compositional matrix adjust.
Identities = 26/91 (28%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 276 SKKLGQGGAGSVYMGSLPN----GTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLV 330
++ LG+G G VY G N VAVK + T ++F +E ++ +++H ++V
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFGN 361
KL+G E P + ++ E P L ++ N
Sbjct: 77 KLIGIIEEEP-TWIIMELYPYGELGHYLERN 106
>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
pdb|2QG5|B Chain B, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
pdb|2QG5|D Chain D, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
Length = 294
Score = 32.7 bits (73), Expect = 0.33, Method: Compositional matrix adjust.
Identities = 23/94 (24%), Positives = 45/94 (47%), Gaps = 3/94 (3%)
Query: 256 KSCLSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTV--AVKRLIFNTRQWVDE 313
+ L F+ T Y+ +G+G G V + ++ GT + A K++ + VD
Sbjct: 11 RENLYFQGSTKGDINQYYTLENTIGRGSWGEVKI-AVQKGTRIRRAAKKIPKYFVEDVDR 69
Query: 314 FFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYE 347
F E+ ++ S++H N+++L + + LV E
Sbjct: 70 FKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 103
>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a
pdb|4H1M|A Chain A, Crystal Structure Of Pyk2 With The Indole 10c
Length = 293
Score = 32.7 bits (73), Expect = 0.34, Method: Compositional matrix adjust.
Identities = 26/91 (28%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 276 SKKLGQGGAGSVYMGSLPN----GTTVAVKRLIFN-TRQWVDEFFNEVNLISSIEHKNLV 330
++ LG+G G VY G N VAVK + T ++F +E ++ +++H ++V
Sbjct: 29 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 88
Query: 331 KLLGCSIEGPESLLVYEYVPNRSLDQFIFGN 361
KL+G E P + ++ E P L ++ N
Sbjct: 89 KLIGIIEEEP-TWIIMELYPYGELGHYLERN 118
>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Indirubin 3'-Monoxime Bound
Length = 313
Score = 32.7 bits (73), Expect = 0.35, Method: Compositional matrix adjust.
Identities = 23/77 (29%), Positives = 35/77 (45%), Gaps = 18/77 (23%)
Query: 262 KYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDE-----FFN 316
KY+ LEK +G+G G VY G VA+KR+ + DE
Sbjct: 22 KYQKLEK----------VGEGTYGVVYKAKDSQGRIVALKRIRLDAE---DEGIPSTAIR 68
Query: 317 EVNLISSIEHKNLVKLL 333
E++L+ + H N+V L+
Sbjct: 69 EISLLKELHHPNIVSLI 85
>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Adp Bound
Length = 311
Score = 32.7 bits (73), Expect = 0.36, Method: Compositional matrix adjust.
Identities = 23/77 (29%), Positives = 35/77 (45%), Gaps = 18/77 (23%)
Query: 262 KYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDE-----FFN 316
KY+ LEK +G+G G VY G VA+KR+ + DE
Sbjct: 22 KYQKLEK----------VGEGTYGVVYKAKDSQGRIVALKRIRLDAE---DEGIPSTAIR 68
Query: 317 EVNLISSIEHKNLVKLL 333
E++L+ + H N+V L+
Sbjct: 69 EISLLKELHHPNIVSLI 85
>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092,
Delete A660- T867) At 2.28 A Resolution
pdb|4G34|A Chain A, Crystal Structure Of Gsk6924 Bound To Perk (R587-R1092,
Delete A660- T867) At 2.70 A Resolution
Length = 299
Score = 32.3 bits (72), Expect = 0.45, Method: Compositional matrix adjust.
Identities = 24/86 (27%), Positives = 39/86 (45%), Gaps = 9/86 (10%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE-FFNEVNLISSIEHKNLV 330
F P + LG+GG G V+ + + A+KR+ R+ E EV ++ +EH +V
Sbjct: 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 331 KLLGCSIEG-------PESLLVYEYV 349
+ +E P S VY Y+
Sbjct: 67 RYFNAWLEKNTTEKLQPSSPKVYLYI 92
>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1G|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 275
Score = 32.3 bits (72), Expect = 0.47, Method: Compositional matrix adjust.
Identities = 19/82 (23%), Positives = 36/82 (43%), Gaps = 4/82 (4%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWV----DEFFNEVNLISSIEHKN 328
F + LG+G G+VY+ + +++F + + EV + S + H N
Sbjct: 13 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 329 LVKLLGCSIEGPESLLVYEYVP 350
+++L G + L+ EY P
Sbjct: 73 ILRLYGYFHDATRVYLILEYAP 94
>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1E|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1F|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 275
Score = 32.3 bits (72), Expect = 0.48, Method: Compositional matrix adjust.
Identities = 19/82 (23%), Positives = 36/82 (43%), Gaps = 4/82 (4%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWV----DEFFNEVNLISSIEHKN 328
F + LG+G G+VY+ + +++F + + EV + S + H N
Sbjct: 13 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 329 LVKLLGCSIEGPESLLVYEYVP 350
+++L G + L+ EY P
Sbjct: 73 ILRLYGYFHDATRVYLILEYAP 94
>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|B Chain B, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|C Chain C, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H10|A Chain A, Aurora A Inhibitor Complex
pdb|3H10|B Chain B, Aurora A Inhibitor Complex
pdb|3H10|D Chain D, Aurora A Inhibitor Complex
pdb|3P9J|A Chain A, Aurora A Kinase Domain With Phthalazinone Pyrazole
Inhibitor
Length = 268
Score = 32.3 bits (72), Expect = 0.49, Method: Compositional matrix adjust.
Identities = 20/82 (24%), Positives = 38/82 (46%), Gaps = 4/82 (4%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
F + LG+G G+VY+ + +++F + V+ + EV + S + H N
Sbjct: 10 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 329 LVKLLGCSIEGPESLLVYEYVP 350
+++L G + L+ EY P
Sbjct: 70 ILRLYGYFHDATRVYLILEYAP 91
>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain
pdb|4BBM|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain With
Bound Tcs 2312
pdb|4BBM|B Chain B, Crystal Structure Of The Human Cdkl2 Kinase Domain With
Bound Tcs 2312
Length = 331
Score = 32.3 bits (72), Expect = 0.49, Method: Compositional matrix adjust.
Identities = 31/108 (28%), Positives = 51/108 (47%), Gaps = 14/108 (12%)
Query: 263 YETLEKATNYFNPSKKLGQGGAGSVYM----GSLPNGTTVAVKRLI-FNTRQWVDEF-FN 316
++++EK N LG G GS M + G VA+K+ + + + V +
Sbjct: 21 FQSMEKYEN-------LGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR 73
Query: 317 EVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF-IFGNCL 363
E+ L+ + H+NLV LL + LV+E+V + LD +F N L
Sbjct: 74 EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGL 121
>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A
Gsk3beta Inhibitor
Length = 287
Score = 32.3 bits (72), Expect = 0.49, Method: Compositional matrix adjust.
Identities = 19/82 (23%), Positives = 36/82 (43%), Gaps = 4/82 (4%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWV----DEFFNEVNLISSIEHKN 328
F + LG+G G+VY+ + +++F + + EV + S + H N
Sbjct: 10 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 329 LVKLLGCSIEGPESLLVYEYVP 350
+++L G + L+ EY P
Sbjct: 70 ILRLYGYFHDATRVYLILEYAP 91
>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And
Tpx2
Length = 268
Score = 32.0 bits (71), Expect = 0.53, Method: Compositional matrix adjust.
Identities = 19/82 (23%), Positives = 36/82 (43%), Gaps = 4/82 (4%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWV----DEFFNEVNLISSIEHKN 328
F + LG+G G+VY+ + +++F + + EV + S + H N
Sbjct: 10 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 329 LVKLLGCSIEGPESLLVYEYVP 350
+++L G + L+ EY P
Sbjct: 70 ILRLYGYFHDATRVYLILEYAP 91
>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With
Adpnp
Length = 275
Score = 32.0 bits (71), Expect = 0.54, Method: Compositional matrix adjust.
Identities = 19/82 (23%), Positives = 36/82 (43%), Gaps = 4/82 (4%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWV----DEFFNEVNLISSIEHKN 328
F + LG+G G+VY+ + +++F + + EV + S + H N
Sbjct: 10 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 329 LVKLLGCSIEGPESLLVYEYVP 350
+++L G + L+ EY P
Sbjct: 70 ILRLYGYFHDATRVYLILEYAP 91
>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase
pdb|2NP8|A Chain A, Structural Basis For The Inhibition Of Aurora A Kinase By
A Novel Class Of High Affinity Disubstituted Pyrimidine
Inhibitors
pdb|2X81|A Chain A, Structure Of Aurora A In Complex With Mln8054
pdb|3MYG|A Chain A, Aurora A Kinase Complexed With Sch 1473759
pdb|3VAP|A Chain A, Synthesis And Sar Studies Of Imidazo-[1,2-A]-Pyrazine
Aurora Kinase Inhibitors With Improved Off Target Kinase
Selectivity
Length = 272
Score = 32.0 bits (71), Expect = 0.54, Method: Compositional matrix adjust.
Identities = 20/82 (24%), Positives = 38/82 (46%), Gaps = 4/82 (4%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
F + LG+G G+VY+ + +++F + V+ + EV + S + H N
Sbjct: 14 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 329 LVKLLGCSIEGPESLLVYEYVP 350
+++L G + L+ EY P
Sbjct: 74 ILRLYGYFHDATRVYLILEYAP 95
>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679
pdb|3UNZ|B Chain B, Aurora A In Complex With Rpm1679
pdb|3UO4|A Chain A, Aurora A In Complex With Rpm1680
pdb|3UO5|A Chain A, Aurora A In Complex With Yl1-038-31
pdb|3UO6|A Chain A, Aurora A In Complex With Yl5-083
pdb|3UO6|B Chain B, Aurora A In Complex With Yl5-083
pdb|3UOD|A Chain A, Aurora A In Complex With Rpm1693
pdb|3UOH|A Chain A, Aurora A In Complex With Rpm1722
pdb|3UOH|B Chain B, Aurora A In Complex With Rpm1722
pdb|3UOJ|A Chain A, Aurora A In Complex With Rpm1715
pdb|3UOJ|B Chain B, Aurora A In Complex With Rpm1715
pdb|3UOK|A Chain A, Aurora A In Complex With Yl5-81-1
pdb|3UOK|B Chain B, Aurora A In Complex With Yl5-81-1
pdb|3UOL|A Chain A, Aurora A In Complex With So2-162
pdb|3UOL|B Chain B, Aurora A In Complex With So2-162
pdb|3UP2|A Chain A, Aurora A In Complex With Rpm1686
pdb|3UP7|A Chain A, Aurora A In Complex With Yl1-038-09
pdb|4DEA|A Chain A, Aurora A In Complex With Yl1-038-18
pdb|4DEB|A Chain A, Aurora A In Complex With Rk2-17-01
pdb|4DED|A Chain A, Aurora A In Complex With Yl1-038-21
pdb|4DEE|A Chain A, Aurora A In Complex With Adp
Length = 279
Score = 32.0 bits (71), Expect = 0.54, Method: Compositional matrix adjust.
Identities = 19/82 (23%), Positives = 36/82 (43%), Gaps = 4/82 (4%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWV----DEFFNEVNLISSIEHKN 328
F + LG+G G+VY+ + +++F + + EV + S + H N
Sbjct: 11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 329 LVKLLGCSIEGPESLLVYEYVP 350
+++L G + L+ EY P
Sbjct: 71 ILRLYGYFHDATRVYLILEYAP 92
>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa
pdb|3O50|B Chain B, Crystal Structure Of Benzamide 9 Bound To Auroraa
pdb|3O51|A Chain A, Crystal Structure Of Anthranilamide 10 Bound To Auroraa
pdb|3EFW|A Chain A, Structure Of Auroraa With Pyridyl-Pyrimidine Urea
Inhibitor
pdb|3EFW|B Chain B, Structure Of Auroraa With Pyridyl-Pyrimidine Urea
Inhibitor
Length = 267
Score = 32.0 bits (71), Expect = 0.54, Method: Compositional matrix adjust.
Identities = 19/82 (23%), Positives = 36/82 (43%), Gaps = 4/82 (4%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWV----DEFFNEVNLISSIEHKN 328
F + LG+G G+VY+ + +++F + + EV + S + H N
Sbjct: 9 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 68
Query: 329 LVKLLGCSIEGPESLLVYEYVP 350
+++L G + L+ EY P
Sbjct: 69 ILRLYGYFHDATRVYLILEYAP 90
>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors
Length = 283
Score = 32.0 bits (71), Expect = 0.54, Method: Compositional matrix adjust.
Identities = 20/82 (24%), Positives = 38/82 (46%), Gaps = 4/82 (4%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
F + LG+G G+VY+ + +++F + V+ + EV + S + H N
Sbjct: 13 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 329 LVKLLGCSIEGPESLLVYEYVP 350
+++L G + L+ EY P
Sbjct: 73 ILRLYGYFHDATRVYLILEYAP 94
>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A
Inhibitors: Structure Basis For Potency And Specificity
pdb|3K5U|A Chain A, Identification, Sar Studies And X-Ray Cocrystal Analysis
Of A Novel Furano-Pyrimidine Aurora Kinase A Inhibitor
pdb|3M11|A Chain A, Crystal Structure Of Aurora A Kinase Complexed With
Inhibitor
Length = 279
Score = 32.0 bits (71), Expect = 0.54, Method: Compositional matrix adjust.
Identities = 19/82 (23%), Positives = 36/82 (43%), Gaps = 4/82 (4%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWV----DEFFNEVNLISSIEHKN 328
F + LG+G G+VY+ + +++F + + EV + S + H N
Sbjct: 11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 329 LVKLLGCSIEGPESLLVYEYVP 350
+++L G + L+ EY P
Sbjct: 71 ILRLYGYFHDATRVYLILEYAP 92
>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2
pdb|3ZZW|B Chain B, Crystal Structure Of The Kinase Domain Of Ror2
Length = 289
Score = 32.0 bits (71), Expect = 0.55, Method: Compositional matrix adjust.
Identities = 26/89 (29%), Positives = 44/89 (49%), Gaps = 7/89 (7%)
Query: 277 KKLGQGGAGSVYMGSL----PNGTT--VAVKRLIFNTRQWV-DEFFNEVNLISSIEHKNL 329
++LG+ G VY G L P T VA+K L + +EF +E L + ++H N+
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFI 358
V LLG + +++ Y + L +F+
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFL 103
>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And
Compound 10
Length = 268
Score = 32.0 bits (71), Expect = 0.55, Method: Compositional matrix adjust.
Identities = 19/82 (23%), Positives = 36/82 (43%), Gaps = 4/82 (4%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWV----DEFFNEVNLISSIEHKN 328
F + LG+G G+VY+ + +++F + + EV + S + H N
Sbjct: 10 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 329 LVKLLGCSIEGPESLLVYEYVP 350
+++L G + L+ EY P
Sbjct: 70 ILRLYGYFHDATRVYLILEYAP 91
>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor
pdb|2X6E|A Chain A, Aurora-A Bound To An Inhibitor
Length = 285
Score = 32.0 bits (71), Expect = 0.56, Method: Compositional matrix adjust.
Identities = 20/82 (24%), Positives = 38/82 (46%), Gaps = 4/82 (4%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
F + LG+G G+VY+ + +++F + V+ + EV + S + H N
Sbjct: 15 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 329 LVKLLGCSIEGPESLLVYEYVP 350
+++L G + L+ EY P
Sbjct: 75 ILRLYGYFHDATRVYLILEYAP 96
>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A
5-Aminopyrimidinyl Quinazoline Inhibitor
pdb|2C6E|B Chain B, Aurora A Kinase Activated Mutant (T287d) In Complex With A
5-Aminopyrimidinyl Quinazoline Inhibitor
Length = 283
Score = 32.0 bits (71), Expect = 0.57, Method: Compositional matrix adjust.
Identities = 19/82 (23%), Positives = 36/82 (43%), Gaps = 4/82 (4%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWV----DEFFNEVNLISSIEHKN 328
F + LG+G G+VY+ + +++F + + EV + S + H N
Sbjct: 15 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 329 LVKLLGCSIEGPESLLVYEYVP 350
+++L G + L+ EY P
Sbjct: 75 ILRLYGYFHDATRVYLILEYAP 96
>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor
pdb|2RGP|A Chain A, Structure Of Egfr In Complex With Hydrazone, A Potent Dual
Inhibitor
Length = 315
Score = 32.0 bits (71), Expect = 0.57, Method: Compositional matrix adjust.
Identities = 20/68 (29%), Positives = 34/68 (50%), Gaps = 6/68 (8%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWV-----DEFFNEVNLISSIEH 326
F K LG G G+VY G +P G V + I R+ E +E +++S+++
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 327 KNLVKLLG 334
++ +LLG
Sbjct: 71 PHVCRLLG 78
>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain
pdb|4GT4|B Chain B, Structure Of Unliganded, Inactive Ror2 Kinase Domain
Length = 308
Score = 32.0 bits (71), Expect = 0.59, Method: Compositional matrix adjust.
Identities = 26/89 (29%), Positives = 44/89 (49%), Gaps = 7/89 (7%)
Query: 277 KKLGQGGAGSVYMGSL----PNGTT--VAVKRLIFNTRQWV-DEFFNEVNLISSIEHKNL 329
++LG+ G VY G L P T VA+K L + +EF +E L + ++H N+
Sbjct: 32 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 91
Query: 330 VKLLGCSIEGPESLLVYEYVPNRSLDQFI 358
V LLG + +++ Y + L +F+
Sbjct: 92 VCLLGVVTKDQPLSMIFSYCSHGDLHEFL 120
>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of
Pyrazolopyridine- Sulfonamides As Potent
Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I)
pdb|3R22|A Chain A, Design, Synthesis, And Biological Evaluation Of
Pyrazolopyridine- Sulfonamides As Potent
Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I)
pdb|4DHF|A Chain A, Structure Of Aurora A Mutant Bound To Biogenidec Cpd 15
pdb|4DHF|B Chain B, Structure Of Aurora A Mutant Bound To Biogenidec Cpd 15
Length = 271
Score = 32.0 bits (71), Expect = 0.59, Method: Compositional matrix adjust.
Identities = 21/86 (24%), Positives = 39/86 (45%), Gaps = 4/86 (4%)
Query: 269 ATNYFNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSI 324
A F + LG+G G+VY+ + +++F + V+ + EV + S +
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 325 EHKNLVKLLGCSIEGPESLLVYEYVP 350
H N+++L G + L+ EY P
Sbjct: 69 RHPNILRLYGYFHDATRVYLILEYAP 94
>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680
Length = 292
Score = 32.0 bits (71), Expect = 0.59, Method: Compositional matrix adjust.
Identities = 20/96 (20%), Positives = 45/96 (46%), Gaps = 4/96 (4%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
F + LG+G G+VY+ + +++F + ++ V+ + E+ + + + H N
Sbjct: 25 FEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPN 84
Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSLDQFIFGNCLF 364
+++L + L+ EY P L + + +C F
Sbjct: 85 ILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTF 120
>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium
Dependent Protein Kinase Cgd7_1840 In Presence Of
Indirubin E804
Length = 277
Score = 32.0 bits (71), Expect = 0.59, Method: Compositional matrix adjust.
Identities = 17/64 (26%), Positives = 35/64 (54%), Gaps = 3/64 (4%)
Query: 271 NYFNPSKKLGQGGAGSVYMGSLPNGTTV--AVKRLIFNTRQWVDEFFNEVNLISSIEHKN 328
Y+ +G+G G V + ++ GT + A K++ + VD F E+ ++ S++H N
Sbjct: 9 QYYTLENTIGRGSWGEVKI-AVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 329 LVKL 332
+++L
Sbjct: 68 IIRL 71
>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287,
Thr288 And Bound To Tpx2 1-43
pdb|1OL7|A Chain A, Structure Of Human Aurora-A 122-403 Phosphorylated On
Thr287, Thr288
Length = 282
Score = 32.0 bits (71), Expect = 0.60, Method: Compositional matrix adjust.
Identities = 19/82 (23%), Positives = 36/82 (43%), Gaps = 4/82 (4%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWV----DEFFNEVNLISSIEHKN 328
F + LG+G G+VY+ + +++F + + EV + S + H N
Sbjct: 12 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 71
Query: 329 LVKLLGCSIEGPESLLVYEYVP 350
+++L G + L+ EY P
Sbjct: 72 ILRLYGYFHDATRVYLILEYAP 93
>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine
Inhibitor
Length = 283
Score = 32.0 bits (71), Expect = 0.61, Method: Compositional matrix adjust.
Identities = 19/82 (23%), Positives = 36/82 (43%), Gaps = 4/82 (4%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWV----DEFFNEVNLISSIEHKN 328
F + LG+G G+VY+ + +++F + + EV + S + H N
Sbjct: 13 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 329 LVKLLGCSIEGPESLLVYEYVP 350
+++L G + L+ EY P
Sbjct: 73 ILRLYGYFHDATRVYLILEYAP 94
>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine
Inhibitor
Length = 272
Score = 32.0 bits (71), Expect = 0.62, Method: Compositional matrix adjust.
Identities = 19/82 (23%), Positives = 36/82 (43%), Gaps = 4/82 (4%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWV----DEFFNEVNLISSIEHKN 328
F + LG+G G+VY+ + +++F + + EV + S + H N
Sbjct: 13 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 329 LVKLLGCSIEGPESLLVYEYVP 350
+++L G + L+ EY P
Sbjct: 73 ILRLYGYFHDATRVYLILEYAP 94
>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form)
Length = 285
Score = 32.0 bits (71), Expect = 0.62, Method: Compositional matrix adjust.
Identities = 20/82 (24%), Positives = 38/82 (46%), Gaps = 4/82 (4%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
F + LG+G G+VY+ + +++F + V+ + EV + S + H N
Sbjct: 15 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 329 LVKLLGCSIEGPESLLVYEYVP 350
+++L G + L+ EY P
Sbjct: 75 ILRLYGYFHDATRVYLILEYAP 96
>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a
Length = 282
Score = 31.6 bits (70), Expect = 0.65, Method: Compositional matrix adjust.
Identities = 19/82 (23%), Positives = 36/82 (43%), Gaps = 4/82 (4%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWV----DEFFNEVNLISSIEHKN 328
F + LG+G G+VY+ + +++F + + EV + S + H N
Sbjct: 12 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 71
Query: 329 LVKLLGCSIEGPESLLVYEYVP 350
+++L G + L+ EY P
Sbjct: 72 ILRLYGYFHDATRVYLILEYAP 93
>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFD|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|C Chain C, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|D Chain D, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
Length = 324
Score = 31.6 bits (70), Expect = 0.66, Method: Compositional matrix adjust.
Identities = 20/68 (29%), Positives = 34/68 (50%), Gaps = 6/68 (8%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWV-----DEFFNEVNLISSIEH 326
F K LG G G+VY G +P G V + I R+ E +E +++S+++
Sbjct: 14 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 73
Query: 327 KNLVKLLG 334
++ +LLG
Sbjct: 74 PHVCRLLG 81
>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358
pdb|2J50|B Chain B, Structure Of Aurora-2 In Complex With Pha-739358
Length = 280
Score = 31.6 bits (70), Expect = 0.66, Method: Compositional matrix adjust.
Identities = 20/82 (24%), Positives = 38/82 (46%), Gaps = 4/82 (4%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
F + LG+G G+VY+ + +++F + V+ + EV + S + H N
Sbjct: 10 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 329 LVKLLGCSIEGPESLLVYEYVP 350
+++L G + L+ EY P
Sbjct: 70 ILRLYGYFHDATRVYLILEYAP 91
>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A
Diaminopyrimidine
Length = 281
Score = 31.6 bits (70), Expect = 0.66, Method: Compositional matrix adjust.
Identities = 20/82 (24%), Positives = 38/82 (46%), Gaps = 4/82 (4%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
F + LG+G G+VY+ + +++F + V+ + EV + S + H N
Sbjct: 11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 329 LVKLLGCSIEGPESLLVYEYVP 350
+++L G + L+ EY P
Sbjct: 71 ILRLYGYFHDATRVYLILEYAP 92
>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure
pdb|2WTV|B Chain B, Aurora-A Inhibitor Structure
pdb|2WTV|C Chain C, Aurora-A Inhibitor Structure
pdb|2WTV|D Chain D, Aurora-A Inhibitor Structure
Length = 285
Score = 31.6 bits (70), Expect = 0.67, Method: Compositional matrix adjust.
Identities = 20/82 (24%), Positives = 38/82 (46%), Gaps = 4/82 (4%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
F + LG+G G+VY+ + +++F + V+ + EV + S + H N
Sbjct: 15 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 329 LVKLLGCSIEGPESLLVYEYVP 350
+++L G + L+ EY P
Sbjct: 75 ILRLYGYFHDATRVYLILEYAP 96
>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp
Length = 285
Score = 31.6 bits (70), Expect = 0.67, Method: Compositional matrix adjust.
Identities = 19/82 (23%), Positives = 36/82 (43%), Gaps = 4/82 (4%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWV----DEFFNEVNLISSIEHKN 328
F + LG+G G+VY+ + +++F + + EV + S + H N
Sbjct: 15 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 329 LVKLLGCSIEGPESLLVYEYVP 350
+++L G + L+ EY P
Sbjct: 75 ILRLYGYFHDATRVYLILEYAP 96
>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300
Length = 280
Score = 31.6 bits (70), Expect = 0.67, Method: Compositional matrix adjust.
Identities = 19/82 (23%), Positives = 36/82 (43%), Gaps = 4/82 (4%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWV----DEFFNEVNLISSIEHKN 328
F + LG+G G+VY+ + +++F + + EV + S + H N
Sbjct: 10 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 329 LVKLLGCSIEGPESLLVYEYVP 350
+++L G + L+ EY P
Sbjct: 70 ILRLYGYFHDATRVYLILEYAP 91
>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor
Receptor
pdb|1M17|A Chain A, Epidermal Growth Factor Receptor Tyrosine Kinase Domain
With 4-Anilinoquinazoline Inhibitor Erlotinib
Length = 333
Score = 31.6 bits (70), Expect = 0.68, Method: Compositional matrix adjust.
Identities = 20/68 (29%), Positives = 34/68 (50%), Gaps = 6/68 (8%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWV-----DEFFNEVNLISSIEH 326
F K LG G G+VY G +P G V + I R+ E +E +++S+++
Sbjct: 23 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 82
Query: 327 KNLVKLLG 334
++ +LLG
Sbjct: 83 PHVCRLLG 90
>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The
Gefitinib/erlotinib Resistant Egfr Kinase Domain
L858r+t790m
pdb|4I22|A Chain A, Structure Of The Monomeric (v948r)gefitinib/erlotinib
Resistant Double Mutant (l858r+t790m) Egfr Kinase Domain
Co-crystallized With Gefitinib
Length = 329
Score = 31.6 bits (70), Expect = 0.69, Method: Compositional matrix adjust.
Identities = 20/68 (29%), Positives = 34/68 (50%), Gaps = 6/68 (8%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWV-----DEFFNEVNLISSIEH 326
F K LG G G+VY G +P G V + I R+ E +E +++S+++
Sbjct: 19 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 327 KNLVKLLG 334
++ +LLG
Sbjct: 79 PHVCRLLG 86
>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase
Domain With Erlotinib
Length = 337
Score = 31.6 bits (70), Expect = 0.69, Method: Compositional matrix adjust.
Identities = 20/68 (29%), Positives = 34/68 (50%), Gaps = 6/68 (8%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWV-----DEFFNEVNLISSIEH 326
F K LG G G+VY G +P G V + I R+ E +E +++S+++
Sbjct: 27 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 86
Query: 327 KNLVKLLG 334
++ +LLG
Sbjct: 87 PHVCRLLG 94
>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
pdb|2JIU|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
Length = 328
Score = 31.6 bits (70), Expect = 0.69, Method: Compositional matrix adjust.
Identities = 20/68 (29%), Positives = 34/68 (50%), Gaps = 6/68 (8%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWV-----DEFFNEVNLISSIEH 326
F K LG G G+VY G +P G V + I R+ E +E +++S+++
Sbjct: 18 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 327 KNLVKLLG 334
++ +LLG
Sbjct: 78 PHVCRLLG 85
>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|2GS7|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|C Chain C, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|D Chain D, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
Length = 330
Score = 31.6 bits (70), Expect = 0.69, Method: Compositional matrix adjust.
Identities = 20/68 (29%), Positives = 34/68 (50%), Gaps = 6/68 (8%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWV-----DEFFNEVNLISSIEH 326
F K LG G G+VY G +P G V + I R+ E +E +++S+++
Sbjct: 20 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 327 KNLVKLLG 334
++ +LLG
Sbjct: 80 PHVCRLLG 87
>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In
Complex With Amppnp
Length = 334
Score = 31.6 bits (70), Expect = 0.70, Method: Compositional matrix adjust.
Identities = 20/68 (29%), Positives = 34/68 (50%), Gaps = 6/68 (8%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWV-----DEFFNEVNLISSIEH 326
F K LG G G+VY G +P G V + I R+ E +E +++S+++
Sbjct: 24 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 327 KNLVKLLG 334
++ +LLG
Sbjct: 84 PHVCRLLG 91
>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation
pdb|2JIT|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation
Length = 327
Score = 31.6 bits (70), Expect = 0.70, Method: Compositional matrix adjust.
Identities = 20/68 (29%), Positives = 34/68 (50%), Gaps = 6/68 (8%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWV-----DEFFNEVNLISSIEH 326
F K LG G G+VY G +P G V + I R+ E +E +++S+++
Sbjct: 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 327 KNLVKLLG 334
++ +LLG
Sbjct: 77 PHVCRLLG 84
>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Aee788
pdb|2ITU|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Afn941
pdb|2ITV|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Amp-pnp
pdb|2ITZ|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Iressa
Length = 327
Score = 31.6 bits (70), Expect = 0.70, Method: Compositional matrix adjust.
Identities = 20/68 (29%), Positives = 34/68 (50%), Gaps = 6/68 (8%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWV-----DEFFNEVNLISSIEH 326
F K LG G G+VY G +P G V + I R+ E +E +++S+++
Sbjct: 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 327 KNLVKLLG 334
++ +LLG
Sbjct: 77 PHVCRLLG 84
>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
pdb|4I21|B Chain B, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
Length = 329
Score = 31.6 bits (70), Expect = 0.71, Method: Compositional matrix adjust.
Identities = 20/68 (29%), Positives = 34/68 (50%), Gaps = 6/68 (8%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWV-----DEFFNEVNLISSIEH 326
F K LG G G+VY G +P G V + I R+ E +E +++S+++
Sbjct: 19 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 327 KNLVKLLG 334
++ +LLG
Sbjct: 79 PHVCRLLG 86
>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285
pdb|3W2P|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 2
pdb|3W2Q|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Hki-272
pdb|3W2R|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 4
Length = 331
Score = 31.6 bits (70), Expect = 0.71, Method: Compositional matrix adjust.
Identities = 20/68 (29%), Positives = 34/68 (50%), Gaps = 6/68 (8%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWV-----DEFFNEVNLISSIEH 326
F K LG G G+VY G +P G V + I R+ E +E +++S+++
Sbjct: 21 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 327 KNLVKLLG 334
++ +LLG
Sbjct: 81 PHVCRLLG 88
>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic
Mutant L858r Egfr Kinase Domain
Length = 329
Score = 31.6 bits (70), Expect = 0.71, Method: Compositional matrix adjust.
Identities = 20/68 (29%), Positives = 34/68 (50%), Gaps = 6/68 (8%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWV-----DEFFNEVNLISSIEH 326
F K LG G G+VY G +P G V + I R+ E +E +++S+++
Sbjct: 19 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 327 KNLVKLLG 334
++ +LLG
Sbjct: 79 PHVCRLLG 86
>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In
Complex With Amppnp
Length = 334
Score = 31.6 bits (70), Expect = 0.71, Method: Compositional matrix adjust.
Identities = 20/68 (29%), Positives = 34/68 (50%), Gaps = 6/68 (8%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWV-----DEFFNEVNLISSIEH 326
F K LG G G+VY G +P G V + I R+ E +E +++S+++
Sbjct: 24 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 327 KNLVKLLG 334
++ +LLG
Sbjct: 84 PHVCRLLG 91
>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5
pdb|1OB3|B Chain B, Structure Of P. Falciparum Pfpk5
pdb|1V0P|A Chain A, Structure Of P. Falciparum Pfpk5-Purvalanol B Ligand
Complex
pdb|1V0P|B Chain B, Structure Of P. Falciparum Pfpk5-Purvalanol B Ligand
Complex
Length = 288
Score = 31.6 bits (70), Expect = 0.73, Method: Compositional matrix adjust.
Identities = 21/78 (26%), Positives = 38/78 (48%), Gaps = 8/78 (10%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDE-----FFNEVNLISSIEHKNLVK 331
+K+G+G G VY G T A+K++ DE E++++ ++H N+VK
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKE---DEGIPSTTIREISILKELKHSNIVK 64
Query: 332 LLGCSIEGPESLLVYEYV 349
L +LV+E++
Sbjct: 65 LYDVIHTKKRLVLVFEHL 82
>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992
Length = 330
Score = 31.6 bits (70), Expect = 0.73, Method: Compositional matrix adjust.
Identities = 20/68 (29%), Positives = 34/68 (50%), Gaps = 6/68 (8%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-----EFFNEVNLISSIEH 326
F K LG G G+VY G +P G V + I R+ E +E +++S+++
Sbjct: 20 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 327 KNLVKLLG 334
++ +LLG
Sbjct: 80 PHVCRLLG 87
>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 34-Jab
pdb|2ITW|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Afn941
pdb|2ITX|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Amp- Pnp
pdb|2ITY|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Iressa
pdb|2J6M|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Aee788
pdb|3POZ|A Chain A, Egfr Kinase Domain Complexed With Tak-285
Length = 327
Score = 31.6 bits (70), Expect = 0.73, Method: Compositional matrix adjust.
Identities = 20/68 (29%), Positives = 34/68 (50%), Gaps = 6/68 (8%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWV-----DEFFNEVNLISSIEH 326
F K LG G G+VY G +P G V + I R+ E +E +++S+++
Sbjct: 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 327 KNLVKLLG 334
++ +LLG
Sbjct: 77 PHVCRLLG 84
>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
pdb|4G5P|B Chain B, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
Length = 330
Score = 31.6 bits (70), Expect = 0.73, Method: Compositional matrix adjust.
Identities = 20/68 (29%), Positives = 34/68 (50%), Gaps = 6/68 (8%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWV-----DEFFNEVNLISSIEH 326
F K LG G G+VY G +P G V + I R+ E +E +++S+++
Sbjct: 20 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 327 KNLVKLLG 334
++ +LLG
Sbjct: 80 PHVCRLLG 87
>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
pdb|3IKA|B Chain B, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
Length = 331
Score = 31.6 bits (70), Expect = 0.73, Method: Compositional matrix adjust.
Identities = 20/68 (29%), Positives = 34/68 (50%), Gaps = 6/68 (8%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-----EFFNEVNLISSIEH 326
F K LG G G+VY G +P G V + I R+ E +E +++S+++
Sbjct: 21 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 327 KNLVKLLG 334
++ +LLG
Sbjct: 81 PHVCRLLG 88
>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor-
Gw572016
Length = 352
Score = 31.6 bits (70), Expect = 0.74, Method: Compositional matrix adjust.
Identities = 20/68 (29%), Positives = 34/68 (50%), Gaps = 6/68 (8%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWV-----DEFFNEVNLISSIEH 326
F K LG G G+VY G +P G V + I R+ E +E +++S+++
Sbjct: 42 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 101
Query: 327 KNLVKLLG 334
++ +LLG
Sbjct: 102 PHVCRLLG 109
>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate
Ligand Complex
pdb|1V0O|B Chain B, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate
Ligand Complex
Length = 288
Score = 31.6 bits (70), Expect = 0.74, Method: Compositional matrix adjust.
Identities = 21/78 (26%), Positives = 38/78 (48%), Gaps = 8/78 (10%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDE-----FFNEVNLISSIEHKNLVK 331
+K+G+G G VY G T A+K++ DE E++++ ++H N+VK
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKE---DEGIPSTTIREISILKELKHSNIVK 64
Query: 332 LLGCSIEGPESLLVYEYV 349
L +LV+E++
Sbjct: 65 LYDVIHTKKRLVLVFEHL 82
>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain
pdb|2GS6|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain In
Complex With An Atp Analog-Peptide Conjugate
pdb|2RF9|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RF9|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|3W2S|A Chain A, Egfr Kinase Domain With Compound4
Length = 330
Score = 31.6 bits (70), Expect = 0.74, Method: Compositional matrix adjust.
Identities = 20/68 (29%), Positives = 34/68 (50%), Gaps = 6/68 (8%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWV-----DEFFNEVNLISSIEH 326
F K LG G G+VY G +P G V + I R+ E +E +++S+++
Sbjct: 20 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 327 KNLVKLLG 334
++ +LLG
Sbjct: 80 PHVCRLLG 87
>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
pdb|4I24|B Chain B, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
Length = 329
Score = 31.6 bits (70), Expect = 0.74, Method: Compositional matrix adjust.
Identities = 20/68 (29%), Positives = 34/68 (50%), Gaps = 6/68 (8%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWV-----DEFFNEVNLISSIEH 326
F K LG G G+VY G +P G V + I R+ E +E +++S+++
Sbjct: 19 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 327 KNLVKLLG 334
++ +LLG
Sbjct: 79 PHVCRLLG 86
>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5
pdb|1V0B|B Chain B, Crystal Structure Of The T198a Mutant Of Pfpk5
Length = 288
Score = 31.6 bits (70), Expect = 0.74, Method: Compositional matrix adjust.
Identities = 21/78 (26%), Positives = 38/78 (48%), Gaps = 8/78 (10%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDE-----FFNEVNLISSIEHKNLVK 331
+K+G+G G VY G T A+K++ DE E++++ ++H N+VK
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKE---DEGIPSTTIREISILKELKHSNIVK 64
Query: 332 LLGCSIEGPESLLVYEYV 349
L +LV+E++
Sbjct: 65 LYDVIHTKKRLVLVFEHL 82
>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|B Chain B, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|C Chain C, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|D Chain D, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|E Chain E, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|F Chain F, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|G Chain G, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|H Chain H, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
Length = 327
Score = 31.6 bits (70), Expect = 0.74, Method: Compositional matrix adjust.
Identities = 20/68 (29%), Positives = 34/68 (50%), Gaps = 6/68 (8%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWV-----DEFFNEVNLISSIEH 326
F K LG G G+VY G +P G V + I R+ E +E +++S+++
Sbjct: 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 327 KNLVKLLG 334
++ +LLG
Sbjct: 77 PHVCRLLG 84
>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In
Complex With Dacomitinib (soaked)
Length = 329
Score = 31.6 bits (70), Expect = 0.75, Method: Compositional matrix adjust.
Identities = 20/68 (29%), Positives = 34/68 (50%), Gaps = 6/68 (8%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWV-----DEFFNEVNLISSIEH 326
F K LG G G+VY G +P G V + I R+ E +E +++S+++
Sbjct: 19 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 327 KNLVKLLG 334
++ +LLG
Sbjct: 79 PHVCRLLG 86
>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant
Length = 262
Score = 31.6 bits (70), Expect = 0.75, Method: Compositional matrix adjust.
Identities = 19/82 (23%), Positives = 36/82 (43%), Gaps = 4/82 (4%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWV----DEFFNEVNLISSIEHKN 328
F + LG+G G+VY+ + +++F + + EV + S + H N
Sbjct: 7 FEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 66
Query: 329 LVKLLGCSIEGPESLLVYEYVP 350
+++L G + L+ EY P
Sbjct: 67 ILRLYGYFHDATRVYLILEYAP 88
>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human
Tbk1 Kinase- Uld Domain
pdb|4EUT|B Chain B, Structure Of Bx-795 Complexed With Unphosphorylated Human
Tbk1 Kinase- Uld Domain
Length = 396
Score = 31.6 bits (70), Expect = 0.76, Method: Compositional matrix adjust.
Identities = 27/85 (31%), Positives = 39/85 (45%), Gaps = 8/85 (9%)
Query: 276 SKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW---VDEFFNEVNLISSIEHKNLVK 331
S LGQG +V+ G G A+K +FN + VD E ++ + HKN+VK
Sbjct: 14 SDILGQGATANVFRGRHKKTGDLFAIK--VFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 332 LLGCSIEGP--ESLLVYEYVPNRSL 354
L E +L+ E+ P SL
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSL 96
>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase
Domain Phosphorylated On Ser172
pdb|4EUU|B Chain B, Structure Of Bx-795 Complexed With Human Tbk1 Kinase
Domain Phosphorylated On Ser172
Length = 319
Score = 31.6 bits (70), Expect = 0.76, Method: Compositional matrix adjust.
Identities = 27/85 (31%), Positives = 39/85 (45%), Gaps = 8/85 (9%)
Query: 276 SKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW---VDEFFNEVNLISSIEHKNLVK 331
S LGQG +V+ G G A+K +FN + VD E ++ + HKN+VK
Sbjct: 14 SDILGQGATANVFRGRHKKTGDLFAIK--VFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 332 LLGCSIEGP--ESLLVYEYVPNRSL 354
L E +L+ E+ P SL
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSL 96
>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
pdb|2JIV|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
Length = 328
Score = 31.6 bits (70), Expect = 0.78, Method: Compositional matrix adjust.
Identities = 20/68 (29%), Positives = 34/68 (50%), Gaps = 6/68 (8%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWV-----DEFFNEVNLISSIEH 326
F K LG G G+VY G +P G V + I R+ E +E +++S+++
Sbjct: 18 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 327 KNLVKLLG 334
++ +LLG
Sbjct: 78 PHVCRLLG 85
>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 13-Jab
Length = 327
Score = 31.6 bits (70), Expect = 0.78, Method: Compositional matrix adjust.
Identities = 20/68 (29%), Positives = 34/68 (50%), Gaps = 6/68 (8%)
Query: 273 FNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWV-----DEFFNEVNLISSIEH 326
F K LG G G+VY G +P G V + I R+ E +E +++S+++
Sbjct: 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 327 KNLVKLLG 334
++ +LLG
Sbjct: 77 PHVCRLLG 84
>pdb|2UV2|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To
4-(4-(
5-Cyclopropyl-1h-Pyrazol-3-Ylamino)-Quinazolin-2-
Ylamino)- Phenyl)-Acetonitrile
Length = 287
Score = 31.6 bits (70), Expect = 0.79, Method: Compositional matrix adjust.
Identities = 19/74 (25%), Positives = 39/74 (52%), Gaps = 5/74 (6%)
Query: 267 EKATNYFNPS---KKLGQ-GGAGSVYMGSLPNGTTVAVKRLI-FNTRQWVDEFFNEVNLI 321
E T NP + +G+ G G VY + +A ++I + + ++++ E++++
Sbjct: 2 EHVTRDLNPEDFWEIIGELGDFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDIL 61
Query: 322 SSIEHKNLVKLLGC 335
+S +H N+VKLL
Sbjct: 62 ASCDHPNIVKLLDA 75
>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796
pdb|3NPC|B Chain B, Crystal Structure Of Jnk2 Complexed With Birb796
Length = 364
Score = 31.2 bits (69), Expect = 0.85, Method: Compositional matrix adjust.
Identities = 27/113 (23%), Positives = 49/113 (43%), Gaps = 21/113 (18%)
Query: 254 MKKSCLSFKYETLEKATNYFNPSKKLGQ-----GGAGSVYMGSLPN--GTTVAVKRL--I 304
M KS + ++ ++E A + F K+ Q GA + + G VAVK+L
Sbjct: 1 MSKSKVDNQFYSVEVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRP 60
Query: 305 FNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF 357
F + + E+ L+ + HKN++ LL + P ++L++F
Sbjct: 61 FQNQTHAKRAYRELVLLKCVNHKNIISLLNV------------FTPQKTLEEF 101
>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3EYH|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 290
Score = 31.2 bits (69), Expect = 0.92, Method: Compositional matrix adjust.
Identities = 25/93 (26%), Positives = 48/93 (51%), Gaps = 8/93 (8%)
Query: 277 KKLGQGGAGSVYMGSLP-----NGTTVAVKRLIFNTR-QWVDEFFNEVNLISSIEHKNLV 330
+ LG+G G V + G VAVK L + + + E+ ++ ++ H+N+V
Sbjct: 15 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 74
Query: 331 KLLG-CSIEGPESL-LVYEYVPNRSLDQFIFGN 361
K G C+ +G + L+ E++P+ SL +++ N
Sbjct: 75 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN 107
>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine-
Threonine Kinase
Length = 297
Score = 31.2 bits (69), Expect = 0.92, Method: Compositional matrix adjust.
Identities = 20/82 (24%), Positives = 38/82 (46%), Gaps = 4/82 (4%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
F + LG+G G+VY+ + +++F + V+ + EV + S + H N
Sbjct: 27 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 86
Query: 329 LVKLLGCSIEGPESLLVYEYVP 350
+++L G + L+ EY P
Sbjct: 87 ILRLYGYFHDATRVYLILEYAP 108
>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed
With Compound 16
Length = 271
Score = 31.2 bits (69), Expect = 0.93, Method: Compositional matrix adjust.
Identities = 24/86 (27%), Positives = 40/86 (46%), Gaps = 5/86 (5%)
Query: 279 LGQGGAGSVYMGSLPNGTTVAVKRLIFNT----RQWVDEFFNEVNLISSIEHKNLVKLLG 334
+G GG G VY + G VAVK + Q ++ E L + ++H N++ L G
Sbjct: 15 IGIGGFGKVYR-AFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 335 CSIEGPESLLVYEYVPNRSLDQFIFG 360
++ P LV E+ L++ + G
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVLSG 99
>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|E Chain E, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|D Chain D, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4N|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E4N|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E5W|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4E5W|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4EHZ|A Chain A, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|B Chain B, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|C Chain C, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|D Chain D, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EI4|A Chain A, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4EI4|B Chain B, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4FK6|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
pdb|4FK6|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
Length = 302
Score = 31.2 bits (69), Expect = 0.96, Method: Compositional matrix adjust.
Identities = 25/93 (26%), Positives = 48/93 (51%), Gaps = 8/93 (8%)
Query: 277 KKLGQGGAGSVYMGSLP-----NGTTVAVKRLIFNTR-QWVDEFFNEVNLISSIEHKNLV 330
+ LG+G G V + G VAVK L + + + E+ ++ ++ H+N+V
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 331 KLLG-CSIEGPESL-LVYEYVPNRSLDQFIFGN 361
K G C+ +G + L+ E++P+ SL +++ N
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN 119
>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The
Murine Receptor Tyrosine Kinase Tyro3 (Sky)
Length = 323
Score = 30.8 bits (68), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 27/115 (23%), Positives = 47/115 (40%), Gaps = 12/115 (10%)
Query: 259 LSFKYETLEKATNYFNPSKKLGQGGAGSVYMGSLPNG----TTVAVKRLIFN--TRQWVD 312
L K E + F + LG+G GSV L VAVK L + ++
Sbjct: 11 LKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIE 70
Query: 313 EFFNEVNLISSIEHKNLVKLLGCSIEG------PESLLVYEYVPNRSLDQFIFGN 361
EF E + +H ++ KL+G S+ P +++ ++ + L F+ +
Sbjct: 71 EFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLAS 125
>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
pdb|3P23|B Chain B, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
pdb|3P23|C Chain C, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
pdb|3P23|D Chain D, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
Length = 432
Score = 30.8 bits (68), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 19/60 (31%), Positives = 30/60 (50%), Gaps = 4/60 (6%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLI-SSIEHKNLVK 331
F P LG G G++ + + VAVKR++ + D EV L+ S EH N+++
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD---REVQLLRESDEHPNVIR 82
>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With
Ind E804
Length = 324
Score = 30.8 bits (68), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 27/84 (32%), Positives = 44/84 (52%), Gaps = 5/84 (5%)
Query: 278 KLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVD-EFFNEVNLISSIEHKNLVKLLGC 335
KLG+G +VY G S VA+K + + EV+L+ ++H N+V L
Sbjct: 9 KLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 336 SIEGPESL-LVYEYVPNRSLDQFI 358
I +SL LV+EY+ ++ L Q++
Sbjct: 69 -IHTEKSLTLVFEYL-DKDLKQYL 90
>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|B Chain B, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|C Chain C, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|D Chain D, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|E Chain E, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|F Chain F, Aurora-2 T287d T288d Complexed With Pha-680632
Length = 306
Score = 30.8 bits (68), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 20/82 (24%), Positives = 38/82 (46%), Gaps = 4/82 (4%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
F + LG+G G+VY+ + +++F + V+ + EV + S + H N
Sbjct: 36 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 95
Query: 329 LVKLLGCSIEGPESLLVYEYVP 350
+++L G + L+ EY P
Sbjct: 96 ILRLYGYFHDATRVYLILEYAP 117
>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626
pdb|2J4Z|B Chain B, Structure Of Aurora-2 In Complex With Pha-680626
Length = 306
Score = 30.8 bits (68), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 20/82 (24%), Positives = 38/82 (46%), Gaps = 4/82 (4%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
F + LG+G G+VY+ + +++F + V+ + EV + S + H N
Sbjct: 36 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 95
Query: 329 LVKLLGCSIEGPESLLVYEYVP 350
+++L G + L+ EY P
Sbjct: 96 ILRLYGYFHDATRVYLILEYAP 117
>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain
Kinase Loc340156.
pdb|2X4F|B Chain B, The Crystal Structure Of The Human Myosin Light Chain
Kinase Loc340156
Length = 373
Score = 30.4 bits (67), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 24/74 (32%), Positives = 37/74 (50%), Gaps = 5/74 (6%)
Query: 279 LGQGGAGSVYM-GSLPNGTTVAVKRLIFNTRQWVD--EFFNEVNLISSIEHKNLVKLLGC 335
LG G G V+ G +A K I TR D E NE+++++ ++H NL++L
Sbjct: 97 LGGGRFGQVHKCEETATGLKLAAK--IIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDA 154
Query: 336 SIEGPESLLVYEYV 349
+ +LV EYV
Sbjct: 155 FESKNDIVLVMEYV 168
>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)
pdb|3CBL|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (v- Fes) In Complex With Staurosporine And A
Consensus Peptide
pdb|4E93|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)in Complex With Tae684
Length = 377
Score = 30.4 bits (67), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 22/79 (27%), Positives = 39/79 (49%), Gaps = 10/79 (12%)
Query: 277 KKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVD-----EFFNEVNLISSIEHKNLV 330
+++G+G G V+ G L + T VAVK + R+ + +F E ++ H N+V
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVK----SCRETLPPDLKAKFLQEARILKQYSHPNIV 175
Query: 331 KLLGCSIEGPESLLVYEYV 349
+L+G + +V E V
Sbjct: 176 RLIGVCTQKQPIYIVMELV 194
>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase
Domain Of The Human Epidermal Growth Factor Receptor 3
(Her3)
pdb|3KEX|B Chain B, Crystal Structure Of The Catalytically Inactive Kinase
Domain Of The Human Epidermal Growth Factor Receptor 3
(Her3)
Length = 325
Score = 30.4 bits (67), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 26/84 (30%), Positives = 44/84 (52%), Gaps = 7/84 (8%)
Query: 277 KKLGQGGAGSVYMGS-LPNGTTVAVK---RLIFNT--RQWVDEFFNEVNLISSIEHKNLV 330
K LG G G+V+ G +P G ++ + ++I + RQ + + I S++H ++V
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 331 KLLGCSIEGPESLLVYEYVPNRSL 354
+LLG G LV +Y+P SL
Sbjct: 79 RLLGLC-PGSSLQLVTQYLPLGSL 101
>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma
Viral Oncogene Homologue (V-Fes) In Complex With
Staurosporine And A Consensus Peptide
Length = 377
Score = 30.4 bits (67), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 22/79 (27%), Positives = 39/79 (49%), Gaps = 10/79 (12%)
Query: 277 KKLGQGGAGSVYMGSL-PNGTTVAVKRLIFNTRQWVD-----EFFNEVNLISSIEHKNLV 330
+++G+G G V+ G L + T VAVK + R+ + +F E ++ H N+V
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVK----SCRETLPPDLKAKFLQEARILKQYSHPNIV 175
Query: 331 KLLGCSIEGPESLLVYEYV 349
+L+G + +V E V
Sbjct: 176 RLIGVCTQKQPIYIVMELV 194
>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex.
pdb|2A19|C Chain C, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex.
pdb|2A1A|B Chain B, Pkr Kinase Domain-Eif2alpha Complex
Length = 284
Score = 30.0 bits (66), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 17/58 (29%), Positives = 30/58 (51%), Gaps = 5/58 (8%)
Query: 279 LGQGGAGSVYMGSLP-NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
+G GG G V+ +G T +KR+ +N ++ EV ++ ++H N+V GC
Sbjct: 19 IGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGC 72
>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex
With Amp-Pnp
pdb|3LMG|B Chain B, Crystal Structure Of The Erbb3 Kinase Domain In Complex
With Amp-Pnp
Length = 344
Score = 30.0 bits (66), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 26/84 (30%), Positives = 44/84 (52%), Gaps = 7/84 (8%)
Query: 277 KKLGQGGAGSVYMGS-LPNGTTVAVK---RLIFNT--RQWVDEFFNEVNLISSIEHKNLV 330
K LG G G+V+ G +P G ++ + ++I + RQ + + I S++H ++V
Sbjct: 37 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 331 KLLGCSIEGPESLLVYEYVPNRSL 354
+LLG G LV +Y+P SL
Sbjct: 97 RLLGLC-PGSSLQLVTQYLPLGSL 119
>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp
Length = 298
Score = 30.0 bits (66), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 28/90 (31%), Positives = 43/90 (47%), Gaps = 8/90 (8%)
Query: 276 SKKLGQGGAGSVYMGSL----PNGTTVAVKRLIFNTR-QWVDEFFNEVNLISSIEHKNLV 330
+ +G+G G VY G N A+K L T Q V+ F E L+ + H N++
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 331 KLLGCSIEGPESL--LVYEYVPNRSLDQFI 358
L+G + PE L ++ Y+ + L QFI
Sbjct: 86 ALIGIMLP-PEGLPHVLLPYMCHGDLLQFI 114
>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In
Complex With Staurosporine
pdb|3S95|B Chain B, Crystal Structure Of The Human Limk1 Kinase Domain In
Complex With Staurosporine
Length = 310
Score = 30.0 bits (66), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 20/81 (24%), Positives = 37/81 (45%), Gaps = 1/81 (1%)
Query: 279 LGQGGAG-SVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGCSI 337
LG+G G ++ + G + +K LI + F EV ++ +EH N++K +G
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 338 EGPESLLVYEYVPNRSLDQFI 358
+ + EY+ +L I
Sbjct: 78 KDKRLNFITEYIKGGTLRGII 98
>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A
Pyrimidinopyridone Inhibitor
Length = 333
Score = 30.0 bits (66), Expect = 2.4, Method: Compositional matrix adjust.
Identities = 29/95 (30%), Positives = 41/95 (43%), Gaps = 12/95 (12%)
Query: 264 ETLEKATNYFNPSKKLGQGGAGSVY------MGSLPNGTTVAVKRLIFNTRQWVDE---F 314
E E N K LG G G V +G VAVK L + DE
Sbjct: 39 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML--KSTAHADEKEAL 96
Query: 315 FNEVNLISSI-EHKNLVKLLGCSIEGPESLLVYEY 348
+E+ ++S + +H+N+V LLG G L++ EY
Sbjct: 97 MSELKIMSHLGQHENIVNLLGACTHGGPVLVITEY 131
>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase
Domain
Length = 317
Score = 30.0 bits (66), Expect = 2.4, Method: Compositional matrix adjust.
Identities = 29/95 (30%), Positives = 41/95 (43%), Gaps = 12/95 (12%)
Query: 264 ETLEKATNYFNPSKKLGQGGAGSVY------MGSLPNGTTVAVKRLIFNTRQWVDE---F 314
E E N K LG G G V +G VAVK L + DE
Sbjct: 31 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML--KSTAHADEKEAL 88
Query: 315 FNEVNLISSI-EHKNLVKLLGCSIEGPESLLVYEY 348
+E+ ++S + +H+N+V LLG G L++ EY
Sbjct: 89 MSELKIMSHLGQHENIVNLLGACTHGGPVLVITEY 123
>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An
Arylamide Inhibitor
Length = 333
Score = 30.0 bits (66), Expect = 2.4, Method: Compositional matrix adjust.
Identities = 29/95 (30%), Positives = 41/95 (43%), Gaps = 12/95 (12%)
Query: 264 ETLEKATNYFNPSKKLGQGGAGSVY------MGSLPNGTTVAVKRLIFNTRQWVDE---F 314
E E N K LG G G V +G VAVK L + DE
Sbjct: 39 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML--KSTAHADEKEAL 96
Query: 315 FNEVNLISSI-EHKNLVKLLGCSIEGPESLLVYEY 348
+E+ ++S + +H+N+V LLG G L++ EY
Sbjct: 97 MSELKIMSHLGQHENIVNLLGACTHGGPVLVITEY 131
>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain
Of Csf-1r
Length = 329
Score = 29.6 bits (65), Expect = 2.5, Method: Compositional matrix adjust.
Identities = 29/95 (30%), Positives = 41/95 (43%), Gaps = 12/95 (12%)
Query: 264 ETLEKATNYFNPSKKLGQGGAGSVY------MGSLPNGTTVAVKRLIFNTRQWVDE---F 314
E E N K LG G G V +G VAVK L + DE
Sbjct: 39 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML--KSTAHADEKEAL 96
Query: 315 FNEVNLISSI-EHKNLVKLLGCSIEGPESLLVYEY 348
+E+ ++S + +H+N+V LLG G L++ EY
Sbjct: 97 MSELKIMSHLGQHENIVNLLGACTHGGPVLVITEY 131
>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase
Domain Of Csf-1r
Length = 324
Score = 29.6 bits (65), Expect = 2.6, Method: Compositional matrix adjust.
Identities = 29/95 (30%), Positives = 41/95 (43%), Gaps = 12/95 (12%)
Query: 264 ETLEKATNYFNPSKKLGQGGAGSVY------MGSLPNGTTVAVKRLIFNTRQWVDE---F 314
E E N K LG G G V +G VAVK L + DE
Sbjct: 24 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML--KSTAHADEKEAL 81
Query: 315 FNEVNLISSI-EHKNLVKLLGCSIEGPESLLVYEY 348
+E+ ++S + +H+N+V LLG G L++ EY
Sbjct: 82 MSELKIMSHLGQHENIVNLLGACTHGGPVLVITEY 116
>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2
pdb|3E7O|B Chain B, Crystal Structure Of Jnk2
Length = 360
Score = 29.6 bits (65), Expect = 2.9, Method: Compositional matrix adjust.
Identities = 22/84 (26%), Positives = 36/84 (42%), Gaps = 15/84 (17%)
Query: 277 KKLGQGGAGSVYMG-SLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVKLL 333
K +G G G V G VAVK+L F + + E+ L+ + HKN++ LL
Sbjct: 28 KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 87
Query: 334 GCSIEGPESLLVYEYVPNRSLDQF 357
+ P ++L++F
Sbjct: 88 NV------------FTPQKTLEEF 99
>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain
pdb|3UIU|B Chain B, Crystal Structure Of Apo-Pkr Kinase Domain
Length = 306
Score = 29.3 bits (64), Expect = 3.3, Method: Compositional matrix adjust.
Identities = 16/58 (27%), Positives = 29/58 (50%), Gaps = 5/58 (8%)
Query: 279 LGQGGAGSVYMGSLP-NGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLGC 335
+G GG G V+ +G T ++R+ +N + EV ++ ++H N+V GC
Sbjct: 20 IGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAE----REVKALAKLDHVNIVHYNGC 73
>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone
Inhibitor
pdb|2I0Y|A Chain A, Cfms Tyrosine Kinase (Fgf Kid) In Complex With An
Arylamide Inhibitor
pdb|3DPK|A Chain A, Cfms Tyrosine Kinase In Complex With A Pyridopyrimidinone
Inhibitor
pdb|3KRJ|A Chain A, Cfms Tyrosine Kinase In Complex With
4-Cyano-1h-Imidazole-2-Carboxylic Acid
(2-Cyclohex-1-Enyl-4-Piperidin-4-Yl-Phenyl)-Amide
pdb|3KRL|A Chain A, Cfms Tyrosine Kinase In Complex With
5-Cyano-Furan-2-Carboxylic Acid
[4-(4-Methyl-Piperazin-1-Yl)-2-Piperidin-1-Yl-Phenyl]-
Amide
Length = 335
Score = 29.3 bits (64), Expect = 3.8, Method: Compositional matrix adjust.
Identities = 29/95 (30%), Positives = 41/95 (43%), Gaps = 12/95 (12%)
Query: 264 ETLEKATNYFNPSKKLGQGGAGSVY------MGSLPNGTTVAVKRLIFNTRQWVDE---F 314
E E N K LG G G V +G VAVK L + DE
Sbjct: 39 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML--KSTAHADEKEAL 96
Query: 315 FNEVNLISSI-EHKNLVKLLGCSIEGPESLLVYEY 348
+E+ ++S + +H+N+V LLG G L++ EY
Sbjct: 97 MSELKIMSHLGQHENIVNLLGACTHGGPVLVITEY 131
>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain
pdb|4AGU|B Chain B, Crystal Structure Of The Human Cdkl1 Kinase Domain
pdb|4AGU|C Chain C, Crystal Structure Of The Human Cdkl1 Kinase Domain
Length = 311
Score = 29.3 bits (64), Expect = 4.1, Method: Compositional matrix adjust.
Identities = 21/74 (28%), Positives = 36/74 (48%), Gaps = 3/74 (4%)
Query: 278 KLGQGGAGSVYM-GSLPNGTTVAVKRLIFNTRQWVDE--FFNEVNLISSIEHKNLVKLLG 334
K+G+G G V+ + G VA+K+ + + V + E+ ++ ++H NLV LL
Sbjct: 10 KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 335 CSIEGPESLLVYEY 348
LV+EY
Sbjct: 70 VFRRKRRLHLVFEY 83
>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880
(Gsk1
Length = 302
Score = 28.9 bits (63), Expect = 4.3, Method: Compositional matrix adjust.
Identities = 30/94 (31%), Positives = 48/94 (51%), Gaps = 10/94 (10%)
Query: 272 YFNPSKKLGQGGAGSVYMGSL--PNGTTV--AVKRL--IFNTRQWVDEFFNEVNLISSIE 325
+FN + +G+G G VY G+L +G + AVK L I + + V +F E ++
Sbjct: 31 HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFLTEGIIMKDFS 87
Query: 326 HKNLVKLLGCSIEGPES-LLVYEYVPNRSLDQFI 358
H N++ LLG + S L+V Y+ + L FI
Sbjct: 88 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 121
>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex
pdb|1H4L|B Chain B, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex
Length = 292
Score = 28.9 bits (63), Expect = 4.3, Method: Compositional matrix adjust.
Identities = 26/93 (27%), Positives = 43/93 (46%), Gaps = 19/93 (20%)
Query: 262 KYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQWVDE-----FF 315
KYE LEK +G+G G+V+ + VA+KR+ + DE
Sbjct: 3 KYEKLEK----------IGEGTYGTVFKAKNRETHEIVALKRVRLDDD---DEGVPSSAL 49
Query: 316 NEVNLISSIEHKNLVKLLGCSIEGPESLLVYEY 348
E+ L+ ++HKN+V+L + LV+E+
Sbjct: 50 REICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82
>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor
pdb|3F66|B Chain B, Human C-Met Kinase In Complex With Quinoxaline Inhibitor
Length = 298
Score = 28.9 bits (63), Expect = 4.4, Method: Compositional matrix adjust.
Identities = 30/94 (31%), Positives = 48/94 (51%), Gaps = 10/94 (10%)
Query: 272 YFNPSKKLGQGGAGSVYMGSL--PNGTTV--AVKRL--IFNTRQWVDEFFNEVNLISSIE 325
+FN + +G+G G VY G+L +G + AVK L I + + V +F E ++
Sbjct: 28 HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFLTEGIIMKDFS 84
Query: 326 HKNLVKLLGCSIEGPES-LLVYEYVPNRSLDQFI 358
H N++ LLG + S L+V Y+ + L FI
Sbjct: 85 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 118
>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain
Of C-Met
pdb|2WKM|A Chain A, X-Ray Structure Of Pha-00665752 Bound To The Kinase Domain
Of C-Met
pdb|3ZXZ|A Chain A, X-Ray Structure Of Pf-04217903 Bound To The Kinase Domain
Of C-Met
pdb|3ZZE|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
N'-
((3z)-4-Chloro-7-Methyl-2-Oxo-1,2-Dihydro-3h-Indol-3-
Ylidene)-2-(4-Hydroxyphenyl)propanohydrazide
pdb|4AOI|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
4-( 3-((1h-
Pyrrolo(2,3-B)pyridin-3-Yl)methyl)-(1,2,4)triazolo(
4,3-B)(1,2,4) Triazin-6-Yl)benzonitrile
pdb|4AP7|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
4-( (6-(4-
Fluorophenyl)-(1,2,4)triazolo(4,3-B)(1,2,
4)triazin-3-Yl)methyl) Phenol
Length = 306
Score = 28.9 bits (63), Expect = 4.4, Method: Compositional matrix adjust.
Identities = 30/94 (31%), Positives = 48/94 (51%), Gaps = 10/94 (10%)
Query: 272 YFNPSKKLGQGGAGSVYMGSL--PNGTTV--AVKRL--IFNTRQWVDEFFNEVNLISSIE 325
+FN + +G+G G VY G+L +G + AVK L I + + V +F E ++
Sbjct: 30 HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFLTEGIIMKDFS 86
Query: 326 HKNLVKLLGCSIEGPES-LLVYEYVPNRSLDQFI 358
H N++ LLG + S L+V Y+ + L FI
Sbjct: 87 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 120
>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor
Length = 292
Score = 28.9 bits (63), Expect = 4.4, Method: Compositional matrix adjust.
Identities = 30/94 (31%), Positives = 48/94 (51%), Gaps = 10/94 (10%)
Query: 272 YFNPSKKLGQGGAGSVYMGSL--PNGTTV--AVKRL--IFNTRQWVDEFFNEVNLISSIE 325
+FN + +G+G G VY G+L +G + AVK L I + + V +F E ++
Sbjct: 25 HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFLTEGIIMKDFS 81
Query: 326 HKNLVKLLGCSIEGPES-LLVYEYVPNRSLDQFI 358
H N++ LLG + S L+V Y+ + L FI
Sbjct: 82 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 115
>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase
pdb|3RHK|A Chain A, Crystal Structure Of The Catalytic Domain Of C-Met Kinase
In Complex With Arq 197
pdb|3RHK|B Chain B, Crystal Structure Of The Catalytic Domain Of C-Met Kinase
In Complex With Arq 197
Length = 318
Score = 28.9 bits (63), Expect = 4.5, Method: Compositional matrix adjust.
Identities = 30/94 (31%), Positives = 48/94 (51%), Gaps = 10/94 (10%)
Query: 272 YFNPSKKLGQGGAGSVYMGSL--PNGTTV--AVKRL--IFNTRQWVDEFFNEVNLISSIE 325
+FN + +G+G G VY G+L +G + AVK L I + + V +F E ++
Sbjct: 51 HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFLTEGIIMKDFS 107
Query: 326 HKNLVKLLGCSIEGPES-LLVYEYVPNRSLDQFI 358
H N++ LLG + S L+V Y+ + L FI
Sbjct: 108 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 141
>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor.
pdb|2RFN|B Chain B, X-ray Structure Of C-met With Inhibitor.
pdb|2RFS|A Chain A, X-Ray Structure Of Su11274 Bound To C-Met
pdb|3CCN|A Chain A, X-Ray Structure Of C-Met With Triazolopyridazine
Inhibitor.
pdb|3CD8|A Chain A, X-Ray Structure Of C-Met With Triazolopyridazine
Inhibitor.
pdb|3EFJ|A Chain A, Structure Of C-Met With Pyrimidone Inhibitor 7
pdb|3EFJ|B Chain B, Structure Of C-Met With Pyrimidone Inhibitor 7
pdb|3EFK|A Chain A, Structure Of C-Met With Pyrimidone Inhibitor 50
pdb|3EFK|B Chain B, Structure Of C-Met With Pyrimidone Inhibitor 50
Length = 310
Score = 28.9 bits (63), Expect = 4.7, Method: Compositional matrix adjust.
Identities = 30/94 (31%), Positives = 48/94 (51%), Gaps = 10/94 (10%)
Query: 272 YFNPSKKLGQGGAGSVYMGSL--PNGTTV--AVKRL--IFNTRQWVDEFFNEVNLISSIE 325
+FN + +G+G G VY G+L +G + AVK L I + + V +F E ++
Sbjct: 33 HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFLTEGIIMKDFS 89
Query: 326 HKNLVKLLGCSIEGPES-LLVYEYVPNRSLDQFI 358
H N++ LLG + S L+V Y+ + L FI
Sbjct: 90 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 123
>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Pyrrolotriazine Based Inhibitor
Length = 373
Score = 28.9 bits (63), Expect = 4.7, Method: Compositional matrix adjust.
Identities = 30/94 (31%), Positives = 48/94 (51%), Gaps = 10/94 (10%)
Query: 272 YFNPSKKLGQGGAGSVYMGSL--PNGTTV--AVKRL--IFNTRQWVDEFFNEVNLISSIE 325
+FN + +G+G G VY G+L +G + AVK L I + + V +F E ++
Sbjct: 92 HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFLTEGIIMKDFS 148
Query: 326 HKNLVKLLGCSIEGPES-LLVYEYVPNRSLDQFI 358
H N++ LLG + S L+V Y+ + L FI
Sbjct: 149 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 182
>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Aminopyridine Based Inhibitor
pdb|3CTJ|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Aminopyridine Based Inhibitor
pdb|3CE3|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Pyrrolopyridinepyridone Based Inhibitor
pdb|3F82|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
N-
(4-(2-Amino-3-Chloropyridin-4-Yloxy)-3-Fluorophenyl)-4-
Ethoxy-1-(4-Fluorophenyl)-2-Oxo-1,2-Dihydropyridine-3-
Carboxamide
pdb|3L8V|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepat Growth Factor Receptor C-Met In Complex With A
Biarylamine Inhibitor
Length = 314
Score = 28.9 bits (63), Expect = 4.9, Method: Compositional matrix adjust.
Identities = 30/94 (31%), Positives = 48/94 (51%), Gaps = 10/94 (10%)
Query: 272 YFNPSKKLGQGGAGSVYMGSL--PNGTTV--AVKRL--IFNTRQWVDEFFNEVNLISSIE 325
+FN + +G+G G VY G+L +G + AVK L I + + V +F E ++
Sbjct: 33 HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFLTEGIIMKDFS 89
Query: 326 HKNLVKLLGCSIEGPES-LLVYEYVPNRSLDQFI 358
H N++ LLG + S L+V Y+ + L FI
Sbjct: 90 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 123
>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor
pdb|4GG7|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor
Length = 319
Score = 28.9 bits (63), Expect = 4.9, Method: Compositional matrix adjust.
Identities = 30/94 (31%), Positives = 48/94 (51%), Gaps = 10/94 (10%)
Query: 272 YFNPSKKLGQGGAGSVYMGSL--PNGTTV--AVKRL--IFNTRQWVDEFFNEVNLISSIE 325
+FN + +G+G G VY G+L +G + AVK L I + + V +F E ++
Sbjct: 52 HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFLTEGIIMKDFS 108
Query: 326 HKNLVKLLGCSIEGPES-LLVYEYVPNRSLDQFI 358
H N++ LLG + S L+V Y+ + L FI
Sbjct: 109 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 142
>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine
Inhibitor 13
pdb|3U6H|A Chain A, Crystal Structure Of C-Met In Complex With Pyrazolone
Inhibitor 26
pdb|3U6I|A Chain A, Crystal Structure Of C-Met In Complex With Pyrazolone
Inhibitor 58a
pdb|4DEG|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridazine Inhibitor 2
pdb|4DEH|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridinone Inhibitor 3
pdb|4DEI|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridinone Inhibitor 24
Length = 309
Score = 28.9 bits (63), Expect = 4.9, Method: Compositional matrix adjust.
Identities = 30/94 (31%), Positives = 48/94 (51%), Gaps = 10/94 (10%)
Query: 272 YFNPSKKLGQGGAGSVYMGSL--PNGTTV--AVKRL--IFNTRQWVDEFFNEVNLISSIE 325
+FN + +G+G G VY G+L +G + AVK L I + + V +F E ++
Sbjct: 32 HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFLTEGIIMKDFS 88
Query: 326 HKNLVKLLGCSIEGPES-LLVYEYVPNRSLDQFI 358
H N++ LLG + S L+V Y+ + L FI
Sbjct: 89 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 122
>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1
pdb|3DKF|A Chain A, Sgx Clone 5698a65kfg1h1
Length = 317
Score = 28.9 bits (63), Expect = 4.9, Method: Compositional matrix adjust.
Identities = 30/94 (31%), Positives = 48/94 (51%), Gaps = 10/94 (10%)
Query: 272 YFNPSKKLGQGGAGSVYMGSL--PNGTTV--AVKRL--IFNTRQWVDEFFNEVNLISSIE 325
+FN + +G+G G VY G+L +G + AVK L I + + V +F E ++
Sbjct: 34 HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFLTEGIIMKDFS 90
Query: 326 HKNLVKLLGCSIEGPES-LLVYEYVPNRSLDQFI 358
H N++ LLG + S L+V Y+ + L FI
Sbjct: 91 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 124
>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972
pdb|3QTI|B Chain B, C-Met Kinase In Complex With Nvp-Bvu972
Length = 314
Score = 28.9 bits (63), Expect = 5.0, Method: Compositional matrix adjust.
Identities = 30/94 (31%), Positives = 48/94 (51%), Gaps = 10/94 (10%)
Query: 272 YFNPSKKLGQGGAGSVYMGSL--PNGTTV--AVKRL--IFNTRQWVDEFFNEVNLISSIE 325
+FN + +G+G G VY G+L +G + AVK L I + + V +F E ++
Sbjct: 33 HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFLTEGIIMKDFS 89
Query: 326 HKNLVKLLGCSIEGPES-LLVYEYVPNRSLDQFI 358
H N++ LLG + S L+V Y+ + L FI
Sbjct: 90 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 123
>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1
Length = 317
Score = 28.9 bits (63), Expect = 5.0, Method: Compositional matrix adjust.
Identities = 30/94 (31%), Positives = 48/94 (51%), Gaps = 10/94 (10%)
Query: 272 YFNPSKKLGQGGAGSVYMGSL--PNGTTV--AVKRL--IFNTRQWVDEFFNEVNLISSIE 325
+FN + +G+G G VY G+L +G + AVK L I + + V +F E ++
Sbjct: 34 HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFLTEGIIMKDFS 90
Query: 326 HKNLVKLLGCSIEGPES-LLVYEYVPNRSLDQFI 358
H N++ LLG + S L+V Y+ + L FI
Sbjct: 91 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 124
>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNG|B Chain B, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNH|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNH|B Chain B, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNL|A Chain A, Structural Mechanism For The Inhibition Of Cd5-P25 From
The Roscovitine, Aloisine And Indirubin.
pdb|1UNL|B Chain B, Structural Mechanism For The Inhibition Of Cd5-P25 From
The Roscovitine, Aloisine And Indirubin.
pdb|3O0G|A Chain A, Crystal Structure Of Cdk5:p25 In Complex With An Atp
Analogue
pdb|3O0G|B Chain B, Crystal Structure Of Cdk5:p25 In Complex With An Atp
Analogue
Length = 292
Score = 28.9 bits (63), Expect = 5.2, Method: Compositional matrix adjust.
Identities = 24/90 (26%), Positives = 41/90 (45%), Gaps = 13/90 (14%)
Query: 262 KYETLEKATNYFNPSKKLGQGGAGSVYMG-SLPNGTTVAVKRLIFNTRQW--VDEFFNEV 318
KYE LEK +G+G G+V+ + VA+KR+ + E+
Sbjct: 3 KYEKLEK----------IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREI 52
Query: 319 NLISSIEHKNLVKLLGCSIEGPESLLVYEY 348
L+ ++HKN+V+L + LV+E+
Sbjct: 53 CLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82
>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
The Microbial Alkaloid K-252a
pdb|1R1W|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met
Length = 312
Score = 28.9 bits (63), Expect = 5.2, Method: Compositional matrix adjust.
Identities = 30/94 (31%), Positives = 48/94 (51%), Gaps = 10/94 (10%)
Query: 272 YFNPSKKLGQGGAGSVYMGSL--PNGTTV--AVKRL--IFNTRQWVDEFFNEVNLISSIE 325
+FN + +G+G G VY G+L +G + AVK L I + + V +F E ++
Sbjct: 31 HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFLTEGIIMKDFS 87
Query: 326 HKNLVKLLGCSIEGPES-LLVYEYVPNRSLDQFI 358
H N++ LLG + S L+V Y+ + L FI
Sbjct: 88 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 121
>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The
Dually-Phosphorylated, Activated State
Length = 308
Score = 28.9 bits (63), Expect = 5.2, Method: Compositional matrix adjust.
Identities = 30/94 (31%), Positives = 48/94 (51%), Gaps = 10/94 (10%)
Query: 272 YFNPSKKLGQGGAGSVYMGSL--PNGTTV--AVKRL--IFNTRQWVDEFFNEVNLISSIE 325
+FN + +G+G G VY G+L +G + AVK L I + + V +F E ++
Sbjct: 33 HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFLTEGIIMKDFS 89
Query: 326 HKNLVKLLGCSIEGPES-LLVYEYVPNRSLDQFI 358
H N++ LLG + S L+V Y+ + L FI
Sbjct: 90 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 123
>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In
Complex With An Mk-2461 Analog With Specificity For The
Activated Receptor
pdb|3R7O|A Chain A, Structure Of Dually Phosphorylated C-Met Receptor Kinase
In Complex With An Mk-2461 Analog
Length = 307
Score = 28.9 bits (63), Expect = 5.3, Method: Compositional matrix adjust.
Identities = 30/94 (31%), Positives = 48/94 (51%), Gaps = 10/94 (10%)
Query: 272 YFNPSKKLGQGGAGSVYMGSL--PNGTTV--AVKRL--IFNTRQWVDEFFNEVNLISSIE 325
+FN + +G+G G VY G+L +G + AVK L I + + V +F E ++
Sbjct: 32 HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFLTEGIIMKDFS 88
Query: 326 HKNLVKLLGCSIEGPES-LLVYEYVPNRSLDQFI 358
H N++ LLG + S L+V Y+ + L FI
Sbjct: 89 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 122
>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With
6-Benzyloxyquinoline Inhibitor
Length = 319
Score = 28.9 bits (63), Expect = 5.4, Method: Compositional matrix adjust.
Identities = 30/94 (31%), Positives = 48/94 (51%), Gaps = 10/94 (10%)
Query: 272 YFNPSKKLGQGGAGSVYMGSL--PNGTTV--AVKRL--IFNTRQWVDEFFNEVNLISSIE 325
+FN + +G+G G VY G+L +G + AVK L I + + V +F E ++
Sbjct: 38 HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFLTEGIIMKDFS 94
Query: 326 HKNLVKLLGCSIEGPES-LLVYEYVPNRSLDQFI 358
H N++ LLG + S L+V Y+ + L FI
Sbjct: 95 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 128
>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7
pdb|1UA2|B Chain B, Crystal Structure Of Human Cdk7
pdb|1UA2|C Chain C, Crystal Structure Of Human Cdk7
pdb|1UA2|D Chain D, Crystal Structure Of Human Cdk7
Length = 346
Score = 28.5 bits (62), Expect = 5.5, Method: Compositional matrix adjust.
Identities = 24/93 (25%), Positives = 40/93 (43%), Gaps = 7/93 (7%)
Query: 279 LGQGGAGSVYMGSLPN-GTTVAVKRLIFNTRQWVDEFFN-----EVNLISSIEHKNLVKL 332
LG+G +VY N VA+K++ R + N E+ L+ + H N++ L
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 333 LGCSIEGPESLLVYEYVPNRSLDQFIFGNCLFL 365
L LV++++ L+ I N L L
Sbjct: 78 LDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVL 109
>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737
Length = 364
Score = 28.5 bits (62), Expect = 5.7, Method: Compositional matrix adjust.
Identities = 22/86 (25%), Positives = 37/86 (43%), Gaps = 19/86 (22%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
K +G G G V Y L VA+K+L F + + E+ L+ + HKN++
Sbjct: 30 KPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIIS 87
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF 357
LL + P ++L++F
Sbjct: 88 LLNV------------FTPQKTLEEF 101
>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 28.5 bits (62), Expect = 5.9, Method: Compositional matrix adjust.
Identities = 23/73 (31%), Positives = 35/73 (47%), Gaps = 4/73 (5%)
Query: 279 LGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVD---EFFNEVNLISSIEHKNLVKLLGC 335
LG+G AG V + ++ T AV I + ++ VD E+ + + H+N+VK G
Sbjct: 14 LGEGAAGEVQL-AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 336 SIEGPESLLVYEY 348
EG L EY
Sbjct: 73 RREGNIQYLFLEY 85
>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis
Length = 394
Score = 28.5 bits (62), Expect = 6.0, Method: Compositional matrix adjust.
Identities = 17/57 (29%), Positives = 30/57 (52%), Gaps = 6/57 (10%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFN-EVNLISSIEHKNLVKL 332
K +G G G V+ L VA+K+++ + R F N E+ ++ ++H N+V L
Sbjct: 46 KVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR-----FKNRELQIMRIVKHPNVVDL 97
>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571
Inhibition Of C-kit Tyrosine Kinase
Length = 313
Score = 28.5 bits (62), Expect = 6.1, Method: Compositional matrix adjust.
Identities = 28/81 (34%), Positives = 40/81 (49%), Gaps = 10/81 (12%)
Query: 277 KKLGQGGAGSVYMGSL------PNGTTVAVKRLIFNTRQWVDE-FFNEVNLISSI-EHKN 328
K LG G G V + TVAVK L + E +E+ ++S + H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 329 LVKLLG-CSIEGPESLLVYEY 348
+V LLG C+I GP +L++ EY
Sbjct: 89 IVNLLGACTIGGP-TLVITEY 108
>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774
Length = 355
Score = 28.5 bits (62), Expect = 6.5, Method: Compositional matrix adjust.
Identities = 22/86 (25%), Positives = 37/86 (43%), Gaps = 19/86 (22%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
K +G G G V Y L VA+K+L F + + E+ L+ + HKN++
Sbjct: 30 KPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIIS 87
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF 357
LL + P ++L++F
Sbjct: 88 LLNV------------FTPQKTLEEF 101
>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16
In Complex With Staurosporine
pdb|2BUJ|B Chain B, Crystal Structure Of The Human Serine-Threonine Kinase 16
In Complex With Staurosporine
Length = 317
Score = 28.5 bits (62), Expect = 6.6, Method: Compositional matrix adjust.
Identities = 17/59 (28%), Positives = 33/59 (55%), Gaps = 1/59 (1%)
Query: 277 KKLGQGGAGSV-YMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLISSIEHKNLVKLLG 334
+KLG+GG V + L +G A+KR++ + +Q +E E ++ H N+++L+
Sbjct: 35 QKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVA 93
>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor,
Sr- 3451
Length = 353
Score = 28.5 bits (62), Expect = 6.7, Method: Compositional matrix adjust.
Identities = 22/86 (25%), Positives = 37/86 (43%), Gaps = 19/86 (22%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
K +G G G V Y L VA+K+L F + + E+ L+ + HKN++
Sbjct: 30 KPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIIS 87
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF 357
LL + P ++L++F
Sbjct: 88 LLNV------------FTPQKTLEEF 101
>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk
Inhibitor For The Prevention Of Ischemia-Reperfusion
Injury
pdb|3TTI|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-930, An Orally
Active Anti-Fibrotic Jnk Inhibitor
Length = 464
Score = 28.1 bits (61), Expect = 7.4, Method: Compositional matrix adjust.
Identities = 22/86 (25%), Positives = 37/86 (43%), Gaps = 19/86 (22%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
K +G G G V Y L VA+K+L F + + E+ L+ + HKN++
Sbjct: 68 KPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 125
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF 357
LL + P ++L++F
Sbjct: 126 LLNV------------FTPQKTLEEF 139
>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex
pdb|1PKG|B Chain B, Structure Of A C-kit Kinase Product Complex
Length = 329
Score = 28.1 bits (61), Expect = 7.8, Method: Compositional matrix adjust.
Identities = 28/81 (34%), Positives = 40/81 (49%), Gaps = 10/81 (12%)
Query: 277 KKLGQGGAGSVYMGSL------PNGTTVAVKRLIFNTRQWVDE-FFNEVNLISSI-EHKN 328
K LG G G V + TVAVK L + E +E+ ++S + H N
Sbjct: 45 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 104
Query: 329 LVKLLG-CSIEGPESLLVYEY 348
+V LLG C+I GP +L++ EY
Sbjct: 105 IVNLLGACTIGGP-TLVITEY 124
>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571
Inhibition Of C- Kit Tyrosine Kinase
Length = 331
Score = 28.1 bits (61), Expect = 8.0, Method: Compositional matrix adjust.
Identities = 28/81 (34%), Positives = 40/81 (49%), Gaps = 10/81 (12%)
Query: 277 KKLGQGGAGSVYMGSL------PNGTTVAVKRLIFNTRQWVDE-FFNEVNLISSI-EHKN 328
K LG G G V + TVAVK L + E +E+ ++S + H N
Sbjct: 47 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 106
Query: 329 LVKLLG-CSIEGPESLLVYEY 348
+V LLG C+I GP +L++ EY
Sbjct: 107 IVNLLGACTIGGP-TLVITEY 126
>pdb|2BFX|A Chain A, Mechanism Of Aurora-B Activation By Incenp And Inhibition
By Hesperidin.
pdb|2BFX|B Chain B, Mechanism Of Aurora-B Activation By Incenp And Inhibition
By Hesperidin.
pdb|2VGP|A Chain A, Crystal Structure Of Aurora B Kinase In Complex With A
Aminothiazole Inhibitor
pdb|2VGP|B Chain B, Crystal Structure Of Aurora B Kinase In Complex With A
Aminothiazole Inhibitor
pdb|2VGO|A Chain A, Crystal Structure Of Aurora B Kinase In Complex With
Reversine Inhibitor
pdb|2VGO|B Chain B, Crystal Structure Of Aurora B Kinase In Complex With
Reversine Inhibitor
pdb|3ZTX|A Chain A, Aurora Kinase Selective Inhibitors Identified Using A
Taxol- Induced Checkpoint Sensitivity Screen.
pdb|3ZTX|B Chain B, Aurora Kinase Selective Inhibitors Identified Using A
Taxol- Induced Checkpoint Sensitivity Screen
Length = 284
Score = 28.1 bits (61), Expect = 8.1, Method: Compositional matrix adjust.
Identities = 17/86 (19%), Positives = 41/86 (47%), Gaps = 4/86 (4%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
F+ + LG+G G+VY+ + +++F + ++ V+ + E+ + S + H N
Sbjct: 16 FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 75
Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSL 354
++++ + L+ E+ P L
Sbjct: 76 ILRMYNYFHDRKRIYLMLEFAPRGEL 101
>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib
pdb|3G0F|B Chain B, Kit Kinase Domain Mutant D816h In Complex With Sunitinib
Length = 336
Score = 28.1 bits (61), Expect = 8.2, Method: Compositional matrix adjust.
Identities = 28/81 (34%), Positives = 40/81 (49%), Gaps = 10/81 (12%)
Query: 277 KKLGQGGAGSVYMGSL------PNGTTVAVKRLIFNTRQWVDE-FFNEVNLISSI-EHKN 328
K LG G G V + TVAVK L + E +E+ ++S + H N
Sbjct: 52 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 111
Query: 329 LVKLLG-CSIEGPESLLVYEY 348
+V LLG C+I GP +L++ EY
Sbjct: 112 IVNLLGACTIGGP-TLVITEY 131
>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib
Length = 336
Score = 28.1 bits (61), Expect = 8.2, Method: Compositional matrix adjust.
Identities = 28/81 (34%), Positives = 40/81 (49%), Gaps = 10/81 (12%)
Query: 277 KKLGQGGAGSVYMGSL------PNGTTVAVKRLIFNTRQWVDE-FFNEVNLISSI-EHKN 328
K LG G G V + TVAVK L + E +E+ ++S + H N
Sbjct: 52 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 111
Query: 329 LVKLLG-CSIEGPESLLVYEY 348
+V LLG C+I GP +L++ EY
Sbjct: 112 IVNLLGACTIGGP-TLVITEY 131
>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With
Mgamp-Pnp
Length = 423
Score = 28.1 bits (61), Expect = 8.4, Method: Compositional matrix adjust.
Identities = 22/86 (25%), Positives = 37/86 (43%), Gaps = 19/86 (22%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
K +G G G V Y L VA+K+L F + + E+ L+ + HKN++
Sbjct: 68 KPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 125
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF 357
LL + P ++L++F
Sbjct: 126 LLNV------------FTPQKTLEEF 139
>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439
pdb|2VRX|B Chain B, Structure Of Aurora B Kinase In Complex With Zm447439
Length = 285
Score = 28.1 bits (61), Expect = 8.6, Method: Compositional matrix adjust.
Identities = 17/86 (19%), Positives = 41/86 (47%), Gaps = 4/86 (4%)
Query: 273 FNPSKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNT---RQWVD-EFFNEVNLISSIEHKN 328
F+ + LG+G G+VY+ + +++F + ++ V+ + E+ + S + H N
Sbjct: 17 FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 76
Query: 329 LVKLLGCSIEGPESLLVYEYVPNRSL 354
++++ + L+ E+ P L
Sbjct: 77 ILRMYNYFHDRKRIYLMLEFAPRGEL 102
>pdb|3A2E|A Chain A, Crystal Structure Of Ginkbilobin-2, The Novel Antifungal
Protein From Ginkgo Biloba Seeds
pdb|3A2E|B Chain B, Crystal Structure Of Ginkbilobin-2, The Novel Antifungal
Protein From Ginkgo Biloba Seeds
pdb|3A2E|C Chain C, Crystal Structure Of Ginkbilobin-2, The Novel Antifungal
Protein From Ginkgo Biloba Seeds
pdb|3A2E|D Chain D, Crystal Structure Of Ginkbilobin-2, The Novel Antifungal
Protein From Ginkgo Biloba Seeds
Length = 108
Score = 28.1 bits (61), Expect = 8.6, Method: Compositional matrix adjust.
Identities = 14/52 (26%), Positives = 25/52 (48%), Gaps = 1/52 (1%)
Query: 28 YALAQCHLDLSHTDCLLCFAASRTKL-PRCLPSLSATIFFDGCFLRYDIYSF 78
Y A C +S +DC C + ++ C ++ A + CF++Y+ SF
Sbjct: 57 YGRATCKQSISQSDCTACLSNLVNRIFSICNNAIGARVQLVDCFIQYEQRSF 108
>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|B Chain B, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|C Chain C, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|D Chain D, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|E Chain E, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|F Chain F, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
Length = 285
Score = 28.1 bits (61), Expect = 8.9, Method: Compositional matrix adjust.
Identities = 15/58 (25%), Positives = 30/58 (51%), Gaps = 2/58 (3%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWV--DEFFNEVNLISSIEHKNLVKL 332
+KLG G G V++ + V + I R V ++ E+ ++ S++H N++K+
Sbjct: 28 RKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKI 85
>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With
N-{3-Cyano-6-[3-(1-
Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2,
3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide
pdb|2O2U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With
N-(3-Cyano-4,5,6,7-
Tetrahydro-1-Benzothien-2-Yl)-2-Fluorobenzamide
pdb|2ZDT|A Chain A, Crystal Structure Of Human Jnk3 Complexed With An
Isoquinolone Inhibitor
pdb|2ZDU|A Chain A, Crystal Structure Of Human Jnk3 Complexed With An
Isoquinolone Inhibitor
pdb|3DA6|A Chain A, Crystal Structure Of Human Jnk3 Complexed With
N-(3-Methyl-
4-(3-(2-(Methylamino)pyrimidin-4-Yl)pyridin-2-Yloxy)
Naphthalen-1-Yl)-1h-Benzo[d]imidazol-2-Amine
pdb|2WAJ|A Chain A, Crystal Structure Of Human Jnk3 Complexed With A
1-Aryl-3,4- Dihydroisoquinoline Inhibitor
pdb|3V6R|A Chain A, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
pdb|3V6R|B Chain B, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
pdb|3V6S|A Chain A, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
pdb|3V6S|B Chain B, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
Length = 364
Score = 28.1 bits (61), Expect = 9.1, Method: Compositional matrix adjust.
Identities = 22/86 (25%), Positives = 37/86 (43%), Gaps = 19/86 (22%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
K +G G G V Y L VA+K+L F + + E+ L+ + HKN++
Sbjct: 30 KPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 87
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF 357
LL + P ++L++F
Sbjct: 88 LLNV------------FTPQKTLEEF 101
>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For
Catalysis And Regulation Of Non-conventional Splicing
pdb|2RIO|B Chain B, Structure Of The Dual Enzyme Ire1 Reveals The Basis For
Catalysis And Regulation Of Non-conventional Splicing
Length = 434
Score = 27.7 bits (60), Expect = 9.5, Method: Compositional matrix adjust.
Identities = 18/56 (32%), Positives = 31/56 (55%), Gaps = 4/56 (7%)
Query: 277 KKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLIS-SIEHKNLVK 331
K LG G +G+V G VAVKR++ + + D E+ L++ S +H N+++
Sbjct: 21 KILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIR 73
>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue
pdb|2PMN|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp-Site
Inhibitor
pdb|2PMO|X Chain X, Crystal Structure Of Pfpk7 In Complex With Hymenialdisine
Length = 348
Score = 27.7 bits (60), Expect = 9.5, Method: Compositional matrix adjust.
Identities = 14/46 (30%), Positives = 27/46 (58%)
Query: 312 DEFFNEVNLISSIEHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQF 357
D+F NE+ +I+ I+++ + G E ++YEY+ N S+ +F
Sbjct: 88 DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKF 133
>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562
Length = 364
Score = 27.7 bits (60), Expect = 9.6, Method: Compositional matrix adjust.
Identities = 22/86 (25%), Positives = 37/86 (43%), Gaps = 19/86 (22%)
Query: 277 KKLGQGGAGSV---YMGSLPNGTTVAVKRL--IFNTRQWVDEFFNEVNLISSIEHKNLVK 331
K +G G G V Y L VA+K+L F + + E+ L+ + HKN++
Sbjct: 30 KPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 87
Query: 332 LLGCSIEGPESLLVYEYVPNRSLDQF 357
LL + P ++L++F
Sbjct: 88 LLNV------------FTPQKTLEEF 101
>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin
pdb|3LJ0|B Chain B, Ire1 Complexed With Adp And Quercetin
pdb|3LJ1|A Chain A, Ire1 Complexed With Cdk12 INHIBITOR III
pdb|3LJ1|B Chain B, Ire1 Complexed With Cdk12 INHIBITOR III
pdb|3LJ2|A Chain A, Ire1 Complexed With Jak Inhibitor I
pdb|3LJ2|B Chain B, Ire1 Complexed With Jak Inhibitor I
Length = 434
Score = 27.7 bits (60), Expect = 9.8, Method: Compositional matrix adjust.
Identities = 18/57 (31%), Positives = 31/57 (54%), Gaps = 4/57 (7%)
Query: 276 SKKLGQGGAGSVYMGSLPNGTTVAVKRLIFNTRQWVDEFFNEVNLIS-SIEHKNLVK 331
K LG G +G+V G VAVKR++ + + D E+ L++ S +H N+++
Sbjct: 20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIR 73
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.324 0.138 0.419
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 10,261,306
Number of Sequences: 62578
Number of extensions: 406867
Number of successful extensions: 1481
Number of sequences better than 100.0: 453
Number of HSP's better than 100.0 without gapping: 187
Number of HSP's successfully gapped in prelim test: 266
Number of HSP's that attempted gapping in prelim test: 1200
Number of HSP's gapped (non-prelim): 454
length of query: 368
length of database: 14,973,337
effective HSP length: 100
effective length of query: 268
effective length of database: 8,715,537
effective search space: 2335763916
effective search space used: 2335763916
T: 11
A: 40
X1: 15 ( 7.0 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 40 (21.5 bits)
S2: 52 (24.6 bits)